https://trial.medpath.com/news/personalised-medicine-and-parp-inhibitors-transform-stage-iv-breast-cancer-outcomes-a-decade-of-progress-in-northern-ireland 2026-07-29T01:07:41+00:00 hourly 0.9 https://trial.medpath.com/news/spring-daylight-saving-time-linked-to-30-increased-risk-of-retinal-vascular-diseases-large-scale-study-finds 2026-07-29T00:53:00+00:00 hourly 0.9 https://trial.medpath.com/news/unr-med-and-renown-health-build-nevada-s-first-integrated-academic-health-system-expanding-clinical-trials-and-research-infrastructure 2026-07-28T22:12:37+00:00 hourly 0.9 https://trial.medpath.com/news/us-hiv-funding-cuts-slashed-new-patient-enrollment-59-across-east-africa-within-weeks 2026-07-28T22:12:36+00:00 hourly 0.9 https://trial.medpath.com/news/uw-health-launches-proton-therapy-program-for-cancer-patients-through-clinical-trial 2026-07-28T22:12:00+00:00 hourly 0.9 https://trial.medpath.com/news/fda-aacr-oncology-educational-fellowship-opens-applications-for-2026-2027-cohort 2026-07-28T22:11:35+00:00 hourly 0.9 https://trial.medpath.com/news/plant-proteins-that-imitate-fiber-reprogram-gut-microbes-to-favor-healthy-metabolites 2026-07-28T21:11:10+00:00 hourly 0.9 https://trial.medpath.com/news/centene-swings-to-1-1-billion-q2-profit-as-medical-costs-stabilize-and-aca-business-rebounds 2026-07-28T20:14:22+00:00 hourly 0.9 https://trial.medpath.com/news/mirae-launches-with-5-4m-to-bring-ai-driven-continuous-care-to-autoimmune-disease 2026-07-28T19:10:27+00:00 hourly 0.9 https://trial.medpath.com/news/belize-achieves-full-membership-in-who-programme-for-international-drug-monitoring 2026-07-28T19:09:34+00:00 hourly 0.9 https://trial.medpath.com/news/first-mrna-vaccine-for-elephants-shows-evidence-of-protection-against-deadly-eehv 2026-07-28T19:09:28+00:00 hourly 0.9 https://trial.medpath.com/news/genetic-makeup-may-determine-whether-low-carb-diets-raise-ldl-cholesterol 2026-07-28T18:07:12+00:00 hourly 0.9 https://trial.medpath.com/news/curebound-strengthens-leadership-with-three-key-executive-hires-to-accelerate-cancer-research 2026-07-28T18:01:00+00:00 hourly 0.9 https://trial.medpath.com/news/fda-lists-patent-for-hemiclor-12-5-mg-chlorthalidone-in-orange-book-securing-formulation-protection-through-2045 2026-07-28T17:12:37+00:00 hourly 0.9 https://trial.medpath.com/news/chinese-yeast-factory-boosts-cancer-drug-production-1000-times 2026-07-28T17:11:47+00:00 hourly 0.9 https://trial.medpath.com/news/rosie-o-donnell-details-slow-titration-mounjaro-regimen-reports-zero-side-effects-over-three-years 2026-07-28T17:11:40+00:00 hourly 0.9 https://trial.medpath.com/news/ono-pharmaceutical-partners-with-phylo-to-embed-agentic-ai-across-drug-discovery 2026-07-28T17:10:49+00:00 hourly 0.9 https://trial.medpath.com/news/agc-biologics-secures-multi-hundred-million-dollar-commercial-manufacturing-agreement-for-new-yokohama-site-ahead-of-2027-opening 2026-07-28T17:08:33+00:00 hourly 0.9 https://trial.medpath.com/news/ich-e6-r3-reshapes-data-governance-accountability-across-sponsors-and-sites 2026-07-28T17:08:30+00:00 hourly 0.9 https://trial.medpath.com/news/human-specific-srgap2-gene-slows-microglia-maturation-shedding-light-on-human-cognitive-evolution 2026-07-28T17:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/industrial-chicken-farming-drives-100-fold-increase-in-campylobacter-spread-oxford-study-finds 2026-07-28T17:07:07+00:00 hourly 0.9 https://trial.medpath.com/news/pfizer-s-hexavalent-gbs-vaccine-clears-phase-1-2-but-the-real-test-lies-in-defining-a-correlate-of-protection 2026-07-28T16:12:58+00:00 hourly 0.9 https://trial.medpath.com/news/treeline-biosciences-registers-first-in-human-phase-i-trial-of-bcl-xl-degrader-tln-499-combined-with-venetoclax-in-solid-tumors 2026-07-28T16:12:53+00:00 hourly 0.9 https://trial.medpath.com/news/cancer-costs-top-121000-annually-in-end-of-life-phase-acs-study-reveals-stark-stage-based-disparities 2026-07-28T16:12:31+00:00 hourly 0.9 https://trial.medpath.com/news/brainstorm-appoints-former-fda-associate-commissioner-peter-pitts-as-executive-chairman-to-lead-nurown-phase-3b-als-strategy 2026-07-28T16:12:05+00:00 hourly 0.9 https://trial.medpath.com/news/vcu-quest-fund-backs-venetoclax-tarlatamab-combination-study-in-small-cell-lung-cancer 2026-07-28T16:12:05+00:00 hourly 0.9 https://trial.medpath.com/news/amorphical-completes-full-enrollment-in-phase-2-trial-of-amor-1-for-hypoparathyroidism-data-readout-expected-q4-2026 2026-07-28T16:11:43+00:00 hourly 0.9 https://trial.medpath.com/news/epigenomics-market-poised-to-reach-69-6-billion-by-2034-on-15-2-cagr-driven-by-oncology-and-precision-medicine 2026-07-28T16:11:24+00:00 hourly 0.9 https://trial.medpath.com/news/uniquity-bio-appoints-jason-moore-as-svp-of-regulatory-quality-ahead-of-pivotal-solrikitug-data-readouts 2026-07-28T16:11:13+00:00 hourly 0.9 https://trial.medpath.com/news/firefly-neuroscience-and-next-health-launch-precision-cognitive-health-platform-following-fda-advisory-committee-recommendation-on-neuroprotective-peptides 2026-07-28T16:11:08+00:00 hourly 0.9 https://trial.medpath.com/news/nord-expands-rare-disease-centers-of-excellence-network-with-three-new-institutions 2026-07-28T16:11:05+00:00 hourly 0.9 https://trial.medpath.com/news/high-dose-vitamin-b3-offers-new-hope-for-children-with-rare-naxd-deficiency 2026-07-28T16:10:18+00:00 hourly 0.9 https://trial.medpath.com/news/state-drug-price-caps-fail-to-lower-patient-costs-and-threaten-rare-disease-access-new-raap-study-finds 2026-07-28T15:11:27+00:00 hourly 0.9 https://trial.medpath.com/news/landmark-gwas-of-2-5-million-individuals-reveals-26-genetic-risk-loci-for-fibromyalgia-implicating-nervous-system-origins 2026-07-28T15:11:14+00:00 hourly 0.9 https://trial.medpath.com/news/philogen-resubmits-nidlegy-marketing-application-to-ema-with-extended-phase-iii-melanoma-data 2026-07-28T15:11:04+00:00 hourly 0.9 https://trial.medpath.com/news/malaysia-registers-26-orphan-medicines-since-2020-as-rare-disease-list-reaches-529-conditions 2026-07-28T15:10:51+00:00 hourly 0.9 https://trial.medpath.com/news/sheba-medical-center-becomes-first-hospital-outside-the-u-s-to-adopt-openai-s-healthcare-ai-models 2026-07-28T15:09:48+00:00 hourly 0.9 https://trial.medpath.com/news/core-biomedicine-secures-21-million-series-a-and-eisai-licensing-deal-to-advance-lineage-based-precision-oncology-pipeline 2026-07-28T14:11:00+00:00 hourly 0.9 https://trial.medpath.com/news/cipla-secures-fda-approval-for-first-u-s-manufactured-generic-advair-diskus-across-all-three-strengths 2026-07-28T14:10:58+00:00 hourly 0.9 https://trial.medpath.com/news/promatix-biosciences-awarded-innovate-uk-grant-to-advance-first-in-class-egfr-x-epha2-cis-bispecific-adc 2026-07-28T14:10:52+00:00 hourly 0.9 https://trial.medpath.com/news/dasher-neuroscience-completes-patient-enrollment-in-phase-2-trial-of-ya-101-for-multiple-system-atrophy 2026-07-28T14:10:26+00:00 hourly 0.9 https://trial.medpath.com/news/kaist-develops-helical-polypeptide-nanoparticle-that-forces-cancer-cells-to-signal-their-own-destruction 2026-07-28T14:10:19+00:00 hourly 0.9 https://trial.medpath.com/news/stimulate-icp-largest-long-covid-trial-finds-specialist-care-reduces-fatigue-but-multi-organ-mri-adds-no-benefit 2026-07-28T11:07:47+00:00 hourly 0.9 https://trial.medpath.com/news/gate-2027-iit-madras-revises-biotechnology-syllabus-expands-two-paper-combinations 2026-07-28T10:10:18+00:00 hourly 0.9 https://trial.medpath.com/news/who-calls-for-urgent-action-on-hepatitis-as-hepatitis-d-remains-an-overlooked-threat 2026-07-28T09:08:10+00:00 hourly 0.9 https://trial.medpath.com/news/india-s-silent-rise-in-chronic-respiratory-diseases-spurs-ai-driven-remote-monitoring-innovation 2026-07-28T09:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/lepu-biopharma-and-astrazeneca-announce-positive-phase-iii-results-for-cmg901-in-advanced-gastric-cancer 2026-07-28T07:09:12+00:00 hourly 0.9 https://trial.medpath.com/news/kidney-biopsies-reveal-how-sglt2-inhibitor-dapagliflozin-protects-against-early-diabetic-kidney-disease-in-youth-with-type-1-diabetes 2026-07-28T05:07:25+00:00 hourly 0.9 https://trial.medpath.com/news/milvexian-fails-to-reduce-cardiovascular-events-after-acute-coronary-syndrome-in-librexia-acs-trial 2026-07-28T04:07:27+00:00 hourly 0.9 https://trial.medpath.com/news/in-person-navigation-outperforms-signposting-in-social-prescribing-trial-with-key-equity-gains-for-language-minorities 2026-07-28T02:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/j-j-secures-fda-510-k-clearance-for-monarch-quest-3-bronchoscopy-system 2026-07-28T00:26:00+00:00 hourly 0.9 https://trial.medpath.com/news/teen-cannabis-use-linked-to-slower-cognitive-growth-thc-identified-as-key-driver 2026-07-28T00:08:23+00:00 hourly 0.9 https://trial.medpath.com/news/researchers-develop-validated-scale-to-measure-generative-ai-addiction-in-undergraduate-students 2026-07-28T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/antioxidant-therapy-bypasses-genetic-defect-in-22q11-2-deletion-syndrome-via-alternative-gene-networks 2026-07-27T23:07:16+00:00 hourly 0.9 https://trial.medpath.com/news/report-calls-on-tiktok-to-shut-down-unregulated-glp-1-gray-market 2026-07-27T23:07:12+00:00 hourly 0.9 https://trial.medpath.com/news/fda-clears-johnson-johnson-s-ottava-robotic-assisted-surgery-system-marking-entry-into-surgical-robotics 2026-07-27T23:06:57+00:00 hourly 0.9 https://trial.medpath.com/news/ai-generated-doctors-on-tiktok-pose-huge-danger-to-public-safety-experts-warn 2026-07-27T23:06:54+00:00 hourly 0.9 https://trial.medpath.com/news/kansas-city-man-becomes-youngest-person-potentially-cured-of-hiv-after-stem-cell-transplant 2026-07-27T22:09:23+00:00 hourly 0.9 https://trial.medpath.com/news/fda-finalizes-three-guidances-to-broaden-cancer-clinical-trial-eligibility 2026-07-27T22:09:19+00:00 hourly 0.9 https://trial.medpath.com/news/saskatchewan-establishes-provincial-advisory-committee-to-tackle-primary-care-access-considers-patient-attachment-registry 2026-07-27T22:09:18+00:00 hourly 0.9 https://trial.medpath.com/news/nih-awards-2-4-million-r01-grant-to-investigate-how-maternal-viral-infections-reprogram-fetal-immune-development-in-a-sex-specific-manner 2026-07-27T22:09:15+00:00 hourly 0.9 https://trial.medpath.com/news/elevar-therapeutics-to-present-three-abstracts-at-esmo-2026-including-phase-2-thrive-trial-of-rivoceranib-in-thymic-tumors 2026-07-27T21:08:29+00:00 hourly 0.9 https://trial.medpath.com/news/sarcomatrix-advances-s-969-toward-first-in-human-dosing-with-sarcovista-modeling-and-expanded-cmc-package 2026-07-27T21:08:26+00:00 hourly 0.9 https://trial.medpath.com/news/asymchem-s-carbapenem-api-facility-passes-first-usfda-pre-approval-inspection 2026-07-27T20:10:59+00:00 hourly 0.9 https://trial.medpath.com/news/apa-2026-real-world-gad-treatment-gaps-and-preclinical-safety-data-for-5-ht2a-agonist-dt120 2026-07-27T20:10:50+00:00 hourly 0.9 https://trial.medpath.com/news/traditional-navajo-medically-tailored-meals-reduced-heart-failure-hospitalizations-by-more-than-half-in-landmark-randomized-trial 2026-07-27T20:10:29+00:00 hourly 0.9 https://trial.medpath.com/news/lipid-nanoparticles-deliver-dual-action-mrna-and-drug-therapy-against-oral-cancer 2026-07-27T19:11:47+00:00 hourly 0.9 https://trial.medpath.com/news/fda-classifies-nationwide-recall-of-levothyroxine-sodium-tablets-as-class-ii-due-to-subpotency 2026-07-27T19:11:40+00:00 hourly 0.9 https://trial.medpath.com/news/siemens-healthineers-and-cleveland-clinic-launch-10-year-strategic-alliance-to-advance-diagnostic-imaging-theranostics-and-clinical-innovation 2026-07-27T18:24:37+00:00 hourly 0.9 https://trial.medpath.com/news/long-acting-injectables-gene-editing-and-bnabs-the-non-vaccine-arsenal-closing-the-gap-in-hiv-prevention 2026-07-27T18:24:34+00:00 hourly 0.9 https://trial.medpath.com/news/uc-davis-researchers-awarded-3-3-million-nih-grant-to-study-cultural-differences-in-subjective-cognitive-decline 2026-07-27T18:24:11+00:00 hourly 0.9 https://trial.medpath.com/news/3d-genome-mapping-reveals-a-hidden-layer-of-alzheimer-s-pathology 2026-07-27T18:24:08+00:00 hourly 0.9 https://trial.medpath.com/news/uva-health-receives-6-5-million-nih-grant-to-develop-salt-mri-for-lymphatic-disease-diagnosis 2026-07-27T18:23:11+00:00 hourly 0.9 https://trial.medpath.com/news/aman-clinics-partners-with-cenegenics-to-launch-precision-medicine-and-longevity-program-in-qatar 2026-07-27T18:23:07+00:00 hourly 0.9 https://trial.medpath.com/news/lapix-therapeutics-appoints-nimbus-ceo-abbas-kazimi-to-board-as-oral-tim-3-tim-4-agonist-advances-through-phase-1b-trials 2026-07-27T18:23:00+00:00 hourly 0.9 https://trial.medpath.com/news/honeynaps-registers-as-cro-accelerating-ai-powered-sleep-data-analytics-for-global-clinical-trials 2026-07-27T18:22:58+00:00 hourly 0.9 https://trial.medpath.com/news/clinton-foundation-launches-policy-institute-to-advance-nonpartisan-health-solutions-at-the-state-level 2026-07-27T18:22:22+00:00 hourly 0.9 https://trial.medpath.com/news/u-s-faces-growing-exodus-of-biomedical-scientists-as-funding-uncertainty-and-visa-costs-erode-research-talent 2026-07-27T18:22:11+00:00 hourly 0.9 https://trial.medpath.com/news/scientists-turn-covid-19-immune-memory-into-a-powerful-new-ally-against-cancer 2026-07-27T18:22:04+00:00 hourly 0.9 https://trial.medpath.com/news/isoprene-pharmaceuticals-secures-1-02m-nci-grant-to-advance-dual-targeting-molecular-glue-degrader-for-castration-resistant-prostate-cancer 2026-07-27T18:20:49+00:00 hourly 0.9 https://trial.medpath.com/news/spero-therapeutics-appoints-dr-debra-jeske-zack-as-cmo-to-lead-phase-2-ready-anti-cd40l-antibody-sp001 2026-07-27T18:20:30+00:00 hourly 0.9 https://trial.medpath.com/news/entera-bio-secures-275-million-to-fund-phase-iii-trial-of-first-oral-osteoanabolic-tablet-for-osteoporosis 2026-07-27T18:20:00+00:00 hourly 0.9 https://trial.medpath.com/news/lgmd-advocates-from-20-states-press-congress-as-first-subtype-treatment-nears 2026-07-27T18:16:55+00:00 hourly 0.9 https://trial.medpath.com/news/revagenix-doses-first-participant-in-phase-1-trial-of-rev-56-a-first-in-class-inhaled-anti-pseudomonal-therapy-for-non-cf-bronchiectasis 2026-07-27T18:16:39+00:00 hourly 0.9 https://trial.medpath.com/news/cognizant-expands-20-year-partnership-with-novartis-for-ai-enabled-global-it-operations-transformation 2026-07-27T18:16:32+00:00 hourly 0.9 https://trial.medpath.com/news/leerink-partners-report-names-carterra-a-core-enabler-of-the-7b-lab-in-the-loop-antibody-discovery-market 2026-07-27T15:08:41+00:00 hourly 0.9 https://trial.medpath.com/news/bristol-myers-squibb-deploys-schrodinger-s-bunsen-ai-co-scientist-at-scale-to-accelerate-drug-discovery 2026-07-27T15:08:21+00:00 hourly 0.9 https://trial.medpath.com/news/difgen-pharmaceuticals-receives-fda-clearance-for-single-injection-breast-cancer-therapy-dfgn-101 2026-07-27T15:08:17+00:00 hourly 0.9 https://trial.medpath.com/news/mana-bio-appoints-gene-therapy-pioneer-laura-sepp-lorenzino-to-scientific-advisory-board 2026-07-27T15:07:38+00:00 hourly 0.9 https://trial.medpath.com/news/circular-eccdna-features-offer-new-prognostic-insights-for-early-stage-lung-adenocarcinoma-recurrence 2026-07-27T13:18:00+00:00 hourly 0.9 https://trial.medpath.com/news/chugai-pharmaceutical-s-core-operating-profit-rises-on-strong-hemlibra-exports-and-growing-royalty-stream 2026-07-27T13:07:56+00:00 hourly 0.9 https://trial.medpath.com/news/lukashenko-proposes-belarus-russia-biotechnology-collaboration-highlighting-bnbc-s-deep-grain-processing-capabilities 2026-07-27T12:11:38+00:00 hourly 0.9 https://trial.medpath.com/news/ema-launches-voluntary-data-submission-pilot-to-build-regulatory-evidence-for-organ-chips-and-other-new-approach-methodologies 2026-07-27T12:10:35+00:00 hourly 0.9 https://trial.medpath.com/news/innocare-s-oral-psoriasis-drug-fadeucravacitinib-meets-primary-goal-in-phase-iii-trial-regulatory-filing-planned 2026-07-27T12:10:19+00:00 hourly 0.9 https://trial.medpath.com/news/bms-launches-india-s-first-lag-3-based-dual-immunotherapy-for-metastatic-melanoma 2026-07-27T11:10:34+00:00 hourly 0.9 https://trial.medpath.com/news/blood-protein-biomarker-panel-predicts-als-symptom-onset-within-two-years 2026-07-27T11:09:39+00:00 hourly 0.9 https://trial.medpath.com/news/trace-neuroscience-launches-first-in-human-trials-of-unc13a-targeting-aso-for-als-while-experts-als-platform-demonstrates-rapid-drug-screening-capability 2026-07-27T11:09:34+00:00 hourly 0.9 https://trial.medpath.com/news/itm-launches-lumara-bio-as-dedicated-oncology-division-ahead-of-pdufa-date-for-lead-radiopharmaceutical-177lu-edotreotide 2026-07-27T11:09:19+00:00 hourly 0.9 https://trial.medpath.com/news/verily-nvidia-and-nih-build-first-multimodal-foundation-model-integrating-ehr-and-genomic-data-to-improve-type-2-diabetes-risk-prediction 2026-07-27T11:09:17+00:00 hourly 0.9 https://trial.medpath.com/news/genetic-trial-diversity-gap-in-parkinson-s-disease-becomes-an-urgent-site-operations-crisis 2026-07-27T10:08:48+00:00 hourly 0.9 https://trial.medpath.com/news/dong-a-st-posts-record-q2-sales-of-krw-207-8-billion-operating-profit-surges-170 2026-07-27T10:08:14+00:00 hourly 0.9 https://trial.medpath.com/news/huonslab-patents-subcutaneous-adc-formulation-using-hydiffuze-platform-demonstrating-126-increase-in-systemic-drug-exposure 2026-07-27T09:08:47+00:00 hourly 0.9 https://trial.medpath.com/news/hofseth-biocare-s-progo-r-bioactive-peptides-show-multi-target-effects-on-healthy-ageing-in-peer-reviewed-clinical-study 2026-07-27T09:07:52+00:00 hourly 0.9 https://trial.medpath.com/news/ultomiris-phase-iii-trial-misses-primary-endpoint-in-adults-with-hsct-tma-but-paediatric-data-show-clinically-meaningful-survival-benefit 2026-07-27T09:07:49+00:00 hourly 0.9 https://trial.medpath.com/news/faron-reports-encouraging-first-overall-survival-data-for-bexmarilimab-in-frontline-hr-mds-median-os-not-yet-reached-in-key-subgroups 2026-07-27T08:08:22+00:00 hourly 0.9 https://trial.medpath.com/news/insilico-medicine-to-present-first-in-human-phase-1-data-for-ai-designed-pan-tead-inhibitor-ism6331-at-esmo-2026 2026-07-27T08:07:19+00:00 hourly 0.9 https://trial.medpath.com/news/samchundang-pharm-reaches-global-settlement-in-eylea-biosimilar-patent-dispute-clearing-path-for-scd411-commercialization 2026-07-27T06:08:37+00:00 hourly 0.9 https://trial.medpath.com/news/oliceridine-20-mg-kg-with-propofol-shows-optimal-balance-for-painless-gastroscopy-but-registry-discrepancies-raise-questions 2026-07-27T06:08:37+00:00 hourly 0.9 https://trial.medpath.com/news/dss-imagetech-charts-growth-path-through-ai-enabled-diagnostics-and-reproductive-care-expansion 2026-07-27T06:07:32+00:00 hourly 0.9 https://trial.medpath.com/news/simvastatin-identified-as-promising-antibiotic-adjuvant-for-periodontitis-treatment 2026-07-27T05:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/imricor-launches-us-commercial-operations-with-first-northstar-radiation-free-cardiac-system-at-rady-children-s-hospital 2026-07-27T03:08:58+00:00 hourly 0.9 https://trial.medpath.com/news/anthony-fauci-s-2020-diaries-reveal-preoccupation-with-media-fame-during-covid-19-pandemic 2026-07-27T03:08:02+00:00 hourly 0.9 https://trial.medpath.com/news/nrc-proposes-eliminating-50-year-alara-radiation-safety-principle-amid-nuclear-expansion-push 2026-07-27T02:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/vietnamese-scientists-build-first-large-scale-population-specific-reference-genome-published-in-nature-communications 2026-07-27T02:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/ascentage-pharma-ceo-dr-dajun-yang-ranked-no-3-on-the-medicine-maker-power-list-2026-in-small-molecules 2026-07-27T01:07:54+00:00 hourly 0.9 https://trial.medpath.com/news/seaweed-derived-fucoidan-demonstrates-clinically-significant-relief-of-bph-symptoms-in-randomized-trial 2026-07-27T01:07:52+00:00 hourly 0.9 https://trial.medpath.com/news/new-tick-data-for-credelio-quattro-strengthens-bullish-case-for-elanco-animal-health 2026-07-27T01:07:01+00:00 hourly 0.9 https://trial.medpath.com/news/19f-nmr-reveals-hidden-bound-state-dynamics-of-sars-cov-2-3clpro-inhibitor-complexes-guiding-next-generation-antiviral-design 2026-07-27T00:07:54+00:00 hourly 0.9 https://trial.medpath.com/news/vector-science-therapeutics-reports-first-quarterly-results-targets-august-2026-revenue-from-peptide-manufacturing 2026-07-27T00:07:43+00:00 hourly 0.9 https://trial.medpath.com/news/tanruprubart-demonstrates-rapid-recovery-in-guillain-barre-syndrome-supporting-2026-bla-submission 2026-07-27T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/mark-wildgust-on-culture-as-the-engine-of-oncology-innovation-at-johnson-johnson 2026-07-26T23:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/experimental-at-home-alzheimer-s-headset-spectris-nears-fda-decision-ochsner-health-prepares-for-louisiana-rollout 2026-07-26T22:08:49+00:00 hourly 0.9 https://trial.medpath.com/news/zimbabwe-s-black-market-arv-use-in-poultry-a-growing-public-health-threat 2026-07-26T22:08:10+00:00 hourly 0.9 https://trial.medpath.com/news/viral-menopause-cocktail-of-allergy-and-antacid-drugs-lacks-evidence-experts-warn 2026-07-26T20:08:58+00:00 hourly 0.9 https://trial.medpath.com/news/ngs-uptake-remains-low-among-medicare-cancer-patients-despite-expanded-coverage-study-finds 2026-07-26T20:08:57+00:00 hourly 0.9 https://trial.medpath.com/news/experimental-drug-davunetide-slows-progression-of-rare-brain-disease-psp-in-women-reanalysis-reveals 2026-07-26T20:08:25+00:00 hourly 0.9 https://trial.medpath.com/news/gallbladder-cancer-foundation-launches-expanded-digital-hub-with-ai-tools-financial-aid-and-virtual-support-for-patients-worldwide 2026-07-26T18:07:22+00:00 hourly 0.9 https://trial.medpath.com/news/analysts-maintain-buy-ratings-on-sino-biopharmaceutical-with-strong-upside-potential 2026-07-26T17:08:19+00:00 hourly 0.9 https://trial.medpath.com/news/geriatric-oncology-in-2040-from-evidence-to-implementation-as-the-next-frontier 2026-07-26T17:08:16+00:00 hourly 0.9 https://trial.medpath.com/news/cayman-islands-confirms-infectious-coryza-outbreak-in-poultry-flocks-launches-vaccination-and-biosecurity-response 2026-07-26T17:08:15+00:00 hourly 0.9 https://trial.medpath.com/news/horsefil-launches-gummy-dietary-supplement-featuring-amino-acid-and-botanical-blend 2026-07-26T17:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/next-gen-preclinical-translation-nams-humanized-mouse-models-and-ai-integration-take-center-stage-at-bio-asia-taiwan-2026 2026-07-26T16:09:43+00:00 hourly 0.9 https://trial.medpath.com/news/msk-harnesses-ai-and-real-world-genomic-data-to-advance-lung-cancer-care 2026-07-26T16:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/rfk-jr-pushes-alzheimer-s-screening-while-uspstf-remains-paralyzed-for-over-a-year 2026-07-26T16:08:03+00:00 hourly 0.9 https://trial.medpath.com/news/postpartum-psychosis-on-trial-the-lindsay-clancy-case-exposes-a-fragmented-maternal-mental-health-system 2026-07-26T14:06:01+00:00 hourly 0.9 https://trial.medpath.com/news/bystro-ai-a-conversational-genomics-platform-aims-to-democratize-genetic-data-analysis 2026-07-26T14:05:58+00:00 hourly 0.9 https://trial.medpath.com/news/china-s-next-new-three-ai-robotics-and-innovative-drugs-reshape-global-pharma-r-d-landscape 2026-07-26T11:06:53+00:00 hourly 0.9 https://trial.medpath.com/news/first-known-transmissible-cancer-discovered-in-wild-freshwater-catfish 2026-07-26T09:07:09+00:00 hourly 0.9 https://trial.medpath.com/news/hdac6-identified-as-biomarker-for-b-all-dissemination-and-relapse-risk 2026-07-26T08:07:14+00:00 hourly 0.9 https://trial.medpath.com/news/planetary-health-diet-linked-to-28-lower-cardiovascular-risk-in-postmenopausal-women 2026-07-26T08:07:13+00:00 hourly 0.9 https://trial.medpath.com/news/kaist-researchers-uncover-molecular-switch-linking-amino-acid-sensing-to-mtorc1-activation-opening-new-avenues-for-cancer-therapy 2026-07-26T08:07:07+00:00 hourly 0.9 https://trial.medpath.com/news/father-overcomes-hepatitis-c-and-fatty-liver-disease-to-become-living-donor-for-son-with-alagille-syndrome 2026-07-26T05:13:54+00:00 hourly 0.9 https://trial.medpath.com/news/after-60-years-scientists-uncover-metformin-s-hidden-brain-effects-through-rap1-signaling 2026-07-26T05:13:21+00:00 hourly 0.9 https://trial.medpath.com/news/south-korean-doctors-arrested-for-illegal-narcotic-administration-and-patient-filming-police-urge-dexmedetomidine-regulation 2026-07-26T05:13:20+00:00 hourly 0.9 https://trial.medpath.com/news/anvisa-approves-clinical-trial-modifications-for-14-investigational-drugs-including-keytruda-and-novel-oncology-agents 2026-07-26T05:12:55+00:00 hourly 0.9 https://trial.medpath.com/news/immune-ecosystem-remodeling-how-single-cell-spatial-omics-and-ai-are-redefining-precision-immunotherapy-in-cancer-and-infectious-diseases 2026-07-26T05:11:23+00:00 hourly 0.9 https://trial.medpath.com/news/whole-body-mri-scans-surge-in-popularity-despite-warnings-from-major-medical-organizations 2026-07-26T05:11:22+00:00 hourly 0.9 https://trial.medpath.com/news/specific-gut-microbes-linked-to-changes-in-biological-aging-rates-study-finds 2026-07-26T01:06:48+00:00 hourly 0.9 https://trial.medpath.com/news/household-drinking-water-identified-as-major-source-of-long-term-lithium-exposure-in-western-u-s-tribal-communities 2026-07-26T00:06:27+00:00 hourly 0.9 https://trial.medpath.com/news/nba-and-chuka-university-sign-mou-to-strengthen-biosafety-education-and-research-in-kenya 2026-07-25T23:07:21+00:00 hourly 0.9 https://trial.medpath.com/news/avantor-s-nusil-expands-partnership-with-population-council-for-three-month-dapivirine-vaginal-ring-to-advance-hiv-prevention 2026-07-25T22:08:36+00:00 hourly 0.9 https://trial.medpath.com/news/society-of-hematologic-oncology-launches-second-educational-podcast-soho-spotlight-on-hematologic-malignancy-management 2026-07-25T21:07:10+00:00 hourly 0.9 https://trial.medpath.com/news/crispr-cas-acts-as-commander-in-chief-of-a-layered-bacterial-immune-network-nature-study-reveals 2026-07-25T21:07:09+00:00 hourly 0.9 https://trial.medpath.com/news/six-year-old-neuroblastoma-survivor-honored-at-uab-for-clinical-trial-participation-that-saved-her-life 2026-07-25T20:07:47+00:00 hourly 0.9 https://trial.medpath.com/news/nih-awards-30-9-million-to-expand-the-neighborhoods-study-linking-social-exposome-to-alzheimer-s-disease-risk 2026-07-25T20:07:09+00:00 hourly 0.9 https://trial.medpath.com/news/cryoport-reports-q2-2026-revenue-growth-of-8-achieves-positive-adjusted-ebitda-milestone 2026-07-25T19:08:55+00:00 hourly 0.9 https://trial.medpath.com/news/cancer-rates-in-sub-saharan-africa-projected-to-more-than-double-by-2050-who-report-warns 2026-07-25T19:08:35+00:00 hourly 0.9 https://trial.medpath.com/news/ani-pharmaceuticals-draws-bullish-analyst-attention-following-positive-iluvien-developments 2026-07-25T19:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/mrbeast-lebron-james-and-amgen-join-forces-to-launch-pediatric-cancer-dream-team-and-global-fundraising-campaign 2026-07-25T18:08:29+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-over-the-counter-fixed-dose-combination-of-acetaminophen-and-naproxen-for-pain-relief 2026-07-25T16:06:44+00:00 hourly 0.9 https://trial.medpath.com/news/cold-chain-technologies-launches-ecoflex-xs-reusable-shipper-for-small-volume-clinical-trial-and-diagnostic-shipments 2026-07-25T16:06:35+00:00 hourly 0.9 https://trial.medpath.com/news/hvivo-doubles-order-book-to-ps65-million-as-integrated-clinical-development-platform-gains-traction 2026-07-25T16:06:34+00:00 hourly 0.9 https://trial.medpath.com/news/aurobindo-pharma-s-apitoria-to-acquire-80-stake-in-a1-biochem-cro-for-17-million-building-integrated-crdmo-platform 2026-07-25T16:06:22+00:00 hourly 0.9 https://trial.medpath.com/news/updated-u-s-dietary-guidelines-raise-protein-recommendations-to-1-2-1-6-g-kg-day-but-experts-question-universal-application 2026-07-25T16:06:10+00:00 hourly 0.9 https://trial.medpath.com/news/advancing-precision-medicine-in-sarcoma-tumor-organoids-and-ai-reshape-rare-cancer-care 2026-07-25T16:06:00+00:00 hourly 0.9 https://trial.medpath.com/news/progranulin-and-jak2-stat3-synergy-identified-as-potential-target-to-overcome-differentiation-block-in-leukemia 2026-07-25T16:05:40+00:00 hourly 0.9 https://trial.medpath.com/news/13-children-sickened-after-consuming-suspected-mushroom-laced-edibles-at-new-jersey-ymca-summer-camp 2026-07-25T15:08:01+00:00 hourly 0.9 https://trial.medpath.com/news/china-poaches-105-top-us-scientists-as-biotech-brain-drain-accelerates 2026-07-25T15:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/first-mrna-vaccine-and-neutralizing-antibodies-show-promise-against-emerging-bourbon-virus 2026-07-25T11:06:55+00:00 hourly 0.9 https://trial.medpath.com/news/cleveland-clinic-study-links-gut-microbe-byproduct-tmao-to-higher-risk-of-atrial-fibrillation 2026-07-25T08:07:24+00:00 hourly 0.9 https://trial.medpath.com/news/beckman-coulter-launches-fully-automated-dxu-1800-urinalysis-system-at-adlm-2026-to-address-rising-testing-demand 2026-07-25T08:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/astrazeneca-s-trixeo-receives-chmp-recommendation-for-eu-approval-in-asthma 2026-07-25T08:06:56+00:00 hourly 0.9 https://trial.medpath.com/news/bone-biologics-doubles-australian-trial-sites-for-nb1-spinal-fusion-study-targets-year-end-2026-enrollment 2026-07-25T07:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/sildenafil-may-block-cancer-metastasis-by-trapping-cholesterol-preclinical-study-finds 2026-07-25T07:06:55+00:00 hourly 0.9 https://trial.medpath.com/news/california-reports-52-measles-cases-in-2026-more-than-double-2025-total-as-cdph-urges-back-to-school-vaccination 2026-07-25T06:07:57+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-receptor-agonists-show-promise-in-addiction-treatment-but-experts-urge-caution 2026-07-25T05:07:07+00:00 hourly 0.9 https://trial.medpath.com/news/novabridge-to-report-first-half-2026-results-and-corporate-update-on-august-20 2026-07-25T04:06:48+00:00 hourly 0.9 https://trial.medpath.com/news/allele-selective-aso-therapy-enables-teen-with-rare-scn2a-epilepsy-to-walk-for-the-first-time 2026-07-25T02:08:28+00:00 hourly 0.9 https://trial.medpath.com/news/canada-s-pharma-task-force-urges-three-month-deadline-to-cut-drug-access-delays-and-pricing-barriers 2026-07-25T00:08:57+00:00 hourly 0.9 https://trial.medpath.com/news/chmp-recommends-eu-approval-of-linerixibat-for-cholestatic-pruritus-in-primary-biliary-cholangitis 2026-07-25T00:08:16+00:00 hourly 0.9 https://trial.medpath.com/news/3d-resnet-deep-learning-model-classifies-cisplatin-response-in-colorectal-cancer-spheroids-using-oct-imaging 2026-07-24T23:08:30+00:00 hourly 0.9 https://trial.medpath.com/news/american-regent-issues-nationwide-recall-of-papaverine-hydrochloride-injection-due-to-glass-and-paraformaldehyde-particulate-contamination 2026-07-24T23:08:26+00:00 hourly 0.9 https://trial.medpath.com/news/cosmos-health-reports-record-q2-revenue-and-expanding-manufacturing-backlog 2026-07-24T23:08:19+00:00 hourly 0.9 https://trial.medpath.com/news/insmed-s-brinsupri-launch-pace-raises-concerns-despite-strong-q2-prescription-trends 2026-07-24T23:08:14+00:00 hourly 0.9 https://trial.medpath.com/news/cambridge-scientists-solve-gipr-paradox-distinct-brain-circuits-explain-why-both-activating-and-blocking-the-same-receptor-drives-weight-loss 2026-07-24T23:08:12+00:00 hourly 0.9 https://trial.medpath.com/news/single-cell-transcriptomics-reveals-new-therapeutic-targets-for-severe-preeclampsia 2026-07-24T23:08:10+00:00 hourly 0.9 https://trial.medpath.com/news/bnt162b2-mrna-vaccine-demonstrates-strong-immunogenicity-and-favorable-safety-profile-in-adolescents-with-juvenile-immune-mediated-inflammatory-disease 2026-07-24T22:07:43+00:00 hourly 0.9 https://trial.medpath.com/news/former-nfl-player-breiden-fehoko-alleges-covid-19-vaccine-side-effects-reignites-debate-over-league-s-pandemic-era-policies 2026-07-24T22:07:41+00:00 hourly 0.9 https://trial.medpath.com/news/global-wellness-summit-2026-precision-longevity-women-s-health-and-neuroaesthetics-take-center-stage-at-landmark-20th-anniversary-conference 2026-07-24T22:07:33+00:00 hourly 0.9 https://trial.medpath.com/news/obesity-weakens-anti-tumor-immune-response-in-lung-cancer-but-exercise-may-restore-it 2026-07-24T19:13:09+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-tylenol-with-naproxen-the-first-otc-fixed-dose-combination-of-acetaminophen-and-naproxen-sodium 2026-07-24T19:12:01+00:00 hourly 0.9 https://trial.medpath.com/news/novel-pseudomonas-aeruginosa-strains-emerge-as-significant-cause-of-utis-in-gulf-coast-region 2026-07-24T19:11:34+00:00 hourly 0.9 https://trial.medpath.com/news/salk-institute-identifies-acid-ceramidase-as-novel-driver-of-ferroptosis-vulnerability-in-senescent-cells-opening-path-to-healthy-aging-therapeutics 2026-07-24T19:11:06+00:00 hourly 0.9 https://trial.medpath.com/news/twist-bioscience-raises-fiscal-2026-guidance-as-ai-enabled-drug-discovery-demand-surges 2026-07-24T18:08:23+00:00 hourly 0.9 https://trial.medpath.com/news/ai-is-already-transforming-oncology-drug-design-and-clinical-trials-astrazeneca-s-reis-filho-tells-aacr 2026-07-24T18:08:21+00:00 hourly 0.9 https://trial.medpath.com/news/community-rallies-to-fund-personalised-mrna-vaccine-for-three-year-old-australian-girl-with-dipg 2026-07-24T18:08:21+00:00 hourly 0.9 https://trial.medpath.com/news/ai-helps-stanford-scientists-discover-natural-ozempic-without-the-usual-side-effects 2026-07-24T18:08:15+00:00 hourly 0.9 https://trial.medpath.com/news/vir-biotechnology-faces-analyst-scrutiny-ahead-of-q2-2026-earnings-amid-pipeline-challenges 2026-07-24T18:07:03+00:00 hourly 0.9 https://trial.medpath.com/news/lipoic-acid-trisulfide-creates-super-hgf-that-doubles-muscle-repair-signaling-and-resists-age-related-damage 2026-07-24T17:10:35+00:00 hourly 0.9 https://trial.medpath.com/news/fda-advisory-committees-under-scrutiny-the-case-for-reform-after-capricor-s-deramiocel-review 2026-07-24T17:10:02+00:00 hourly 0.9 https://trial.medpath.com/news/cycletrack-study-to-build-world-s-largest-menstrual-fluid-biobank-in-bid-to-transform-heavy-menstrual-bleeding-care 2026-07-24T17:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/japan-approves-vtama-cream-0-5-for-atopic-dermatitis-in-children-under-12 2026-07-24T16:10:19+00:00 hourly 0.9 https://trial.medpath.com/news/phase-1-trial-of-first-in-class-adc-dyp688-shows-promising-activity-in-metastatic-uveal-melanoma 2026-07-24T16:08:06+00:00 hourly 0.9 https://trial.medpath.com/news/dabrafenib-plus-trametinib-significantly-improves-pfs-in-braf-v600e-positive-advanced-thyroid-cancer 2026-07-24T15:09:09+00:00 hourly 0.9 https://trial.medpath.com/news/chmp-recommends-minoryx-s-nezglyal-as-first-pharmacological-treatment-for-pediatric-cerebral-adrenoleukodystrophy 2026-07-24T15:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/elephas-demonstrates-elivetm-platform-measures-cytotoxicity-in-targeted-therapies-expanding-functional-precision-medicine-reach 2026-07-24T15:08:21+00:00 hourly 0.9 https://trial.medpath.com/news/who-searo-and-university-of-colombo-sign-agreement-to-scale-ai-enabled-precision-medicine-across-south-east-asia 2026-07-24T15:08:19+00:00 hourly 0.9 https://trial.medpath.com/news/removing-regnase-1-immune-brake-improves-car-t-cell-therapy-for-osteosarcoma 2026-07-24T15:07:17+00:00 hourly 0.9 https://trial.medpath.com/news/roche-receives-fda-510-k-clearance-for-cobas-r-bv-cv-assay-bringing-pcr-precision-to-vaginitis-diagnosis 2026-07-24T14:08:03+00:00 hourly 0.9 https://trial.medpath.com/news/biotech-experts-demand-fda-drug-reviews-based-on-science-not-politics-amid-leadership-turmoil 2026-07-24T14:07:45+00:00 hourly 0.9 https://trial.medpath.com/news/jubilant-biosys-convenes-2nd-edge-innovation-forum-uniting-biotech-founders-investors-and-pharma-leaders-to-accelerate-next-generation-therapies 2026-07-24T14:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/estrella-immunopharma-doses-first-patient-in-starlight-1-dose-expansion-phase-for-eb103-artemis-t-cell-therapy-in-r-r-b-cell-nhl 2026-07-24T14:07:39+00:00 hourly 0.9 https://trial.medpath.com/news/advancing-smart-healthcare-integrating-ai-and-iot-for-enhanced-patient-care-and-system-efficiency 2026-07-24T13:46:00+00:00 hourly 0.9 https://trial.medpath.com/news/par-health-launches-first-and-only-generic-version-of-janumet-r-xr-in-the-united-states 2026-07-24T13:07:46+00:00 hourly 0.9 https://trial.medpath.com/news/phoenix-nest-secures-1-49-million-nih-grant-to-advance-gene-therapy-manufacturing-for-sanfilippo-syndrome-type-c 2026-07-24T13:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/fda-revokes-orange-b-authorization-proposes-citrus-red-no-2-ban-in-push-to-eliminate-petroleum-based-food-dyes 2026-07-24T12:07:56+00:00 hourly 0.9 https://trial.medpath.com/news/oral-antiviral-ghp-88310-blocks-measles-transmission-in-ferret-model-paving-way-for-clinical-trials 2026-07-24T12:07:44+00:00 hourly 0.9 https://trial.medpath.com/news/two-karolinska-institutet-researchers-awarded-wallenberg-proof-of-concept-funding-for-epigenomics-and-immunotherapy-innovations 2026-07-24T12:07:41+00:00 hourly 0.9 https://trial.medpath.com/news/infinitopes-doses-first-patient-in-phase-i-iia-trial-of-off-the-shelf-cancer-vaccine-itop1-for-resectable-esophageal-adenocarcinoma 2026-07-24T11:07:19+00:00 hourly 0.9 https://trial.medpath.com/news/onsite-mainstream-genetic-testing-doubles-brca-testing-rates-in-colorado-prostate-cancer-patients 2026-07-24T10:08:37+00:00 hourly 0.9 https://trial.medpath.com/news/ipsen-s-phase-iii-bold-trial-of-bylvay-in-biliary-atresia-misses-primary-endpoint 2026-07-24T06:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/resonance-health-achieves-positive-operating-cash-flow-across-fy26-as-mri-liver-fibrosis-trial-advances 2026-07-24T06:07:58+00:00 hourly 0.9 https://trial.medpath.com/news/oral-antibiotics-noninferior-to-iv-therapy-for-severe-pediatric-pneumonia-landmark-pedicap-trial-shows 2026-07-24T05:07:03+00:00 hourly 0.9 https://trial.medpath.com/news/laminar-pharma-completes-lam561-phase-2b-3-trial-enrollment-in-newly-diagnosed-glioblastoma-topline-os-data-expected-q2-2027 2026-07-24T05:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/superagers-exceptional-memory-cannot-be-explained-by-low-alzheimer-s-genetic-risk-study-finds 2026-07-24T03:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/patient-death-in-china-gene-editing-trial-raises-alarms-over-regulatory-oversight-and-transparency 2026-07-24T03:07:22+00:00 hourly 0.9 https://trial.medpath.com/news/arkbio-completes-all-cohort-dosing-in-australian-phase-i-trial-of-novel-long-acting-influenza-afc-drug-ak0406 2026-07-24T02:22:22+00:00 hourly 0.9 https://trial.medpath.com/news/fda-advisory-committee-votes-against-compounding-emideltide-citing-safety-and-efficacy-concerns 2026-07-24T02:22:21+00:00 hourly 0.9 https://trial.medpath.com/news/first-fully-integrated-smart-ring-monitors-glucose-ketone-and-other-biomarkers-in-sweat-simultaneously 2026-07-24T02:21:00+00:00 hourly 0.9 https://trial.medpath.com/news/activation-capital-expands-virginia-bio-tech-center-doubling-wet-lab-capacity-to-accelerate-life-sciences-commercialization 2026-07-24T02:20:56+00:00 hourly 0.9 https://trial.medpath.com/news/longer-less-fragmented-physical-activity-bouts-linked-to-lower-future-dementia-depression-and-anxiety-risk 2026-07-24T01:53:00+00:00 hourly 0.9 https://trial.medpath.com/news/harbour-biomed-reports-seventh-consecutive-profitable-half-year-driven-by-strategic-collaborations-and-ai-enabled-pipeline-advances 2026-07-24T01:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/11-year-old-becomes-first-uk-patient-to-receive-gene-therapy-for-bardet-biedl-syndrome-blindness 2026-07-24T01:07:26+00:00 hourly 0.9 https://trial.medpath.com/news/pharmacy-students-gain-hands-on-advocacy-and-industry-experience-through-summer-internships 2026-07-24T00:12:08+00:00 hourly 0.9 https://trial.medpath.com/news/india-s-bioe3-policy-drives-over-270-biomanufacturing-projects-and-15-bio-ai-hubs-nationwide 2026-07-24T00:11:58+00:00 hourly 0.9 https://trial.medpath.com/news/pitchmi-selects-20-michigan-startups-to-compete-for-2-million-in-funding 2026-07-23T23:08:33+00:00 hourly 0.9 https://trial.medpath.com/news/sphingotec-to-present-new-penkid-sepsis-data-and-co-host-sepsis-symposium-at-esicm-lives-2026 2026-07-23T23:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/alps-dx-to-debut-xpressor-filtration-and-capping-device-at-adlm-2026-targeting-preanalytical-bottlenecks-in-oral-fluid-testing 2026-07-23T22:09:22+00:00 hourly 0.9 https://trial.medpath.com/news/hyundai-hope-on-wheels-funds-two-pediatric-aml-research-programs-targeting-relapse-and-treatment-resistance 2026-07-23T22:08:35+00:00 hourly 0.9 https://trial.medpath.com/news/simbiosys-and-ferrum-health-partner-to-expand-access-to-fda-cleared-ai-surgical-planning-platform-for-breast-cancer 2026-07-23T21:08:30+00:00 hourly 0.9 https://trial.medpath.com/news/landmark-epoch-study-finds-socioeconomic-position-outweighs-parental-health-behaviors-in-child-health-outcomes 2026-07-23T21:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/study-reveals-how-dna-misfolding-causes-congenital-heart-disease 2026-07-23T20:18:00+00:00 hourly 0.9 https://trial.medpath.com/news/omada-health-to-report-second-quarter-2026-financial-results-on-august-6 2026-07-23T20:09:30+00:00 hourly 0.9 https://trial.medpath.com/news/biobuilder-awarded-1-million-mlsc-grant-for-ai-powered-biotechnology-training-in-massachusetts-high-schools 2026-07-23T20:09:27+00:00 hourly 0.9 https://trial.medpath.com/news/white-house-ostp-proposes-sweeping-overhaul-of-federal-research-funding-shifting-focus-from-universities-to-industry-and-ai 2026-07-23T20:08:44+00:00 hourly 0.9 https://trial.medpath.com/news/biomarin-completes-amicus-therapeutics-acquisition-expanding-rare-disease-portfolio-in-fabry-and-pompe 2026-07-23T19:13:28+00:00 hourly 0.9 https://trial.medpath.com/news/nsf-awards-20-million-to-northwestern-for-nation-s-first-ai-powered-protein-engineering-cloud-lab 2026-07-23T19:13:23+00:00 hourly 0.9 https://trial.medpath.com/news/lilac-biosciences-and-soin-neuroscience-publish-clinical-review-on-rna-biomarkers-for-objective-neuropathic-pain-assessment 2026-07-23T19:12:17+00:00 hourly 0.9 https://trial.medpath.com/news/federal-appeals-court-blocks-drugmakers-unilateral-340b-rebate-models-preserving-upfront-discounts-for-safety-net-hospitals 2026-07-23T19:12:15+00:00 hourly 0.9 https://trial.medpath.com/news/endometriosis-a-systemic-inflammatory-disease-still-plagued-by-diagnostic-delays-and-underfunded-research 2026-07-23T19:11:53+00:00 hourly 0.9 https://trial.medpath.com/news/thyora-therapeutics-launches-with-novel-covalent-chemistry-platform-to-target-undruggable-disease-proteins 2026-07-23T19:11:04+00:00 hourly 0.9 https://trial.medpath.com/news/brainstorm-advances-nurown-toward-phase-3b-endurance-trial-in-als-under-first-ever-spa-for-an-als-therapeutic 2026-07-23T19:11:02+00:00 hourly 0.9 https://trial.medpath.com/news/precision-diabetes-and-nagase-diagnostics-announce-exclusive-u-s-commercialization-partnership-for-lucica-r-glycated-albumin-l-the-only-fda-cleared-glycated-albumin-assay 2026-07-23T19:09:05+00:00 hourly 0.9 https://trial.medpath.com/news/paddington-life-sciences-to-lead-london-wide-life-sciences-talent-hub-backed-by-ps3-2-million-mayoral-investment 2026-07-23T18:09:55+00:00 hourly 0.9 https://trial.medpath.com/news/norway-s-health-system-renews-nationwide-adoption-of-wolters-kluwer-uptodate-enterprise-edition-adding-ai-powered-clinical-decision-support 2026-07-23T18:09:45+00:00 hourly 0.9 https://trial.medpath.com/news/sanofi-s-lantus-solostar-insulin-pen-faces-intermittent-supply-disruptions-across-the-u-s-amid-rising-demand 2026-07-23T18:09:42+00:00 hourly 0.9 https://trial.medpath.com/news/west-pharmaceutical-raises-2026-profit-forecast-on-surging-demand-for-injectable-drug-components-driven-by-glp-1-boom 2026-07-23T18:09:40+00:00 hourly 0.9 https://trial.medpath.com/news/abelzeta-and-astrazeneca-s-armored-gpc3-car-t-therapy-shows-promising-efficacy-in-advanced-hepatocellular-carcinoma-published-in-nature 2026-07-23T18:09:12+00:00 hourly 0.9 https://trial.medpath.com/news/alabama-teenager-will-roberts-whose-viral-plea-for-bone-cancer-drug-captured-national-attention-dies-at-15 2026-07-23T18:08:27+00:00 hourly 0.9 https://trial.medpath.com/news/united-therapeutics-appoints-victor-dzau-pioneer-of-ace-inhibitor-research-to-board-of-directors 2026-07-23T18:07:22+00:00 hourly 0.9 https://trial.medpath.com/news/donor-derived-cell-free-dna-emerges-as-leading-biomarker-in-kidney-transplant-rejection-surveillance-market-to-reach-3-98-billion-by-2036 2026-07-23T17:09:14+00:00 hourly 0.9 https://trial.medpath.com/news/midwest-poultry-services-recalls-nearly-1-6-million-dozen-eggs-across-gulf-states-over-salmonella-risk 2026-07-23T17:07:15+00:00 hourly 0.9 https://trial.medpath.com/news/beone-medicines-invests-additional-300-million-in-new-jersey-manufacturing-campus-total-commitment-surpasses-1-billion 2026-07-23T17:06:44+00:00 hourly 0.9 https://trial.medpath.com/news/vyne-therapeutics-and-yarrow-bioscience-merger-nears-completion-cash-dividend-distributed-reverse-stock-split-set-and-yb-101-poised-to-advance-autoimmune-thyroid-disease-pipeline 2026-07-23T16:26:00+00:00 hourly 0.9 https://trial.medpath.com/news/first-clinical-study-demonstrates-feasibility-of-fluorescence-imaging-in-orthopaedic-surgery 2026-07-23T16:07:49+00:00 hourly 0.9 https://trial.medpath.com/news/trialbee-appoints-michael-meerovich-as-cfo-to-drive-ai-powered-clinical-trial-recruitment-expansion 2026-07-23T16:07:44+00:00 hourly 0.9 https://trial.medpath.com/news/oncology-drug-development-in-the-uk-25-year-analysis-reveals-shifting-trial-landscape-and-regulatory-reboot 2026-07-23T16:07:38+00:00 hourly 0.9 https://trial.medpath.com/news/car-t-cell-therapy-targets-calr-mutation-driving-rare-blood-cancers 2026-07-23T16:07:33+00:00 hourly 0.9 https://trial.medpath.com/news/intravenous-iron-drugs-market-projected-to-reach-us-7-4-billion-by-2034 2026-07-23T16:07:32+00:00 hourly 0.9 https://trial.medpath.com/news/cancer-survivors-and-providers-show-significant-gaps-in-medical-cannabis-risk-awareness-and-communication-vcu-study-finds 2026-07-23T16:07:30+00:00 hourly 0.9 https://trial.medpath.com/news/niki-biosolutions-enters-strategic-agreement-to-provide-apoe-genotyping-services-for-progressive-medical-research 2026-07-23T16:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/ai-guided-technique-improves-targeted-therapy-delivery-for-malignant-brain-tumors 2026-07-23T16:06:55+00:00 hourly 0.9 https://trial.medpath.com/news/fresenius-launches-eur200m-corporate-venture-fund-to-tap-early-stage-healthcare-innovation 2026-07-23T16:06:45+00:00 hourly 0.9 https://trial.medpath.com/news/galderma-lifts-full-year-guidance-as-h1-2026-sales-surge-24-6-to-3-13-billion 2026-07-23T16:06:44+00:00 hourly 0.9 https://trial.medpath.com/news/aavantgarde-cso-prof-alberto-auricchio-to-present-advances-in-aav-gene-therapy-for-inherited-retinal-diseases-at-jsgct-2026 2026-07-23T16:06:43+00:00 hourly 0.9 https://trial.medpath.com/news/kiniksa-raises-arcalyst-guidance-to-995m-as-kpl-387-advances-into-pivotal-phase-3-for-recurrent-pericarditis 2026-07-23T16:01:00+00:00 hourly 0.9 https://trial.medpath.com/news/synaptiq-therapeutics-launches-with-acquisition-of-syn-001-a-phase-ii-ready-small-molecule-for-22q11-2-deletion-syndrome 2026-07-23T15:07:00+00:00 hourly 0.9 https://trial.medpath.com/news/protein-maxxing-obsession-debunked-experts-warn-excess-protein-offers-little-benefit-and-may-harm 2026-07-23T14:07:49+00:00 hourly 0.9 https://trial.medpath.com/news/bio-thera-solutions-doses-first-patient-in-phase-1-trial-of-cd25-targeting-adc-bat8013-for-advanced-solid-tumors 2026-07-23T14:07:27+00:00 hourly 0.9 https://trial.medpath.com/news/lantern-pharma-secures-uspto-notice-of-allowance-for-biomarker-guided-patent-on-lp-184-in-multiple-solid-tumors 2026-07-23T14:07:19+00:00 hourly 0.9 https://trial.medpath.com/news/r-d-portfolio-prioritization-emerges-as-critical-lever-as-pharma-faces-patent-cliff-and-capital-constraints 2026-07-23T13:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/samsung-bioepis-q3-2026-report-us-biosimilar-market-reaches-96-approvals-47-average-market-share 2026-07-23T13:06:50+00:00 hourly 0.9 https://trial.medpath.com/news/functional-mushroom-products-outpace-clinical-evidence-experts-caution 2026-07-23T13:06:41+00:00 hourly 0.9 https://trial.medpath.com/news/hhs-and-white-house-launch-clinical-ai-standards-sprint-with-closed-door-industry-demos 2026-07-23T13:06:00+00:00 hourly 0.9 https://trial.medpath.com/news/pmwc-joins-life-science-connect-to-expand-precision-medicine-community-engagement-year-round 2026-07-23T12:09:28+00:00 hourly 0.9 https://trial.medpath.com/news/russia-s-first-trametinib-generic-hits-market-as-promomed-challenges-novartis-mekinist 2026-07-23T12:09:10+00:00 hourly 0.9 https://trial.medpath.com/news/single-dose-of-rapamycin-reverses-autism-like-symptoms-in-adult-mice-within-hours-ucla-study-finds 2026-07-23T12:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/newly-released-documents-reveal-fbi-intervened-to-block-questioning-of-covid-researcher-peter-daszak 2026-07-23T12:07:34+00:00 hourly 0.9 https://trial.medpath.com/news/curcumin-shows-best-balance-of-anticancer-activity-and-safety-against-fibrosarcoma-cells-in-comparative-study 2026-07-23T12:06:44+00:00 hourly 0.9 https://trial.medpath.com/news/easier-biologic-access-linked-to-higher-remission-rates-in-severe-asthma-global-study-finds 2026-07-23T10:07:52+00:00 hourly 0.9 https://trial.medpath.com/news/dassault-systemes-to-acquire-arisglobal-for-1-8-billion-building-unified-ai-platform-for-life-sciences 2026-07-23T10:07:50+00:00 hourly 0.9 https://trial.medpath.com/news/evotec-selects-navan-s-ai-powered-platform-to-unify-global-travel-and-expense-management 2026-07-23T10:07:33+00:00 hourly 0.9 https://trial.medpath.com/news/sknv-licenses-washington-university-immunotherapy-patent-for-fluorouracil-calcipotriene-combination-in-actinic-keratosis 2026-07-23T09:08:05+00:00 hourly 0.9 https://trial.medpath.com/news/ancient-immune-protein-c3-boosts-cancer-immunotherapy-when-produced-inside-tumors 2026-07-23T08:08:50+00:00 hourly 0.9 https://trial.medpath.com/news/venus-medtech-completes-enrollment-in-prevails-pivotal-trial-for-fully-retrievable-tavr-device-venus-powerx 2026-07-23T08:07:47+00:00 hourly 0.9 https://trial.medpath.com/news/zydus-lifesciences-advances-desidustat-into-phase-iii-sickle-cell-trial-in-partnership-with-icmr 2026-07-23T08:07:18+00:00 hourly 0.9 https://trial.medpath.com/news/zarpet-family-foundation-s-12-million-gift-fuels-polycystic-kidney-disease-research-at-cu-anschutz 2026-07-23T07:07:50+00:00 hourly 0.9 https://trial.medpath.com/news/derriford-hospital-tops-uk-clinical-trial-recruitment-rankings-with-over-45000-patients-enrolled 2026-07-23T07:07:48+00:00 hourly 0.9 https://trial.medpath.com/news/arkansas-attorney-general-sues-22-drug-companies-over-alleged-340b-discount-restrictions 2026-07-23T06:07:34+00:00 hourly 0.9 https://trial.medpath.com/news/raps-names-2026-fellows-recognizing-leaders-in-rare-disease-and-regulatory-affairs 2026-07-23T05:07:08+00:00 hourly 0.9 https://trial.medpath.com/news/sparrow-pharmaceuticals-bets-cortisol-not-glp-1-is-the-next-frontier-in-type-2-diabetes 2026-07-23T04:07:53+00:00 hourly 0.9 https://trial.medpath.com/news/semaglutide-linked-to-56-lower-risk-of-adult-onset-seizures-in-type-2-diabetes-patients 2026-07-23T04:07:52+00:00 hourly 0.9 https://trial.medpath.com/news/genetic-background-shapes-cancer-evolution-trajectory-despite-identical-risk-factors-landmark-mouse-study-reveals 2026-07-23T02:31:00+00:00 hourly 0.9 https://trial.medpath.com/news/roche-unveils-automated-mass-spectrometry-ngs-platform-and-alzheimer-s-blood-test-at-adlm-2026 2026-07-23T02:09:04+00:00 hourly 0.9 https://trial.medpath.com/news/secondary-care-gap-tied-to-racial-disparities-in-prostate-cancer-mortality 2026-07-23T02:08:57+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-receptor-agonists-linked-to-increased-hair-loss-risk-in-type-2-diabetes-study-finds 2026-07-23T01:07:39+00:00 hourly 0.9 https://trial.medpath.com/news/bd-president-dr-michael-garrison-to-retire-after-two-decades-biopharma-systems-to-report-directly-to-ceo 2026-07-23T01:07:25+00:00 hourly 0.9 https://trial.medpath.com/news/portal-innovations-opens-new-jersey-innovation-hub-at-helix-with-16-founding-biotech-companies 2026-07-23T00:09:45+00:00 hourly 0.9 https://trial.medpath.com/news/usp-to-open-biopharma-analytical-innovation-summit-with-plenary-on-monoclonal-antibody-standards 2026-07-23T00:09:36+00:00 hourly 0.9 https://trial.medpath.com/news/university-of-auckland-establishes-new-department-of-cancer-sciences-advancing-vision-for-comprehensive-cancer-centre 2026-07-23T00:09:32+00:00 hourly 0.9 https://trial.medpath.com/news/cheiron-raises-8m-seed-round-to-build-ai-native-operating-system-for-drug-development-programs 2026-07-23T00:09:31+00:00 hourly 0.9 https://trial.medpath.com/news/concurrent-palliative-care-remains-underused-among-young-adults-with-advanced-cancer-despite-doubling-over-13-years 2026-07-22T23:59:00+00:00 hourly 0.9 https://trial.medpath.com/news/fda-issues-untitled-letters-to-sanofi-and-viatris-over-misleading-drug-promotions 2026-07-22T21:27:00+00:00 hourly 0.9 https://trial.medpath.com/news/methylation-mesa-define-functional-regulatory-elements-for-targeted-gene-activation 2026-07-22T21:09:22+00:00 hourly 0.9 https://trial.medpath.com/news/boebert-introduces-botanical-drug-development-act-of-2026-to-support-fda-regulated-botanical-therapies 2026-07-22T21:09:20+00:00 hourly 0.9 https://trial.medpath.com/news/gut-derived-regulatory-b-cells-may-explain-efficacy-of-ms-immunotherapy 2026-07-22T20:12:57+00:00 hourly 0.9 https://trial.medpath.com/news/nyu-langone-study-links-glyphosate-exposure-during-mid-pregnancy-to-increased-preterm-birth-risk 2026-07-22T20:12:15+00:00 hourly 0.9 https://trial.medpath.com/news/wuxi-biologics-recognized-among-industry-leaders-for-sustainable-biopharma-practices 2026-07-22T20:12:03+00:00 hourly 0.9 https://trial.medpath.com/news/arcstone-kingswood-names-karen-sterling-phd-cfa-as-head-of-biotechnology-investment-banking 2026-07-22T19:11:35+00:00 hourly 0.9 https://trial.medpath.com/news/structures-and-nucleotide-analog-inhibition-of-the-cchfv-polymerase-reveal-sofosbuvir-like-compounds-as-potent-chain-terminators 2026-07-22T19:11:32+00:00 hourly 0.9 https://trial.medpath.com/news/transcripta-bio-raises-24-million-to-advance-ai-powered-drug-discovery-platform-for-neurological-and-neuromuscular-diseases 2026-07-22T19:10:54+00:00 hourly 0.9 https://trial.medpath.com/news/us-5-million-partnership-to-accelerate-minimally-invasive-biomarker-development-for-parkinson-s-and-alzheimer-s-disease 2026-07-22T19:10:43+00:00 hourly 0.9 https://trial.medpath.com/news/4th-dzg-munich-day-2026-ai-driven-drug-repurposing-takes-center-stage-at-munich-health-research-summit 2026-07-22T19:10:18+00:00 hourly 0.9 https://trial.medpath.com/news/strategic-tech-transfer-in-cell-therapy-navigating-the-critical-path-from-development-to-gmp-manufacturing 2026-07-22T18:09:41+00:00 hourly 0.9 https://trial.medpath.com/news/nabp-launches-pulse-digital-platform-for-dispensers-to-strengthen-drug-supply-chain-security-and-dscsa-compliance 2026-07-22T18:09:15+00:00 hourly 0.9 https://trial.medpath.com/news/sfu-chemists-develop-light-driven-method-to-rapidly-generate-nucleoside-analog-libraries-accelerating-antiviral-drug-discovery 2026-07-22T17:09:05+00:00 hourly 0.9 https://trial.medpath.com/news/formation-bio-appoints-michael-ehlers-as-chief-scientific-officer-and-head-of-r-d 2026-07-22T17:08:17+00:00 hourly 0.9 https://trial.medpath.com/news/healthcare-institute-of-new-jersey-elects-bayer-s-chuck-leitgeb-as-board-chair 2026-07-22T17:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/chicago-bears-host-inaugural-alumni-wellness-weekend-with-novartis-emphasizing-early-detection-and-mental-health 2026-07-22T17:07:52+00:00 hourly 0.9 https://trial.medpath.com/news/one-in-four-u-s-workers-report-job-lock-due-to-health-insurance-marking-sharp-rise-since-2021 2026-07-22T17:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/william-shatner-and-daughter-both-declared-cancer-free-after-concurrent-stage-4-cancer-battles-highlighting-advances-in-immunotherapy-and-her2-targeted-treatment 2026-07-22T16:09:48+00:00 hourly 0.9 https://trial.medpath.com/news/high-dose-oral-vitamin-d-shows-rapid-relief-for-cancer-therapy-induced-skin-toxicities 2026-07-22T16:09:36+00:00 hourly 0.9 https://trial.medpath.com/news/fsu-colleges-of-nursing-and-medicine-awarded-1-6m-nih-grant-to-train-nurse-scientists-in-digital-health-and-ai 2026-07-22T16:09:14+00:00 hourly 0.9 https://trial.medpath.com/news/texas-h-1b-visa-restrictions-threaten-cancer-research-momentum-at-md-anderson 2026-07-22T15:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/science-corp-launches-prima-first-ce-marked-bci-implant-for-vision-restoration-in-dry-amd 2026-07-22T15:08:30+00:00 hourly 0.9 https://trial.medpath.com/news/kalamazoo-county-board-weighs-cutting-glp-1-obesity-drug-coverage-as-prescription-costs-surge-past-1-5-million 2026-07-22T15:07:49+00:00 hourly 0.9 https://trial.medpath.com/news/in-utero-gene-therapy-trial-targets-gm1-gangliosidosis-before-birth 2026-07-22T15:07:32+00:00 hourly 0.9 https://trial.medpath.com/news/repligen-to-acquire-biolife-solutions-in-1-5-billion-deal-expanding-into-cell-therapy-market 2026-07-22T15:07:24+00:00 hourly 0.9 https://trial.medpath.com/news/genetically-engineered-american-chestnut-clears-first-federal-regulatory-hurdle-toward-restoration 2026-07-22T14:08:53+00:00 hourly 0.9 https://trial.medpath.com/news/trinity-biotech-and-latch-medical-forge-strategic-alliance-to-combine-ai-powered-cgm-biosensing-with-intradermal-drug-delivery-for-metabolic-disease 2026-07-22T14:07:20+00:00 hourly 0.9 https://trial.medpath.com/news/all-five-longitude-health-member-systems-join-as-design-partners-for-cell-and-gene-therapy-utility 2026-07-22T13:10:36+00:00 hourly 0.9 https://trial.medpath.com/news/mrna-vaccine-technology-and-r-d-sovereignty-africa-s-path-beyond-fill-and-finish 2026-07-22T13:10:34+00:00 hourly 0.9 https://trial.medpath.com/news/3p-innovation-delivers-custom-aseptic-reconstitutable-powder-filling-system-for-global-medtech-client 2026-07-22T13:10:00+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-discontinues-phase-2-grpr-targeted-radioligand-lu-neob-in-breast-cancer-reaffirms-platform-commitment 2026-07-22T13:09:47+00:00 hourly 0.9 https://trial.medpath.com/news/hewlett-foundation-launches-100-million-initiative-targeting-ai-biotechnology-and-quantum-security 2026-07-22T13:09:31+00:00 hourly 0.9 https://trial.medpath.com/news/flatiron-health-presents-three-real-world-evidence-studies-on-nsclc-treatment-patterns-at-wclc-2026 2026-07-22T13:03:00+00:00 hourly 0.9 https://trial.medpath.com/news/mira-launches-a-woman-s-maze-campaign-with-rumer-willis-to-address-gaps-in-women-s-hormonal-health-literacy 2026-07-22T12:37:00+00:00 hourly 0.9 https://trial.medpath.com/news/fda-expands-ryaltris-nasal-spray-approval-to-children-aged-6-to-11-years-with-seasonal-allergic-rhinitis 2026-07-22T12:08:22+00:00 hourly 0.9 https://trial.medpath.com/news/ub-s-cheri-awards-over-600000-to-east-side-community-groups-and-researchers-to-tackle-social-determinants-of-health 2026-07-22T12:08:16+00:00 hourly 0.9 https://trial.medpath.com/news/eli-lilly-tops-inaugural-pipeline-to-patient-productivity-index-as-industry-r-d-efficiency-faces-mounting-pressure 2026-07-22T11:06:48+00:00 hourly 0.9 https://trial.medpath.com/news/circulating-biomarkers-mediate-obesity-endometrial-cancer-link-with-distinct-pathways-in-pre-and-postmenopausal-women 2026-07-22T10:07:58+00:00 hourly 0.9 https://trial.medpath.com/news/non-tyrosine-kinase-inhibitors-market-to-reach-usd-18-7-billion-by-2036-driven-by-biomarker-linked-oncology-approvals 2026-07-22T10:07:25+00:00 hourly 0.9 https://trial.medpath.com/news/chinese-medicine-hospital-of-hong-kong-launches-integrated-chinese-western-clinical-programmes-for-post-stroke-and-low-back-pain-care 2026-07-22T10:07:18+00:00 hourly 0.9 https://trial.medpath.com/news/jupiter-neurosciences-secures-exclusive-u-s-rights-to-pharmala-s-ala-002-in-deal-valued-at-up-to-100-million 2026-07-22T09:09:33+00:00 hourly 0.9 https://trial.medpath.com/news/pd-1-backbone-contracts-across-u-s-clinical-trial-pipeline-as-keytruda-slide-extends 2026-07-22T09:08:47+00:00 hourly 0.9 https://trial.medpath.com/news/mastel-surgical-receives-fda-510-k-clearance-for-steribest-sterilization-tray-system 2026-07-22T09:08:22+00:00 hourly 0.9 https://trial.medpath.com/news/ai-designed-protein-and-needle-based-endoscope-overcome-dual-barriers-to-photothermal-cancer-therapy 2026-07-22T09:07:38+00:00 hourly 0.9 https://trial.medpath.com/news/tikva-allocell-closes-8m-series-a-to-advance-off-the-shelf-car-t-for-solid-tumors 2026-07-22T08:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/healx-doses-first-patient-in-phase-1-2-trial-of-hlx-4310-targeting-metastatic-recurrence-in-osteosarcoma 2026-07-22T08:08:32+00:00 hourly 0.9 https://trial.medpath.com/news/uk-humanitarian-worker-under-ebola-monitoring-in-london-following-potential-exposure-in-drc 2026-07-22T07:07:58+00:00 hourly 0.9 https://trial.medpath.com/news/sharp-rise-in-type-2-diabetes-among-young-women-in-england-sparks-concern 2026-07-22T05:07:12+00:00 hourly 0.9 https://trial.medpath.com/news/ctx001-gene-therapy-shows-early-tolerability-and-slowed-lesion-progression-in-geographic-atrophy 2026-07-22T05:07:11+00:00 hourly 0.9 https://trial.medpath.com/news/tractor-mix-new-computational-method-uncovers-hidden-disease-linked-genes-in-diverse-populations 2026-07-22T03:07:16+00:00 hourly 0.9 https://trial.medpath.com/news/bill-ackman-commits-260-million-to-establish-brain-research-institute-in-manhattan-following-daughter-s-hemorrhage 2026-07-22T03:07:13+00:00 hourly 0.9 https://trial.medpath.com/news/trump-announces-phased-tariffs-on-generic-drugs-starting-2028-to-force-onshore-manufacturing 2026-07-22T02:14:28+00:00 hourly 0.9 https://trial.medpath.com/news/fda-announces-nationwide-cetirizine-recall-after-cross-contamination-with-ranitidine-discovered 2026-07-22T01:07:14+00:00 hourly 0.9 https://trial.medpath.com/news/cancer-drug-parity-act-reintroduced-to-eliminate-out-of-pocket-cost-disparities-between-oral-and-iv-cancer-therapies 2026-07-22T01:07:08+00:00 hourly 0.9 https://trial.medpath.com/news/protein-partnership-specificity-explains-regional-brain-vulnerability-in-sca1-and-beyond 2026-07-22T00:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/maxcyte-licenses-multi-platform-cell-engineering-technology-to-genentech-for-cell-therapy-development 2026-07-22T00:07:57+00:00 hourly 0.9 https://trial.medpath.com/news/integrated-single-cell-and-spatial-transcriptomics-reveals-multicellular-programs-in-disease-pathogenesis 2026-07-21T23:08:03+00:00 hourly 0.9 https://trial.medpath.com/news/unsw-precision-care-clinic-expands-genomic-guided-cancer-care-to-over-200-australians-with-rare-tumours 2026-07-21T23:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/harvard-business-school-names-2026-2027-blavatnik-fellows-marking-13th-cohort-of-life-science-entrepreneurs 2026-07-21T23:07:57+00:00 hourly 0.9 https://trial.medpath.com/news/study-charts-raav-dose-costs-by-indication-and-identifies-cost-cutting-strategies 2026-07-21T21:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/real-world-study-finds-new-dry-amd-therapies-do-not-increase-treatment-burden-for-wet-amd 2026-07-21T21:07:32+00:00 hourly 0.9 https://trial.medpath.com/news/newly-discovered-braf-protein-conformation-offers-fresh-target-for-cancer-drug-development 2026-07-21T20:13:00+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-drugs-linked-to-17-reduction-in-long-term-sick-leave-economic-study-finds 2026-07-21T20:12:39+00:00 hourly 0.9 https://trial.medpath.com/news/fda-establishes-cross-center-framework-for-digital-measures-in-clinical-trials 2026-07-21T20:12:12+00:00 hourly 0.9 https://trial.medpath.com/news/thymulin-restrains-age-associated-myeloid-inflammation-and-enhances-cancer-immunotherapy-in-preclinical-models 2026-07-21T19:09:51+00:00 hourly 0.9 https://trial.medpath.com/news/veeva-pushes-site-owned-esource-as-the-final-layer-in-clinical-trial-data-capture 2026-07-21T19:09:47+00:00 hourly 0.9 https://trial.medpath.com/news/ensuring-supply-chain-reliability-and-regulatory-compliance-in-upstream-biopharmaceutical-manufacturing 2026-07-21T19:09:46+00:00 hourly 0.9 https://trial.medpath.com/news/patientslikeme-and-science-37-forge-strategic-partnership-to-accelerate-clinical-trial-enrollment-and-expand-patient-access 2026-07-21T19:09:17+00:00 hourly 0.9 https://trial.medpath.com/news/car-t-cell-therapy-achieves-95-complete-response-in-al-amyloidosis-trial-offering-new-hope-for-relapsed-patients 2026-07-21T18:10:27+00:00 hourly 0.9 https://trial.medpath.com/news/intelligent-bio-solutions-completes-precision-testing-for-fda-510-k-submission-of-fingerprint-based-codeine-drug-screening-system 2026-07-21T18:10:05+00:00 hourly 0.9 https://trial.medpath.com/news/olorofim-shows-promise-for-severe-valley-fever-in-salvage-trial-offering-potential-curative-approach 2026-07-21T18:09:06+00:00 hourly 0.9 https://trial.medpath.com/news/spain-unveils-comprehensive-drug-law-reform-with-dynamic-pricing-nurse-prescribing-and-strategic-medicine-provisions 2026-07-21T18:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/medtech-pioneer-max-reinhardt-joins-exex-as-president-healthcare-to-drive-canopus-surgery-intelligence-platform-growth 2026-07-21T18:08:06+00:00 hourly 0.9 https://trial.medpath.com/news/novel-mrna-cancer-vaccine-prevents-melanoma-recurrence-in-high-risk-patients 2026-07-21T17:08:55+00:00 hourly 0.9 https://trial.medpath.com/news/trump-administration-admits-using-keywords-to-terminate-billions-in-nih-and-federal-research-grants-at-university-of-california 2026-07-21T17:07:20+00:00 hourly 0.9 https://trial.medpath.com/news/the-medicine-maker-power-list-2026-celebrates-60-leaders-driving-pharmaceutical-innovation-across-modalities 2026-07-21T17:06:55+00:00 hourly 0.9 https://trial.medpath.com/news/china-becomes-first-globally-to-approve-takeda-s-novel-narcolepsy-drug-tak-861 2026-07-21T17:06:54+00:00 hourly 0.9 https://trial.medpath.com/news/zeo-scientifix-to-expand-regenerative-medicine-operations-into-georgia-and-tennessee-after-new-state-laws-take-effect 2026-07-21T17:06:39+00:00 hourly 0.9 https://trial.medpath.com/news/trump-administration-s-pepfar-funding-cuts-cause-widespread-disruption-to-global-hiv-services-new-report-finds 2026-07-21T16:12:05+00:00 hourly 0.9 https://trial.medpath.com/news/allogenetics-appoints-dr-jeroen-rovers-as-chief-medical-officer-to-advance-alg-115-toward-clinical-trials-in-lung-transplantation 2026-07-21T16:11:46+00:00 hourly 0.9 https://trial.medpath.com/news/allergene-ai-therapeutics-to-unveil-first-in-class-in-vivo-mrna-lnp-car-t-platform-targeting-mast-cells-at-hanson-wade-summit 2026-07-21T16:10:53+00:00 hourly 0.9 https://trial.medpath.com/news/synergy-disc-reaches-100-u-s-cases-in-100-days-following-fda-approval-advancing-motion-preserving-cervical-disc-replacement 2026-07-21T16:10:33+00:00 hourly 0.9 https://trial.medpath.com/news/elephas-biosciences-expands-personalized-oncology-to-india-through-exclusive-partnership-with-neuberg-diagnostics 2026-07-21T16:10:12+00:00 hourly 0.9 https://trial.medpath.com/news/t-maximum-s-universal-car-t-mt027-to-debut-brain-metastasis-data-at-wclc-2026-as-intracranial-tumors-emerge-as-solid-tumor-car-t-s-second-battlefield 2026-07-21T16:09:35+00:00 hourly 0.9 https://trial.medpath.com/news/pharmather-partners-with-ketamist-inventor-to-pursue-fda-approval-for-needle-free-ketamine-platform-in-treatment-resistant-depression 2026-07-21T16:09:11+00:00 hourly 0.9 https://trial.medpath.com/news/fda-grants-emergency-use-authorization-to-seegene-s-allplex-multiplex-pcr-assay-for-simultaneous-detection-of-four-viral-pathogens 2026-07-21T16:09:11+00:00 hourly 0.9 https://trial.medpath.com/news/delhi-high-court-sets-aside-refusal-of-array-biopharma-s-cancer-drug-combination-patent-orders-fresh-review 2026-07-21T16:08:27+00:00 hourly 0.9 https://trial.medpath.com/news/bioelectronics-doubles-facility-space-to-support-actipatch-dtc-launch-and-recoveryrx-demand 2026-07-21T16:08:06+00:00 hourly 0.9 https://trial.medpath.com/news/immorta-bio-and-collaborators-publish-blueprint-for-ai-driven-p4-precision-medicine-in-journal-of-translational-medicine 2026-07-21T16:07:17+00:00 hourly 0.9 https://trial.medpath.com/news/medical-student-in-nepal-behind-international-research-factory-exposed-preprints-withdrawn 2026-07-21T15:07:04+00:00 hourly 0.9 https://trial.medpath.com/news/immitra-bio-raises-chf-2-4-million-to-advance-in-vivo-gene-editing-platform-for-inherited-anemia 2026-07-21T15:07:01+00:00 hourly 0.9 https://trial.medpath.com/news/who-marks-25-years-of-research4life-expanding-equitable-access-to-scientific-knowledge-across-120-countries 2026-07-21T15:06:58+00:00 hourly 0.9 https://trial.medpath.com/news/icmr-licenses-three-indigenous-biomedical-technologies-to-emcure-and-biological-e-for-cancer-and-infectious-disease-control 2026-07-21T15:06:33+00:00 hourly 0.9 https://trial.medpath.com/news/vesalio-s-envast-thrombectomy-system-nature-trial-selected-as-late-breaker-at-esc-congress-2026 2026-07-21T14:08:16+00:00 hourly 0.9 https://trial.medpath.com/news/dime-launches-initiative-to-translate-ai-governance-from-principle-to-practice-in-healthcare 2026-07-21T14:07:36+00:00 hourly 0.9 https://trial.medpath.com/news/devonian-health-group-receives-health-canada-authorization-to-initiate-phase-ii-iii-pediatric-trial-of-thykamine-for-atopic-dermatitis 2026-07-21T14:07:35+00:00 hourly 0.9 https://trial.medpath.com/news/axiom-biosciences-plans-landmark-hong-kong-ipo-becoming-first-u-s-biotech-to-list-on-hkex 2026-07-21T13:07:20+00:00 hourly 0.9 https://trial.medpath.com/news/nektar-launches-phase-3-zenith-ad-program-for-first-in-class-t-reg-biologic-rezpegaldesleukin-in-moderate-to-severe-atopic-dermatitis 2026-07-21T13:07:13+00:00 hourly 0.9 https://trial.medpath.com/news/eli-lilly-to-acquire-psychedelic-drugmaker-ataibeckley-for-2-8-billion 2026-07-21T13:07:07+00:00 hourly 0.9 https://trial.medpath.com/news/systematic-review-of-52053-patients-confirms-cancer-cachexia-erodes-function-and-quality-of-life-across-nearly-every-measure 2026-07-21T12:06:56+00:00 hourly 0.9 https://trial.medpath.com/news/personalized-aso-gene-therapy-dramatically-reduces-seizures-and-restores-walking-in-children-with-scn2a-related-epilepsy 2026-07-21T10:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/exempting-rare-disease-drugs-from-medicare-pricing-pilots-would-erase-most-retail-savings-harvard-analysis-finds 2026-07-21T10:07:47+00:00 hourly 0.9 https://trial.medpath.com/news/nanosystem-mediated-phototherapy-chemodynamic-therapy-synergistic-mechanisms-and-translational-barriers-in-precision-oncology 2026-07-21T08:07:30+00:00 hourly 0.9 https://trial.medpath.com/news/omeicos-omt-28-heads-directly-to-pivotal-phase-3-in-primary-mitochondrial-diseases-following-fda-endorsement 2026-07-21T08:07:15+00:00 hourly 0.9 https://trial.medpath.com/news/lupin-spins-out-two-oncology-assets-into-kaveri-therapeutics-retains-82-2-controlling-stake 2026-07-21T07:08:37+00:00 hourly 0.9 https://trial.medpath.com/news/innate-pharma-completes-enrollment-in-phase-1-dose-escalation-of-iph4502-a-novel-nectin-4-exatecan-adc-with-preliminary-data-expected-by-year-end 2026-07-21T07:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/kansas-city-biohub-secures-34-million-federal-grant-to-advance-biomanufacturing-and-strengthen-domestic-drug-supply-chain 2026-07-21T07:07:35+00:00 hourly 0.9 https://trial.medpath.com/news/car-t-cell-therapy-enables-67-year-old-mantle-cell-lymphoma-survivor-to-paddle-2300-miles-after-four-years-cancer-free 2026-07-21T05:08:18+00:00 hourly 0.9 https://trial.medpath.com/news/chugai-and-ucsf-establish-master-collaboration-agreement-for-drug-discovery-research 2026-07-21T05:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/dissolving-microneedles-show-dual-potential-to-enhance-drug-and-light-delivery-in-photodynamic-therapy-for-skin-cancer 2026-07-21T05:07:26+00:00 hourly 0.9 https://trial.medpath.com/news/redwire-opens-space-based-pharmaceutical-research-and-manufacturing-facility-in-southern-indiana 2026-07-21T03:06:55+00:00 hourly 0.9 https://trial.medpath.com/news/aptar-beauty-launches-neodropper-autoload-next-generation-auto-loading-dropper-technology-debuts-with-dermalogica-s-futurecode-booster 2026-07-21T03:06:42+00:00 hourly 0.9 https://trial.medpath.com/news/colossal-biosciences-eyes-20b-30b-valuation-in-new-funding-round-doubling-prior-worth 2026-07-21T02:07:11+00:00 hourly 0.9 https://trial.medpath.com/news/verismo-therapeutics-expands-kir-car-solid-tumor-pipeline-with-novel-cldn6-binder-from-penn-collaboration 2026-07-21T01:06:26+00:00 hourly 0.9 https://trial.medpath.com/news/aft-pharmaceuticals-secures-fda-tentative-approval-for-scomara-in-facial-angiofibromas-us-launch-delayed-until-2029 2026-07-21T01:06:05+00:00 hourly 0.9 https://trial.medpath.com/news/gates-foundation-awards-540-million-10-year-grant-to-uw-s-ihme-to-strengthen-global-health-evidence 2026-07-21T00:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/dignity-health-north-state-hospitals-earn-multiple-american-heart-association-awards-for-cardiovascular-and-stroke-care-excellence 2026-07-21T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/investigator-initiated-trial-combining-doxorubicin-with-checkpoint-inhibitors-yields-durable-complete-response-in-metastatic-cardiac-sarcoma 2026-07-20T22:09:03+00:00 hourly 0.9 https://trial.medpath.com/news/virginia-s-advanced-pharmaceutical-manufacturing-tech-hub-secures-15-97-million-federal-investment-for-end-to-end-domestic-medicine-commercialization 2026-07-20T22:08:41+00:00 hourly 0.9 https://trial.medpath.com/news/pharmacy-benefit-trends-shaping-2026-glp-1-expansion-biosimilar-savings-and-shifting-anti-inflammatory-prescribing 2026-07-20T21:11:12+00:00 hourly 0.9 https://trial.medpath.com/news/brenus-pharma-secures-eur11m-series-a-extension-attracting-first-asia-pacific-investor-for-lead-immunotherapy-stc-1010 2026-07-20T21:10:28+00:00 hourly 0.9 https://trial.medpath.com/news/rising-antimicrobial-resistance-in-children-threatens-life-saving-antibiotics-globally-landmark-study-finds 2026-07-20T21:09:16+00:00 hourly 0.9 https://trial.medpath.com/news/seagen-s-antibody-drug-conjugate-pipeline-and-revenue-growth-anchor-investor-outlook-amid-oncology-competition 2026-07-20T19:11:18+00:00 hourly 0.9 https://trial.medpath.com/news/conceivable-life-sciences-appoints-president-and-svp-of-commercial-operations-ahead-of-u-s-launch-of-world-s-first-automation-assisted-ivf-lab 2026-07-20T19:10:54+00:00 hourly 0.9 https://trial.medpath.com/news/vogenx-raises-81-3m-in-nasdaq-ipo-to-advance-sglt1-inhibitor-mizagliflozin-in-metabolic-disorders 2026-07-20T19:10:14+00:00 hourly 0.9 https://trial.medpath.com/news/epa-approves-crispr-based-hlb-resistant-citrus-rootstock-to-combat-citrus-greening 2026-07-20T19:09:52+00:00 hourly 0.9 https://trial.medpath.com/news/circulating-epigenetic-and-epitranscriptomic-biomarkers-identify-egfr-status-and-predict-tki-response-in-nsclc 2026-07-20T19:09:51+00:00 hourly 0.9 https://trial.medpath.com/news/vaxart-reports-favorable-safety-data-for-oral-covid-19-vaccine-eyes-2027-readout-for-5000-patient-cohort 2026-07-20T19:09:38+00:00 hourly 0.9 https://trial.medpath.com/news/rand-report-finds-stable-access-to-medical-care-for-most-injured-workers-but-flags-regional-gaps-in-california-s-workers-compensation-system 2026-07-20T18:09:21+00:00 hourly 0.9 https://trial.medpath.com/news/wellspan-health-hospitals-earn-u-s-news-best-hospitals-recognition-for-cardiovascular-rehabilitation-cancer-and-orthopedic-care 2026-07-20T18:08:35+00:00 hourly 0.9 https://trial.medpath.com/news/uk-patents-court-rejects-msd-s-bid-for-wider-disclosure-in-halozyme-hyaluronidase-patent-dispute-over-keytruda-subcutaneous-formulation 2026-07-20T18:07:49+00:00 hourly 0.9 https://trial.medpath.com/news/resmed-astral-100-150-ventilators-linked-to-serious-injuries-from-unexpected-therapy-interruption 2026-07-20T18:07:21+00:00 hourly 0.9 https://trial.medpath.com/news/2026-cholesterol-guidelines-reveal-massive-treatment-gaps-1-in-3-americans-miss-ldl-goals-21-5-million-newly-eligible-for-statins 2026-07-20T16:11:06+00:00 hourly 0.9 https://trial.medpath.com/news/mrna-cancer-therapeutics-advance-from-molecular-design-to-clinical-trials 2026-07-20T16:11:00+00:00 hourly 0.9 https://trial.medpath.com/news/zhengye-biotechnology-stock-surges-68-amid-speculative-momentum-and-nasdaq-compliance-hopes 2026-07-20T16:10:46+00:00 hourly 0.9 https://trial.medpath.com/news/psp-trial-platform-enrolls-first-participant-in-landmark-multi-drug-trial-for-progressive-supranuclear-palsy 2026-07-20T16:09:19+00:00 hourly 0.9 https://trial.medpath.com/news/uc-san-diego-joins-innovative-genomics-institute-to-advance-next-generation-genome-editing-for-health-and-climate 2026-07-20T16:09:17+00:00 hourly 0.9 https://trial.medpath.com/news/xenco-medical-unveils-xenvision-ai-powered-musculoskeletal-screening-platform-at-siggraph-2026 2026-07-20T16:08:42+00:00 hourly 0.9 https://trial.medpath.com/news/ascp-and-pfizer-launch-quality-improvement-grants-to-advance-biomarker-testing-in-metastatic-colorectal-cancer 2026-07-20T16:08:01+00:00 hourly 0.9 https://trial.medpath.com/news/tempus-ai-to-acquire-personalis-for-1-5-billion-adding-mrd-based-cancer-test-to-precision-oncology-portfolio 2026-07-20T16:07:56+00:00 hourly 0.9 https://trial.medpath.com/news/fau-joins-3-8m-nih-funded-consortium-to-develop-novel-antimalarial-drugs-targeting-pfgarp 2026-07-20T15:17:29+00:00 hourly 0.9 https://trial.medpath.com/news/dach-cleanroom-market-faces-drug-pricing-uncertainty-ai-impacts-and-consolidation-trends 2026-07-20T15:17:05+00:00 hourly 0.9 https://trial.medpath.com/news/abelzeta-s-c-car168-receives-ema-prime-designation-for-refractory-sle-and-lupus-nephritis 2026-07-20T15:15:44+00:00 hourly 0.9 https://trial.medpath.com/news/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in-alzheimer-s-disease-psychosis 2026-07-20T14:10:47+00:00 hourly 0.9 https://trial.medpath.com/news/kinaset-therapeutics-doses-first-patient-in-phase-2b-panairama-trial-of-inhaled-pan-jak-inhibitor-frevecitinib-for-severe-asthma 2026-07-20T14:10:31+00:00 hourly 0.9 https://trial.medpath.com/news/nebraska-medicine-marks-a-decade-of-car-t-cell-therapy-innovation 2026-07-20T14:09:58+00:00 hourly 0.9 https://trial.medpath.com/news/mentari-therapeutics-appoints-former-avadel-ceo-greg-divis-to-lead-migraine-pipeline-toward-regulatory-filings 2026-07-20T14:07:50+00:00 hourly 0.9 https://trial.medpath.com/news/vgll3-gene-dysregulation-identified-as-root-cause-of-preeclampsia-opening-door-to-new-diagnostics-and-treatments 2026-07-20T14:07:12+00:00 hourly 0.9 https://trial.medpath.com/news/immuron-reports-four-consecutive-quarters-of-travelan-sales-growth-driven-by-australian-and-u-s-market-expansion 2026-07-20T13:07:39+00:00 hourly 0.9 https://trial.medpath.com/news/bristol-myers-squibb-becomes-first-life-sciences-company-to-acquire-nvidia-s-vera-rubin-dgx-superpod-for-ai-driven-drug-discovery 2026-07-20T13:07:04+00:00 hourly 0.9 https://trial.medpath.com/news/marengo-secures-esmo-2026-oral-presentation-for-phase-2-invikafusp-alfa-data-in-pd-1-resistant-solid-tumors-appoints-keytruda-development-leader-eric-rubin-to-scientific-advisory-board 2026-07-20T12:09:09+00:00 hourly 0.9 https://trial.medpath.com/news/chinese-phase-3-trial-shows-serplulimab-based-regimen-reduces-gastric-cancer-recurrence-risk-by-33-while-sparing-postoperative-chemotherapy 2026-07-20T12:08:22+00:00 hourly 0.9 https://trial.medpath.com/news/ema-accepts-gsk-s-submission-for-single-dose-bexsero-booster-in-adolescents-and-young-adults 2026-07-20T12:08:14+00:00 hourly 0.9 https://trial.medpath.com/news/kolon-tissuegene-s-tg-c-fails-to-meet-co-primary-endpoints-in-first-u-s-phase-3-osteoarthritis-trial 2026-07-20T12:07:00+00:00 hourly 0.9 https://trial.medpath.com/news/india-approves-takeda-s-qdenga-its-first-dengue-vaccine-amid-11-fold-surge-in-cases 2026-07-20T11:07:11+00:00 hourly 0.9 https://trial.medpath.com/news/aha-scientific-statement-up-to-400-mg-of-caffeine-daily-is-safe-for-most-adults-and-may-offer-cardiovascular-benefits 2026-07-20T10:07:37+00:00 hourly 0.9 https://trial.medpath.com/news/former-lifemd-employees-allege-patient-safety-compromised-in-pursuit-of-glp-1-prescription-volume 2026-07-20T10:07:34+00:00 hourly 0.9 https://trial.medpath.com/news/lundbeck-completes-randomization-in-landmark-deep-ocean-phase-iii-trial-of-bexicaserin-for-developmental-and-epileptic-encephalopathies 2026-07-20T09:07:12+00:00 hourly 0.9 https://trial.medpath.com/news/cytosurge-elects-biotech-veteran-luba-greenwood-to-board-as-it-builds-causal-data-foundation-for-ai-drug-discovery 2026-07-20T08:07:46+00:00 hourly 0.9 https://trial.medpath.com/news/histone-lactylation-emerges-as-key-epigenetic-link-between-glycolysis-and-ferroptosis-in-neurological-diseases 2026-07-20T08:07:44+00:00 hourly 0.9 https://trial.medpath.com/news/bile-acid-buildup-driven-by-gut-dysbiosis-fuels-breast-cancer-metastasis-uva-research-reveals 2026-07-20T08:07:36+00:00 hourly 0.9 https://trial.medpath.com/news/beigene-raises-2026-revenue-guidance-as-brukinsa-sales-momentum-continues-cea-adc-data-slated-for-esmo-2026 2026-07-20T06:07:56+00:00 hourly 0.9 https://trial.medpath.com/news/40-life-saving-medicines-remain-out-of-reach-in-pakistan-as-government-delays-price-approvals 2026-07-20T05:07:46+00:00 hourly 0.9 https://trial.medpath.com/news/two-new-methods-break-down-forever-chemicals-in-water 2026-07-20T05:07:44+00:00 hourly 0.9 https://trial.medpath.com/news/climate-variability-drives-nearly-one-million-infectious-disease-cases-in-coastal-sindh-over-four-years-study-finds 2026-07-20T05:07:18+00:00 hourly 0.9 https://trial.medpath.com/news/centenary-institute-s-2026-when-art-meets-science-image-prize-winners-reveal-the-hidden-beauty-of-medical-research 2026-07-20T05:07:12+00:00 hourly 0.9 https://trial.medpath.com/news/nppa-ramps-up-drug-price-enforcement-demand-notices-surge-four-fold-recoveries-jump-seven-fold-in-fy-2025-26 2026-07-20T04:07:33+00:00 hourly 0.9 https://trial.medpath.com/news/antimicrobial-resistance-crisis-common-infections-becoming-harder-to-treat-as-drug-resistant-germs-spread-globally 2026-07-20T02:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/umbilical-cord-blood-biomarkers-uch-l1-and-gfap-reveal-fetal-neural-stress-in-maternal-sleep-disordered-breathing 2026-07-20T02:07:33+00:00 hourly 0.9 https://trial.medpath.com/news/samsung-biologics-to-acquire-polypeptide-group-in-1-8-billion-deal-entering-the-booming-peptide-cdmo-market 2026-07-20T02:07:32+00:00 hourly 0.9 https://trial.medpath.com/news/creative-life-science-showcases-pic-s-gmp-compliant-cell-therapy-manufacturing-platform-at-bio-asia-taiwan-2026 2026-07-20T01:07:37+00:00 hourly 0.9 https://trial.medpath.com/news/neuronata-r-retains-conditional-approval-in-south-korea-as-corestemchemon-eyes-u-s-expansion 2026-07-20T00:07:55+00:00 hourly 0.9 https://trial.medpath.com/news/nsf-awards-15-million-to-iowa-state-led-ruralstamina-initiative-for-biomanufacturing-innovation-in-nebraska-and-iowa 2026-07-20T00:07:43+00:00 hourly 0.9 https://trial.medpath.com/news/silicon-chip-synthesizes-64-dna-sequences-in-water-advancing-enzymatic-dna-manufacturing 2026-07-20T00:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/tissue-resident-memory-t-cells-explain-site-specific-relapse-in-atopic-dermatitis 2026-07-19T23:59:00+00:00 hourly 0.9 https://trial.medpath.com/news/mesoblast-advances-late-stage-pipeline-with-phase-3-progress-in-chronic-low-back-pain-and-bla-filing-for-heart-failure 2026-07-19T23:07:27+00:00 hourly 0.9 https://trial.medpath.com/news/the-pink-salt-trick-experts-debunk-viral-tiktok-weight-loss-hack-warn-of-cardiovascular-risks 2026-07-19T22:08:43+00:00 hourly 0.9 https://trial.medpath.com/news/dbv-technologies-files-2026-half-year-report-and-schedules-second-quarter-financial-results-conference-call 2026-07-19T21:09:02+00:00 hourly 0.9 https://trial.medpath.com/news/japan-signals-strategic-shift-toward-open-innovation-and-cross-border-biotech-collaboration-at-bio-asia-taiwan-2026 2026-07-19T21:08:40+00:00 hourly 0.9 https://trial.medpath.com/news/l7-bassist-jennifer-finch-dies-at-59-following-aggressive-brain-cancer-battle 2026-07-19T20:08:02+00:00 hourly 0.9 https://trial.medpath.com/news/former-rhoc-star-jeana-keough-70-battling-tongue-cancer-after-squamous-cell-carcinoma-diagnosis 2026-07-19T20:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/bacteria-convert-toxic-uranium-into-a-stable-compound-opening-new-paths-for-environmental-remediation 2026-07-19T18:06:23+00:00 hourly 0.9 https://trial.medpath.com/news/tour-de-france-anti-doping-testers-wake-pogacar-and-vingegaard-in-early-hours-sparking-rider-backlash 2026-07-19T18:05:45+00:00 hourly 0.9 https://trial.medpath.com/news/new-york-city-makes-controversial-cash-for-syringes-program-permanent-with-3-million-budget-allocation 2026-07-19T17:08:30+00:00 hourly 0.9 https://trial.medpath.com/news/alcohol-related-liver-disease-diagnosis-spurs-early-drinking-cessation-but-37-relapse-within-90-days 2026-07-19T17:07:28+00:00 hourly 0.9 https://trial.medpath.com/news/tripura-sma-type-1-case-highlights-india-s-rare-disease-funding-gap-as-risdiplam-vials-supplied-zolgensma-awaits-dcgi-approval 2026-07-19T17:06:49+00:00 hourly 0.9 https://trial.medpath.com/news/the-max-foundation-and-novartis-mark-25-year-partnership-built-on-equitable-global-access-to-care 2026-07-19T17:06:43+00:00 hourly 0.9 https://trial.medpath.com/news/inovio-pharmaceuticals-faces-binary-outcome-as-fda-decision-on-ino-3107-looms-in-october-2026 2026-07-19T16:07:40+00:00 hourly 0.9 https://trial.medpath.com/news/caidya-and-simbec-orion-unite-to-form-a-differentiated-global-cro-spanning-first-in-human-to-registration 2026-07-19T16:07:00+00:00 hourly 0.9 https://trial.medpath.com/news/city-of-hope-ceo-robert-stone-honored-with-inaugural-lifetime-achievement-award-outlines-vision-for-ai-driven-cancer-care-and-national-expansion 2026-07-19T15:07:08+00:00 hourly 0.9 https://trial.medpath.com/news/usfda-classifies-cipla-s-invagen-new-york-unit-3-inspection-as-voluntary-action-indicated 2026-07-19T14:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/dubai-launches-uae-s-first-national-digital-platform-for-addiction-recovery-masar-wellness 2026-07-19T14:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/south-korea-remains-among-five-oecd-nations-blocking-abortion-pill-access-as-101-countries-adopt-who-essential-medication 2026-07-19T14:06:55+00:00 hourly 0.9 https://trial.medpath.com/news/merck-group-announces-strategic-restructuring-of-israeli-operations-cutting-dozens-of-jobs-while-pivoting-toward-ai-driven-drug-development 2026-07-19T12:06:45+00:00 hourly 0.9 https://trial.medpath.com/news/gumitide-and-burntide-launch-2026-weight-loss-gummies-apple-cider-vinegar-and-bhb-formulas-enter-the-supplement-market 2026-07-19T11:06:47+00:00 hourly 0.9 https://trial.medpath.com/news/ozempic-culture-how-glp-1-drugs-are-reshaping-beauty-standards-and-the-cultural-imagination 2026-07-19T09:06:55+00:00 hourly 0.9 https://trial.medpath.com/news/frankfurt-airport-employee-dies-of-malaria-in-rare-airport-malaria-outbreak 2026-07-19T08:07:43+00:00 hourly 0.9 https://trial.medpath.com/news/south-korea-revisits-mifepristone-approval-amid-seven-year-abortion-law-vacuum 2026-07-19T08:07:28+00:00 hourly 0.9 https://trial.medpath.com/news/ai-driven-trading-signals-highlight-divergent-sentiment-in-biotech-etfs-fbt-and-bbc 2026-07-19T04:07:27+00:00 hourly 0.9 https://trial.medpath.com/news/robert-koch-institute-to-host-3rd-symposium-on-artificial-intelligence-in-public-health-research-in-berlin 2026-07-19T01:08:02+00:00 hourly 0.9 https://trial.medpath.com/news/alexandria-real-estate-posts-73-7m-q2-loss-as-life-sciences-real-estate-slump-deepens 2026-07-19T00:09:29+00:00 hourly 0.9 https://trial.medpath.com/news/colestzen-launches-cholesterol-support-supplement-in-us-uk-canada-and-australia-markets 2026-07-19T00:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/validating-tracheal-aspirates-for-microbiome-profiling-in-icu-pneumonia-patients 2026-07-18T23:07:48+00:00 hourly 0.9 https://trial.medpath.com/news/type-1-diabetes-may-cause-false-positive-celiac-blood-tests-complicating-screening-in-children 2026-07-18T23:07:41+00:00 hourly 0.9 https://trial.medpath.com/news/natco-pharma-secures-usfda-tentative-approval-for-generic-olaparib-tablets-partnering-with-alembic-for-u-s-distribution 2026-07-18T19:10:13+00:00 hourly 0.9 https://trial.medpath.com/news/brachytherapy-precision-radiation-oncology-s-high-value-underappreciated-modality-gains-renewed-recognition 2026-07-18T19:09:45+00:00 hourly 0.9 https://trial.medpath.com/news/asrs-2026-durable-retina-therapies-take-center-stage-as-gene-therapy-implant-and-oral-data-mature 2026-07-18T19:09:19+00:00 hourly 0.9 https://trial.medpath.com/news/from-fashion-week-to-cancer-free-a-model-s-journey-with-triple-negative-breast-cancer-highlights-barriers-to-timely-care 2026-07-18T19:09:17+00:00 hourly 0.9 https://trial.medpath.com/news/prenatal-estrogen-in-early-pregnancy-linked-to-male-newborn-brain-size-twin-studies-show 2026-07-18T18:08:01+00:00 hourly 0.9 https://trial.medpath.com/news/novo-nordisk-to-launch-cheaper-ozempic-copy-in-south-africa-through-acino-partnership 2026-07-18T18:07:17+00:00 hourly 0.9 https://trial.medpath.com/news/dbv-technologies-renews-150-million-at-the-market-offering-program-to-fund-viaskin-r-peanut-development-and-pre-commercial-activities 2026-07-18T18:06:48+00:00 hourly 0.9 https://trial.medpath.com/news/real-world-study-confirms-atezolizumab-plus-chemotherapy-is-feasible-and-safe-first-line-therapy-for-extensive-stage-small-cell-lung-cancer 2026-07-18T17:09:03+00:00 hourly 0.9 https://trial.medpath.com/news/quebec-launches-first-ever-genomic-medicine-policy-to-advance-precision-medicine-across-the-province 2026-07-18T17:08:57+00:00 hourly 0.9 https://trial.medpath.com/news/custom-synthia-search-configuration-cuts-synthesis-route-planning-to-hours-case-study-shows 2026-07-18T17:08:19+00:00 hourly 0.9 https://trial.medpath.com/news/somatic-mutations-cap-human-lifespan-at-146-194-years-even-if-all-other-aging-hallmarks-are-cured-study-finds 2026-07-18T17:07:37+00:00 hourly 0.9 https://trial.medpath.com/news/chinese-researchers-discover-novel-hla-allele-hla-dqb1-03-03-38-with-clinical-promise 2026-07-18T17:07:34+00:00 hourly 0.9 https://trial.medpath.com/news/latigo-biotherapeutics-files-for-ipo-as-non-opioid-pain-drug-ltg-001-advances-to-late-stage-testing 2026-07-18T17:07:19+00:00 hourly 0.9 https://trial.medpath.com/news/astrazeneca-pharma-india-ceases-manufacturing-operations-in-strategic-pivot-to-office-based-model 2026-07-18T16:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/cathie-wood-doubles-down-on-ionis-pharmaceuticals-amid-eplontersen-setback-and-tryngolza-market-expansion 2026-07-18T16:07:46+00:00 hourly 0.9 https://trial.medpath.com/news/neighborhood-disadvantage-accelerates-cardiovascular-decline-in-midlife-women-two-decade-study-finds 2026-07-18T16:07:14+00:00 hourly 0.9 https://trial.medpath.com/news/high-social-media-use-linked-to-youth-anxiety-and-suicidal-ideation-new-longitudinal-study-finds 2026-07-18T14:08:31+00:00 hourly 0.9 https://trial.medpath.com/news/faulty-hospital-drug-tests-disproportionately-flag-black-newborns-to-law-enforcement-analysis-finds 2026-07-18T13:08:26+00:00 hourly 0.9 https://trial.medpath.com/news/v-foundation-awards-1-8-million-to-chop-researchers-for-car-t-cell-therapy-and-liquid-biopsy-advances-in-pediatric-cancer 2026-07-18T13:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/chemotherapy-induced-cognitive-impairment-a-first-person-account-of-chemo-brain-and-its-impact-on-professional-function 2026-07-18T13:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/hcg-aastha-cancer-centre-achieves-first-car-t-cell-therapy-milestone-for-refractory-lymphoma-in-gujarat 2026-07-18T13:07:44+00:00 hourly 0.9 https://trial.medpath.com/news/harmony-biosciences-reports-phase-1-data-for-orexin-2-agonist-bp-205-reinforcing-best-in-class-potential 2026-07-18T13:07:43+00:00 hourly 0.9 https://trial.medpath.com/news/exact-sciences-seeks-director-of-medical-development-to-lead-mrd-breast-cancer-portfolio-strategy 2026-07-18T13:07:38+00:00 hourly 0.9 https://trial.medpath.com/news/parotid-gland-cancer-in-young-adults-a-case-study-of-diagnosis-treatment-and-recovery 2026-07-18T11:06:52+00:00 hourly 0.9 https://trial.medpath.com/news/endothelial-klf4-loss-identified-as-key-driver-of-blood-brain-barrier-breakdown-and-age-related-cognitive-decline 2026-07-18T09:07:40+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-weight-loss-drugs-enter-clinical-trials-for-obese-cats-as-pet-care-shifts-toward-medicalization 2026-07-18T08:07:22+00:00 hourly 0.9 https://trial.medpath.com/news/sun-fanglin-pioneering-chinese-cancer-researcher-who-uncovered-pathways-to-reverse-drug-resistance-dies-at-58 2026-07-18T08:07:18+00:00 hourly 0.9 https://trial.medpath.com/news/rara-targeting-protac-delivered-by-plant-nanoparticles-shows-potent-activity-in-colorectal-cancer 2026-07-18T00:08:41+00:00 hourly 0.9 https://trial.medpath.com/news/patient-derived-pancreatic-organoids-uncover-cftr-dysfunction-as-therapeutic-target-in-chronic-pancreatitis 2026-07-18T00:08:11+00:00 hourly 0.9 https://trial.medpath.com/news/topology-based-biomarkers-outperform-traditional-methods-in-predicting-breast-cancer-survival 2026-07-17T23:07:41+00:00 hourly 0.9 https://trial.medpath.com/news/emestedastat-shows-late-emerging-antidepressant-signal-in-difficult-to-treat-mdd-despite-missing-cognitive-endpoint 2026-07-17T22:09:02+00:00 hourly 0.9 https://trial.medpath.com/news/icgeb-opens-september-2026-fellowship-call-with-new-two-stage-application-process 2026-07-17T22:09:00+00:00 hourly 0.9 https://trial.medpath.com/news/nuvox-therapeutics-files-for-20-million-ipo-to-advance-hypoxia-targeting-nano2-platform 2026-07-17T21:09:40+00:00 hourly 0.9 https://trial.medpath.com/news/linking-clinical-trial-data-with-real-world-data-methodologies-and-recommendations-for-enhanced-evidence-generation 2026-07-17T20:09:38+00:00 hourly 0.9 https://trial.medpath.com/news/belarusian-scientists-leverage-ai-for-drug-repurposing-target-identification-and-de-novo-molecule-design 2026-07-17T19:09:48+00:00 hourly 0.9 https://trial.medpath.com/news/inflammasome-therapeutics-k8-slows-geographic-atrophy-lesion-growth-by-54-and-shows-visual-acuity-benefit-in-phase-2-trial 2026-07-17T19:08:49+00:00 hourly 0.9 https://trial.medpath.com/news/wildfire-smoke-a-systemic-threat-to-human-health-from-acute-inflammation-to-cancer-and-dementia 2026-07-17T18:09:36+00:00 hourly 0.9 https://trial.medpath.com/news/engineered-human-spinal-interneurons-restore-breathing-function-in-injured-rats-paving-way-for-regenerative-therapies 2026-07-17T18:08:08+00:00 hourly 0.9 https://trial.medpath.com/news/md-anderson-receives-1-82-million-nci-grant-to-investigate-bhlhe40-transcription-factor-as-novel-target-for-improving-immunotherapy-response 2026-07-17T17:09:10+00:00 hourly 0.9 https://trial.medpath.com/news/glioblastoma-patient-sells-home-to-access-experimental-treatments-unavailable-on-the-nhs-highlighting-urgent-need-for-research-investment 2026-07-17T17:08:20+00:00 hourly 0.9 https://trial.medpath.com/news/russian-scientists-develop-hybrid-molecules-that-evade-cancer-drug-resistance 2026-07-17T17:08:20+00:00 hourly 0.9 https://trial.medpath.com/news/blossomhill-therapeutics-files-for-100m-nasdaq-ipo-to-advance-macrocyclic-cancer-pipeline 2026-07-17T17:08:15+00:00 hourly 0.9 https://trial.medpath.com/news/elastography-and-blood-biomarkers-improve-early-detection-of-sinusoidal-obstruction-syndrome-after-stem-cell-transplant 2026-07-17T17:07:40+00:00 hourly 0.9 https://trial.medpath.com/news/bemotrizinol-bemt-cleared-by-fda-a-new-photostable-chemical-sunscreen-filter-reaches-the-u-s-market 2026-07-17T16:39:00+00:00 hourly 0.9 https://trial.medpath.com/news/jcvi-recommends-csl-seqirus-aujemflu-for-2027-28-uk-flu-season-moderna-s-mrna-vaccine-deferred 2026-07-17T16:10:49+00:00 hourly 0.9 https://trial.medpath.com/news/ai-and-biosecurity-risks-outpace-federal-regulatory-response-crs-report-warns 2026-07-17T16:10:47+00:00 hourly 0.9 https://trial.medpath.com/news/gsk-halts-camlipixant-development-for-refractory-chronic-cough-after-dual-phase-iii-trial-failure 2026-07-17T16:10:22+00:00 hourly 0.9 https://trial.medpath.com/news/aqemia-and-sanofi-expand-ai-drug-discovery-collaboration-with-new-target-nomination 2026-07-17T16:09:49+00:00 hourly 0.9 https://trial.medpath.com/news/nevada-ag-joins-400-million-settlement-with-sandoz-over-generic-drug-price-fixing-conspiracy 2026-07-17T16:09:19+00:00 hourly 0.9 https://trial.medpath.com/news/kourtney-kardashian-s-lemme-launches-skin-firming-hydrating-gummy-rings-with-ceramosides 2026-07-17T16:09:02+00:00 hourly 0.9 https://trial.medpath.com/news/enzyme-powered-dna-encoded-libraries-a-gentler-path-to-small-molecule-drug-discovery 2026-07-17T16:07:50+00:00 hourly 0.9 https://trial.medpath.com/news/combination-therapies-emerge-as-a-path-to-disease-modification-in-parkinson-s-disease 2026-07-17T15:08:38+00:00 hourly 0.9 https://trial.medpath.com/news/finger-prick-glucose-ketone-index-test-proposed-as-practical-tool-to-monitor-mitochondrial-and-metabolic-health 2026-07-17T15:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/iveena-delivery-systems-announces-successful-phase-1-results-for-ivmed-85-a-first-in-class-lysyl-oxidase-activator-for-pediatric-myopia 2026-07-17T15:08:28+00:00 hourly 0.9 https://trial.medpath.com/news/thalassax-doses-first-u-s-patient-in-phase-i-trial-of-brain-penetrant-aurora-b-kinase-inhibitor-cs231295 2026-07-17T15:08:12+00:00 hourly 0.9 https://trial.medpath.com/news/clinical-stage-partnering-and-royalty-rate-trends-in-biopharma-new-reports-analyze-over-3400-deals-from-2015-2026 2026-07-17T15:07:26+00:00 hourly 0.9 https://trial.medpath.com/news/aptar-pharma-launches-integrated-system-level-framework-to-support-injectable-drug-development 2026-07-17T15:07:21+00:00 hourly 0.9 https://trial.medpath.com/news/dna-script-expands-on-demand-enzymatic-dna-synthesis-to-india-through-imperial-life-sciences-partnership 2026-07-17T15:07:04+00:00 hourly 0.9 https://trial.medpath.com/news/g-h-to-showcase-integrated-diagnostic-device-development-and-manufacturing-capabilities-at-adlm-2026 2026-07-17T13:35:00+00:00 hourly 0.9 https://trial.medpath.com/news/antisense-oligonucleotides-rewriting-the-future-of-rare-inherited-genetic-diseases 2026-07-17T13:14:44+00:00 hourly 0.9 https://trial.medpath.com/news/illumina-launches-trupath-genome-a-395-whole-genome-workflow-targeting-rare-genetic-disease 2026-07-17T13:14:43+00:00 hourly 0.9 https://trial.medpath.com/news/amneal-secures-fda-approval-for-additional-generic-iohexol-injection-vial-presentations-expanding-contrast-media-portfolio 2026-07-17T13:14:29+00:00 hourly 0.9 https://trial.medpath.com/news/landmark-nhs-approval-of-dabrafenib-and-brentuximab-vedotin-combination-offers-new-hope-for-patients-with-rare-blood-cancers 2026-07-17T12:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/new-review-calls-for-prioritizing-maternal-mental-health-and-ssri-treatment-during-pregnancy 2026-07-17T11:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/gsk-halts-camlipixant-development-for-refractory-chronic-cough-after-mixed-phase-iii-results 2026-07-17T11:06:55+00:00 hourly 0.9 https://trial.medpath.com/news/human-cells-are-rewriting-the-rules-of-drug-development-ipscs-organoids-and-ai-converge-to-challenge-animal-models 2026-07-17T10:07:15+00:00 hourly 0.9 https://trial.medpath.com/news/the-next-era-of-aesthetic-medicine-from-treatment-stacking-to-regenerative-science 2026-07-17T09:29:00+00:00 hourly 0.9 https://trial.medpath.com/news/first-mrna-cancer-vaccine-clears-phase-3-moderna-and-merck-s-intismeran-autogene-succeeds-in-melanoma-trial 2026-07-17T09:07:11+00:00 hourly 0.9 https://trial.medpath.com/news/nurse-calls-for-mandatory-drug-safety-training-in-guernsey-to-address-gaps-in-adverse-drug-reaction-reporting 2026-07-17T08:07:09+00:00 hourly 0.9 https://trial.medpath.com/news/natera-s-signatera-becomes-first-approved-mrd-test-for-colorectal-cancer-in-japan 2026-07-17T06:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/three-strategies-to-reduce-data-friction-and-build-leaner-clinical-data-management-operations 2026-07-17T06:07:19+00:00 hourly 0.9 https://trial.medpath.com/news/dna-nanoplatform-delivers-dual-agent-therapy-to-combat-periodontitis-in-preclinical-study 2026-07-17T05:07:35+00:00 hourly 0.9 https://trial.medpath.com/news/hhs-research-agency-terminates-dozens-of-health-services-grants-halting-patient-care-studies-nationwide 2026-07-17T02:23:32+00:00 hourly 0.9 https://trial.medpath.com/news/lig1-loss-exposes-therapeutic-vulnerability-in-chemotherapy-resistant-triple-negative-breast-cancer 2026-07-17T02:23:26+00:00 hourly 0.9 https://trial.medpath.com/news/phgdh-driven-epigenetic-silencing-creates-immune-scarce-sanctuary-for-metastatic-seeds 2026-07-17T02:22:29+00:00 hourly 0.9 https://trial.medpath.com/news/terminally-ill-glioblastoma-patients-turn-to-unproven-treatments-abroad-amid-calls-for-more-uk-brain-cancer-research 2026-07-17T02:21:32+00:00 hourly 0.9 https://trial.medpath.com/news/house-bill-proposes-dedicated-biotechnology-official-at-the-state-department 2026-07-17T01:05:32+00:00 hourly 0.9 https://trial.medpath.com/news/the-test-of-time-why-breakthrough-drugs-so-often-disappoint 2026-07-17T00:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/senate-pushes-for-audit-of-tricare-pharmacy-program-amid-conflict-of-interest-concerns-over-express-scripts-dual-role 2026-07-17T00:01:00+00:00 hourly 0.9 https://trial.medpath.com/news/porcine-rotavirus-vaccines-face-a-cross-protection-gap-as-reassortant-strains-emerge 2026-07-17T00:01:00+00:00 hourly 0.9 https://trial.medpath.com/news/rare-gist-diagnosis-at-31-highlights-critical-need-for-early-detection-and-awareness-of-gastrointestinal-stromal-tumours 2026-07-16T23:08:38+00:00 hourly 0.9 https://trial.medpath.com/news/trellis-bioscience-raises-9-million-series-c-to-advance-novel-biofilm-disrupting-antibody-for-prosthetic-joint-infections 2026-07-16T23:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/researchers-uncover-novel-actin-mitochondria-glutamate-pathway-driving-epilepsy-opening-new-avenues-for-genetic-diagnosis-and-treatment 2026-07-16T23:08:33+00:00 hourly 0.9 https://trial.medpath.com/news/tampa-general-hospital-becomes-first-in-nation-to-sign-make-hospital-food-healthier-pledge-led-by-rfk-jr-and-michelin-star-chef 2026-07-16T23:08:18+00:00 hourly 0.9 https://trial.medpath.com/news/mirador-therapeutics-licenses-kp-301-a-long-acting-anti-c5a-antibody-expanding-into-anca-associated-vasculitis 2026-07-16T23:07:43+00:00 hourly 0.9 https://trial.medpath.com/news/jasper-therapeutics-merges-with-kira-pharmaceuticals-secures-132-million-to-advance-complement-and-immunology-pipeline 2026-07-16T22:09:59+00:00 hourly 0.9 https://trial.medpath.com/news/georgia-tech-launches-ai-driven-health-innovation-center-to-model-disease-at-the-cellular-level 2026-07-16T22:09:48+00:00 hourly 0.9 https://trial.medpath.com/news/cambridge-study-reveals-sweetener-isosteviol-combined-with-antidepressant-duloxetine-disrupts-key-gut-bacteria 2026-07-16T22:09:27+00:00 hourly 0.9 https://trial.medpath.com/news/deep-origin-secures-31-7m-arpa-h-contract-to-build-fda-qualifiable-virtual-human-platform-for-drug-testing 2026-07-16T22:09:03+00:00 hourly 0.9 https://trial.medpath.com/news/financial-conflicts-of-interest-pervasive-across-us-cancer-ecosystem-yale-meta-analysis-finds 2026-07-16T22:08:59+00:00 hourly 0.9 https://trial.medpath.com/news/elizabethtown-college-and-harford-community-college-launch-2-2-biotechnology-transfer-pathway 2026-07-16T20:11:27+00:00 hourly 0.9 https://trial.medpath.com/news/long-sleep-duration-linked-to-elevated-alzheimer-s-blood-biomarker-p-tau181 2026-07-16T20:10:05+00:00 hourly 0.9 https://trial.medpath.com/news/grifols-doses-first-patients-in-two-phase-3-trials-to-expand-labels-for-gamunex-c-and-xembify 2026-07-16T19:09:18+00:00 hourly 0.9 https://trial.medpath.com/news/amt-medical-s-sutureless-elana-bypass-system-meets-primary-endpoint-in-first-prospective-cabg-trial 2026-07-16T18:08:11+00:00 hourly 0.9 https://trial.medpath.com/news/first-in-vivo-pet-evidence-reveals-widespread-m1-receptor-deficits-in-living-schizophrenia-patients 2026-07-16T18:08:10+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-q2-earnings-cosentyx-and-kisqali-drive-growth-amid-entresto-decline-and-generic-pressures 2026-07-16T18:08:08+00:00 hourly 0.9 https://trial.medpath.com/news/ihh-healthcare-s-futurehealth-now-2026-redefining-the-care-stack-through-ai-precision-medicine-and-value-based-care 2026-07-16T18:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/definium-therapeutics-launches-wired-for-worry-initiative-to-advance-gad-education-for-healthcare-providers 2026-07-16T18:07:53+00:00 hourly 0.9 https://trial.medpath.com/news/ent-devices-market-to-reach-usd-44-91-billion-by-2035-as-minimally-invasive-surgery-and-otc-hearing-aids-drive-growth 2026-07-16T17:09:58+00:00 hourly 0.9 https://trial.medpath.com/news/oxford-researchers-map-multi-organ-damage-trajectories-in-hypertensive-pregnancy-to-predict-long-term-cardiovascular-risk 2026-07-16T17:08:16+00:00 hourly 0.9 https://trial.medpath.com/news/illumina-expands-billion-cell-atlas-program-with-ai-native-drug-developer-formation-bio 2026-07-16T17:07:53+00:00 hourly 0.9 https://trial.medpath.com/news/molecular-imaging-world-summit-2026-lafov-pet-ct-immunopet-and-theranostics-redefine-diagnostic-precision 2026-07-16T17:07:44+00:00 hourly 0.9 https://trial.medpath.com/news/cryo-em-reveals-first-3d-map-of-asic1a-channel-opening-new-avenues-for-stroke-drug-development 2026-07-16T17:07:07+00:00 hourly 0.9 https://trial.medpath.com/news/samsung-bioepis-and-organon-expand-australian-biosimilar-partnership-to-four-products-as-pbs-default-reform-looms 2026-07-16T16:09:42+00:00 hourly 0.9 https://trial.medpath.com/news/double-neural-bypass-brain-implant-restores-movement-and-sensation-in-man-with-quadriplegia 2026-07-16T16:09:19+00:00 hourly 0.9 https://trial.medpath.com/news/gary-r-morrow-pioneer-of-cancer-supportive-care-and-symptom-management-research-dies-at-82 2026-07-16T16:09:17+00:00 hourly 0.9 https://trial.medpath.com/news/drug-resistant-gonorrhoea-on-the-rise-in-europe-as-domestic-transmission-emerges-ecdc-warns 2026-07-16T16:09:12+00:00 hourly 0.9 https://trial.medpath.com/news/nash-treatment-market-accelerates-as-rezdiffra-and-wegovy-establish-fibrosis-defined-drug-pathways 2026-07-16T16:08:38+00:00 hourly 0.9 https://trial.medpath.com/news/university-of-naples-federico-ii-launches-pharmatech-academy-2026-2027-for-rna-and-gene-therapy-workforce-training 2026-07-16T16:08:12+00:00 hourly 0.9 https://trial.medpath.com/news/gsk-s-m72-as01e-tuberculosis-vaccine-candidate-advances-toward-global-access-with-serum-institute-of-india-manufacturing-agreement 2026-07-16T16:08:07+00:00 hourly 0.9 https://trial.medpath.com/news/crown-bioscience-joins-c-path-s-nams-developer-coalition-to-advance-human-relevant-models-in-oncology-drug-development 2026-07-16T16:07:22+00:00 hourly 0.9 https://trial.medpath.com/news/fda-accepts-shionogi-s-snda-for-fetroja-cefiderocol-in-pediatric-patients-with-serious-gram-negative-infections 2026-07-16T15:07:07+00:00 hourly 0.9 https://trial.medpath.com/news/ireland-defers-decision-on-skyclarys-for-friedreich-s-ataxia-amid-mounting-patient-pressure 2026-07-16T15:07:03+00:00 hourly 0.9 https://trial.medpath.com/news/cytotoxicity-assays-market-projected-to-reach-41-2-billion-by-2034-driven-by-drug-safety-demands-and-advanced-cell-models 2026-07-16T15:06:58+00:00 hourly 0.9 https://trial.medpath.com/news/attovia-therapeutics-raises-289m-in-upsized-ipo-to-advance-biparatopic-nanobody-pipeline-in-immunology 2026-07-16T14:08:53+00:00 hourly 0.9 https://trial.medpath.com/news/cryotherapeutics-treats-first-patient-in-icecap-trial-evaluating-localized-cryotherapy-for-vulnerable-coronary-plaques 2026-07-16T14:08:09+00:00 hourly 0.9 https://trial.medpath.com/news/shape-memory-medical-raises-10-million-to-advance-first-randomized-pivotal-trial-of-aneurysm-sac-embolization-after-evar 2026-07-16T14:07:44+00:00 hourly 0.9 https://trial.medpath.com/news/mhra-and-ema-accept-eisai-s-marketing-authorization-applications-for-insomnia-drug-lemborexant 2026-07-16T14:07:43+00:00 hourly 0.9 https://trial.medpath.com/news/arletta-pharma-secures-fda-endorsement-for-lybrido-phase-2-program-eyes-streamlined-path-to-nda-for-female-sexual-interest-arousal-disorder 2026-07-16T13:09:17+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-merck-s-oral-pcsk9-drug-a-first-in-class-cholesterol-treatment 2026-07-16T13:09:09+00:00 hourly 0.9 https://trial.medpath.com/news/new-jersey-adopts-landmark-reforms-requiring-confirmatory-drug-testing-before-reporting-pregnant-patients-to-child-welfare 2026-07-16T13:08:04+00:00 hourly 0.9 https://trial.medpath.com/news/ubrigene-launches-uvivo-lentiviral-vector-platform-to-accelerate-next-generation-in-vivo-car-t-therapies 2026-07-16T13:07:45+00:00 hourly 0.9 https://trial.medpath.com/news/telo-genomics-reports-positive-interim-data-for-3d-telomere-based-relapse-risk-assay-in-multiple-myeloma 2026-07-16T13:07:21+00:00 hourly 0.9 https://trial.medpath.com/news/mustardseed-launches-uk-operations-to-support-life-sciences-and-advanced-manufacturing-sectors-under-britain-s-modern-industrial-strategy 2026-07-16T12:09:12+00:00 hourly 0.9 https://trial.medpath.com/news/insmed-reports-positive-12-month-data-for-once-daily-inhaled-tpip-in-pulmonary-arterial-hypertension-showing-sustained-efficacy-and-favorable-safety 2026-07-16T12:09:11+00:00 hourly 0.9 https://trial.medpath.com/news/synthetic-control-arms-in-hematology-generative-ai-poised-to-reshape-cancer-trial-design 2026-07-16T12:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/cornerstone-robotics-to-showcase-sentire-surgical-system-and-ai-driven-vision-at-global-health-summit-2026 2026-07-16T12:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/4teen4-s-invobenitug-receives-fda-fast-track-designation-for-cardiogenic-shock 2026-07-16T10:14:10+00:00 hourly 0.9 https://trial.medpath.com/news/grunenthal-joins-munich-nucleic-acid-therapeutics-cluster-to-advance-oligonucleotide-based-pain-and-neurology-pipeline 2026-07-16T10:13:47+00:00 hourly 0.9 https://trial.medpath.com/news/eeg-and-machine-learning-reveal-how-autistic-brains-process-faces-differently-pointing-to-new-biomarker 2026-07-16T10:13:01+00:00 hourly 0.9 https://trial.medpath.com/news/california-employer-health-premiums-to-hit-30000-in-2027-largest-increase-in-16-years 2026-07-16T09:59:00+00:00 hourly 0.9 https://trial.medpath.com/news/rani-therapeutics-oral-glp-1-glp-2-capsule-rt-114-achieves-bioavailability-exceeding-150-of-subcutaneous-dose-in-phase-1a-trial 2026-07-16T08:08:03+00:00 hourly 0.9 https://trial.medpath.com/news/china-s-lab-monkey-prices-surge-to-pandemic-era-highs-disrupting-drug-r-d-studies 2026-07-16T08:07:34+00:00 hourly 0.9 https://trial.medpath.com/news/delaware-biomarker-testing-bill-heads-to-governor-after-legislative-approval 2026-07-16T08:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/oxb-selected-as-gmp-manufacturing-partner-for-plowshare-therapies-aav-gene-therapy-programme-targeting-rare-genetic-diseases 2026-07-16T07:09:37+00:00 hourly 0.9 https://trial.medpath.com/news/immune-cells-use-previously-unknown-tcr-dependent-mhc-independent-pathway-to-eliminate-aml 2026-07-16T07:08:47+00:00 hourly 0.9 https://trial.medpath.com/news/persistent-racial-and-gender-inequalities-in-nhs-specialty-training-recruitment-revealed-by-national-data 2026-07-16T06:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/eculizumab-induced-acute-heart-failure-decompensation-a-novel-cardiotoxic-signal-in-complement-mediated-tma 2026-07-16T05:08:15+00:00 hourly 0.9 https://trial.medpath.com/news/world-drowning-prevention-day-2026-who-led-global-initiative-targets-35-reduction-in-drowning-deaths-by-2035 2026-07-16T05:07:37+00:00 hourly 0.9 https://trial.medpath.com/news/vvmf-and-mirugen-partner-to-advance-aav-based-gene-therapy-manufacturing-for-retinitis-pigmentosa-in-australia 2026-07-16T05:07:35+00:00 hourly 0.9 https://trial.medpath.com/news/cyclosporiasis-cases-surge-to-55-in-kansas-as-cdc-investigates-nationwide-outbreaks 2026-07-16T04:06:49+00:00 hourly 0.9 https://trial.medpath.com/news/deaths-from-coronary-artery-disease-have-fallen-by-over-half-since-1990-yet-nearly-90-of-recent-deaths-remain-preventable 2026-07-16T04:06:40+00:00 hourly 0.9 https://trial.medpath.com/news/whiddon-college-of-medicine-hosts-53rd-annual-medical-student-research-day-with-69-student-researchers 2026-07-16T04:06:39+00:00 hourly 0.9 https://trial.medpath.com/news/new-york-state-health-department-issues-mosquito-borne-disease-alert-as-west-nile-virus-detected-in-three-counties 2026-07-16T03:06:42+00:00 hourly 0.9 https://trial.medpath.com/news/telix-opens-australia-s-first-integrated-radiopharmaceutical-facility-to-accelerate-cancer-theranostics 2026-07-16T03:06:06+00:00 hourly 0.9 https://trial.medpath.com/news/loneliness-linked-to-poorer-mental-and-general-health-distinct-from-social-isolation-triangulation-study-finds 2026-07-16T02:09:35+00:00 hourly 0.9 https://trial.medpath.com/news/cdd-vault-user-group-meeting-brings-drug-discovery-professionals-together-in-boston 2026-07-16T01:07:09+00:00 hourly 0.9 https://trial.medpath.com/news/emergent-vibrio-parahaemolyticus-gastroenteritis-outbreaks-in-new-zealand-2019-2022-trans-pacific-spread-of-st36-and-emergence-of-st50 2026-07-16T00:07:52+00:00 hourly 0.9 https://trial.medpath.com/news/shy-therapeutics-doses-first-patient-in-phase-i-trial-of-novel-19s-proteasome-inhibitor-shy-onc6-for-solid-tumors 2026-07-16T00:07:50+00:00 hourly 0.9 https://trial.medpath.com/news/mississippi-joins-29-6-million-multistate-settlement-with-glenmark-over-generic-drug-price-fixing-allegations 2026-07-15T23:07:20+00:00 hourly 0.9 https://trial.medpath.com/news/nih-launches-population-genomic-screening-network-to-bring-preventative-genomics-into-primary-care 2026-07-15T22:12:15+00:00 hourly 0.9 https://trial.medpath.com/news/study-narrows-list-of-genetic-suspects-behind-adolescent-idiopathic-scoliosis 2026-07-15T22:11:32+00:00 hourly 0.9 https://trial.medpath.com/news/vietnam-s-pharma-market-set-to-top-10-billion-by-2026-amid-regulatory-reforms-and-demographic-shifts 2026-07-15T22:11:21+00:00 hourly 0.9 https://trial.medpath.com/news/telangana-merges-food-safety-and-drugs-control-departments-into-unified-regulatory-body-tg-safe 2026-07-15T20:14:58+00:00 hourly 0.9 https://trial.medpath.com/news/aladynoulli-a-bayesian-generative-model-integrates-ehr-and-genetic-data-to-outperform-clinical-risk-scores-in-disease-prediction 2026-07-15T20:14:54+00:00 hourly 0.9 https://trial.medpath.com/news/retraction-count-for-anesthesiologist-joachim-boldt-reaches-240-as-journals-continue-purging-fraudulent-papers 2026-07-15T20:14:38+00:00 hourly 0.9 https://trial.medpath.com/news/ai-tool-aladynoulli-predicts-risk-of-348-diseases-from-routine-health-records-outperforming-existing-risk-models 2026-07-15T20:14:34+00:00 hourly 0.9 https://trial.medpath.com/news/how-epstein-barr-virus-triggers-immune-response-in-multiple-sclerosis-new-mechanistic-insights 2026-07-15T20:13:57+00:00 hourly 0.9 https://trial.medpath.com/news/bipartisan-bill-seeks-to-streamline-fda-biosimilar-approvals-expand-access-to-lower-cost-biologics 2026-07-15T20:13:55+00:00 hourly 0.9 https://trial.medpath.com/news/thyme-care-raises-125-million-valuation-tops-2-billion-as-it-expands-beyond-navigation 2026-07-15T20:13:51+00:00 hourly 0.9 https://trial.medpath.com/news/pepmd-launches-to-establish-credentialing-and-trust-standards-for-peptide-medicine 2026-07-15T20:12:22+00:00 hourly 0.9 https://trial.medpath.com/news/cumberland-pharmaceuticals-ifetroban-advances-across-multiple-rare-disease-indications 2026-07-15T20:11:31+00:00 hourly 0.9 https://trial.medpath.com/news/bipartisan-bill-seeks-to-streamline-biosimilar-approvals-lower-prescription-drug-costs 2026-07-15T20:11:29+00:00 hourly 0.9 https://trial.medpath.com/news/sinopia-biosciences-sb-0110-shows-preclinical-promise-in-boosting-l-dopa-efficacy-while-reducing-dyskinesia-in-parkinson-s-disease 2026-07-15T19:10:02+00:00 hourly 0.9 https://trial.medpath.com/news/illinois-advances-breakthrough-psychedelic-therapies-for-veteran-suicide-prevention-through-new-legislation 2026-07-15T19:09:32+00:00 hourly 0.9 https://trial.medpath.com/news/advancell-raises-record-450-million-to-advance-lead-212-alpha-therapy-into-phase-iii-for-prostate-cancer 2026-07-15T19:09:18+00:00 hourly 0.9 https://trial.medpath.com/news/nature-portfolio-opens-submissions-for-macrophages-in-cancer-collection 2026-07-15T19:09:16+00:00 hourly 0.9 https://trial.medpath.com/news/fast-02-trial-shows-proton-flash-radiotherapy-delivers-75-complete-pain-relief-for-thoracic-bone-metastases-with-no-serious-adverse-events 2026-07-15T18:07:39+00:00 hourly 0.9 https://trial.medpath.com/news/global-childhood-immunization-rates-stall-at-90-dtp-coverage-13-5-million-children-remain-zero-dose-in-2025 2026-07-15T18:07:26+00:00 hourly 0.9 https://trial.medpath.com/news/anova-and-nouveau-biosciences-partner-to-advance-first-in-human-trial-of-nanomedicine-kromastat-for-t-cell-lymphomas 2026-07-15T18:06:37+00:00 hourly 0.9 https://trial.medpath.com/news/johnson-johnson-launches-up-to-750-million-pharmaceutical-supply-chain-restructuring-exiting-select-manufacturing-sites 2026-07-15T18:06:30+00:00 hourly 0.9 https://trial.medpath.com/news/johnson-johnson-beats-q2-estimates-raises-full-year-2026-guidance-on-strong-pharmaceutical-sales 2026-07-15T17:07:04+00:00 hourly 0.9 https://trial.medpath.com/news/cdc-director-nominee-erica-schwartz-affirms-support-for-mrna-vaccines-in-senate-confirmation-hearing 2026-07-15T17:07:01+00:00 hourly 0.9 https://trial.medpath.com/news/leading-women-s-health-organizations-launch-national-strategy-to-close-the-women-s-health-gap-calling-for-20-billion-congressional-investment 2026-07-15T16:13:11+00:00 hourly 0.9 https://trial.medpath.com/news/adlm-2026-to-showcase-breakthroughs-in-diabetes-space-medicine-alzheimer-s-down-syndrome-link-and-cancer-diagnostics 2026-07-15T16:12:38+00:00 hourly 0.9 https://trial.medpath.com/news/dyne-therapeutics-nears-first-commercial-launch-with-z-rostudirsen-pdufa-set-for-january-21-in-duchenne-muscular-dystrophy 2026-07-15T16:12:36+00:00 hourly 0.9 https://trial.medpath.com/news/texas-children-s-physician-scientist-wins-700000-burroughs-wellcome-fund-award-to-uncover-genetic-drivers-of-rare-immune-disorders 2026-07-15T16:11:56+00:00 hourly 0.9 https://trial.medpath.com/news/phase-1b-trial-shows-short-lived-anti-pd-l1-antibody-ibc-ab002-is-well-tolerated-in-early-alzheimer-s-disease 2026-07-15T16:11:52+00:00 hourly 0.9 https://trial.medpath.com/news/fighting-data-fragmentation-emerges-as-the-next-frontier-for-life-sciences-innovation 2026-07-15T16:11:08+00:00 hourly 0.9 https://trial.medpath.com/news/septa-pharmaceuticals-acquires-ceenu-lomustine-from-bristol-myers-squibb-canada-strengthening-oncology-portfolio 2026-07-15T16:09:51+00:00 hourly 0.9 https://trial.medpath.com/news/allogeneic-car-t-cell-therapy-allo-316-demonstrates-durable-responses-in-advanced-clear-cell-renal-cell-carcinoma 2026-07-15T16:09:26+00:00 hourly 0.9 https://trial.medpath.com/news/maxona-pharmaceuticals-receives-fda-ind-clearance-for-max-001-phase-2-acute-pain-trial 2026-07-15T16:08:40+00:00 hourly 0.9 https://trial.medpath.com/news/optimaize-ai-driven-closed-loop-platform-aims-to-accelerate-antibiotic-development-against-multidrug-resistant-bacteria 2026-07-15T16:08:39+00:00 hourly 0.9 https://trial.medpath.com/news/nutrafol-study-demonstrates-19-37-faster-hair-growth-in-women-using-multi-targeting-nutraceuticals 2026-07-15T16:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/new-therapeutic-targets-and-immunotherapy-approaches-emerge-for-cerebral-small-vessel-disease 2026-07-15T16:07:56+00:00 hourly 0.9 https://trial.medpath.com/news/wearable-microneedle-patches-move-toward-real-time-closed-loop-drug-monitoring 2026-07-15T16:07:24+00:00 hourly 0.9 https://trial.medpath.com/news/bambusa-therapeutics-appoints-howard-liang-to-board-establishes-scientific-advisory-board-to-guide-bispecific-antibody-pipeline 2026-07-15T16:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/latent-labs-launches-latent-y-first-lab-validated-ai-drug-design-agent-to-researchers-worldwide 2026-07-15T16:07:20+00:00 hourly 0.9 https://trial.medpath.com/news/mhra-strengthens-safety-warnings-for-botulinum-toxin-type-a-products-following-rare-cases-of-iatrogenic-botulism 2026-07-15T15:07:53+00:00 hourly 0.9 https://trial.medpath.com/news/orasis-pharmaceuticals-and-aspen-submit-new-drug-application-in-australia-for-beska-pilocarpine-hcl-0-4-for-presbyopia 2026-07-15T15:07:52+00:00 hourly 0.9 https://trial.medpath.com/news/florida-cancer-specialists-research-institute-appoints-dr-amanda-olson-as-medical-director-of-late-phase-research 2026-07-15T15:07:47+00:00 hourly 0.9 https://trial.medpath.com/news/neurothera-labs-initiates-phase-iib-trial-of-cannabinoid-based-sci-110-for-tourette-syndrome-at-hannover-medical-school 2026-07-15T14:07:01+00:00 hourly 0.9 https://trial.medpath.com/news/tonix-pharmaceuticals-identifies-three-new-murine-models-for-mpox-reveals-2022-clade-iib-is-up-to-100000-fold-less-virulent-than-2003-clade-iia 2026-07-15T14:06:50+00:00 hourly 0.9 https://trial.medpath.com/news/kairos-pharma-reports-zero-grade-3-toxicities-in-phase-1-trial-of-env-105-for-egfr-mutated-lung-cancer 2026-07-15T14:06:41+00:00 hourly 0.9 https://trial.medpath.com/news/fgfr-inhibitor-cancer-drugs-linked-to-dry-eye-and-corneal-damage-in-faers-analysis 2026-07-15T13:07:49+00:00 hourly 0.9 https://trial.medpath.com/news/nmpa-clears-ind-for-hbm7575-skb575-a-long-acting-tslp-bispecific-antibody-for-asthma 2026-07-15T12:08:56+00:00 hourly 0.9 https://trial.medpath.com/news/genetic-study-reveals-elevated-risk-of-rare-inherited-diseases-in-scottish-traveller-founder-population 2026-07-15T12:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/gw-rhythmx-launches-rhythmx-pulse-on-microsoft-marketplace-integrating-precision-care-ai-with-dragon-copilot 2026-07-15T12:08:52+00:00 hourly 0.9 https://trial.medpath.com/news/lemon-frost-gecko-emerges-as-promising-natural-model-for-human-cancer-research 2026-07-15T12:07:33+00:00 hourly 0.9 https://trial.medpath.com/news/recell-go-demonstrates-successful-first-clinical-use-in-uk-burn-surgery-supporting-global-adoption-of-automated-autologous-cell-therapy 2026-07-15T12:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/simris-biologics-appoints-adc-expert-professor-andreas-pahl-as-ceo-to-advance-microcystin-payload-platform 2026-07-15T11:07:02+00:00 hourly 0.9 https://trial.medpath.com/news/nbj-summit-2026-announces-keynote-lineup-ai-driven-healthcare-biohacking-and-leadership-take-center-stage 2026-07-15T11:05:00+00:00 hourly 0.9 https://trial.medpath.com/news/mapping-the-tumor-microenvironment-immune-pathway-signatures-predict-immunotherapy-outcomes-in-melanoma 2026-07-15T10:07:48+00:00 hourly 0.9 https://trial.medpath.com/news/roche-s-trontinemab-enters-landmark-trial-to-prevent-alzheimer-s-before-symptoms-emerge 2026-07-15T10:07:42+00:00 hourly 0.9 https://trial.medpath.com/news/england-on-track-to-eliminate-hepatitis-c-ahead-of-who-2030-target-following-nhs-drug-deal-and-targeted-screening 2026-07-15T10:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/bangladesh-drug-pricing-deadlock-stalls-hundreds-of-new-medicines-threatens-industry-innovation 2026-07-15T10:07:17+00:00 hourly 0.9 https://trial.medpath.com/news/59-of-clinical-trial-sites-losing-eligible-patients-to-process-inefficiencies-survey-reveals 2026-07-15T10:06:41+00:00 hourly 0.9 https://trial.medpath.com/news/moderna-files-countersuit-against-curevac-in-ongoing-covid-19-mrna-vaccine-patent-dispute 2026-07-15T09:06:50+00:00 hourly 0.9 https://trial.medpath.com/news/ai-accelerates-cancer-drug-discovery-sk-telecom-and-sk-biopharmaceuticals-identify-ror1-targeting-compounds-in-five-months 2026-07-15T09:06:36+00:00 hourly 0.9 https://trial.medpath.com/news/permanent-daylight-saving-time-vs-standard-time-what-the-science-says-about-health-impacts 2026-07-15T08:12:00+00:00 hourly 0.9 https://trial.medpath.com/news/egfr-tkis-pose-highest-cardiovascular-risk-among-tyrosine-kinase-inhibitors-meta-analysis-finds 2026-07-15T08:09:25+00:00 hourly 0.9 https://trial.medpath.com/news/billiontoone-to-report-second-quarter-2026-financial-results-on-august-5-2026 2026-07-15T08:06:00+00:00 hourly 0.9 https://trial.medpath.com/news/sandoz-reshuffles-leadership-bouye-to-head-generics-manufacturing-haruvi-adds-global-m-a-oversight 2026-07-15T07:10:56+00:00 hourly 0.9 https://trial.medpath.com/news/judge-tosses-vanda-s-fight-against-fda-s-drug-approval-structure 2026-07-15T07:10:16+00:00 hourly 0.9 https://trial.medpath.com/news/tissue-resident-macrophages-emerge-as-master-regulators-of-aging-through-ep2-driven-neutrophil-clearance 2026-07-15T07:09:43+00:00 hourly 0.9 https://trial.medpath.com/news/guided-therapeutics-advances-china-expansion-with-new-distribution-agreement-and-purchase-order-payments-for-luviva-cervical-scan 2026-07-15T07:09:17+00:00 hourly 0.9 https://trial.medpath.com/news/recursion-pharmaceuticals-ai-driven-drug-discovery-platform-faces-pipeline-validation-hurdles-amid-mixed-analyst-sentiment 2026-07-15T07:09:10+00:00 hourly 0.9 https://trial.medpath.com/news/south-korea-s-mfds-advances-formal-regulatory-framework-for-cell-cultured-processed-foods 2026-07-15T06:34:00+00:00 hourly 0.9 https://trial.medpath.com/news/gem-commits-up-to-nt-500-million-to-senhwa-biosciences-to-advance-oncology-pipeline 2026-07-15T06:07:24+00:00 hourly 0.9 https://trial.medpath.com/news/lytac-therapy-targets-root-cause-of-diabetic-foot-ulcers-by-removing-excess-inflammatory-proteins 2026-07-15T04:07:25+00:00 hourly 0.9 https://trial.medpath.com/news/cancervax-unveils-polyepitope-smart-mrna-platform-that-disguises-cancer-as-multiple-viral-infections-achieving-99-5-global-population-coverage 2026-07-15T04:07:15+00:00 hourly 0.9 https://trial.medpath.com/news/rts-s-malaria-vaccine-shows-early-impact-in-cameroon-but-fourth-dose-drop-off-threatens-durability-of-protection 2026-07-15T01:17:00+00:00 hourly 0.9 https://trial.medpath.com/news/alabama-state-university-and-callan-jmb-forge-landmark-partnership-to-transform-marion-into-a-national-pharmaceutical-manufacturing-hub 2026-07-15T01:06:44+00:00 hourly 0.9 https://trial.medpath.com/news/snmmi-and-pcf-award-600000-to-young-investigators-advancing-next-generation-radiopharmaceutical-and-combination-therapies-for-prostate-cancer 2026-07-15T01:06:33+00:00 hourly 0.9 https://trial.medpath.com/news/tumor-microenvironment-ecotypes-may-explain-differences-in-multiple-myeloma-outcomes 2026-07-15T01:06:29+00:00 hourly 0.9 https://trial.medpath.com/news/hudsonalpha-s-bridges-engine-secures-up-to-160-million-nsf-award-to-build-rural-bioeconomy-in-alabama-and-tennessee 2026-07-15T01:06:25+00:00 hourly 0.9 https://trial.medpath.com/news/full-spectrum-cannabis-oil-linked-to-improved-quality-of-life-and-sleep-satisfaction-in-medical-marijuana-patients 2026-07-15T01:06:22+00:00 hourly 0.9 https://trial.medpath.com/news/mri-linac-adoption-expands-as-centers-report-real-time-precision-radiation-therapy 2026-07-14T23:07:09+00:00 hourly 0.9 https://trial.medpath.com/news/trump-administration-abandons-rule-to-withhold-medicare-and-medicaid-funding-over-pediatric-gender-affirming-care 2026-07-14T22:09:11+00:00 hourly 0.9 https://trial.medpath.com/news/hawley-walks-out-of-senate-patent-hearing-after-clash-over-drug-prices-and-pera-legislation 2026-07-14T22:08:10+00:00 hourly 0.9 https://trial.medpath.com/news/environmental-testing-begins-in-ladera-ranch-after-rare-childhood-cancer-cluster-concerns 2026-07-14T21:41:00+00:00 hourly 0.9 https://trial.medpath.com/news/boostimmune-secures-japanese-patent-for-tctp-targeting-antibody-technology-to-advance-cancer-immunotherapy 2026-07-14T21:07:43+00:00 hourly 0.9 https://trial.medpath.com/news/high-q-technologies-deploys-quantum-epr-sensors-to-accelerate-drug-discovery-for-alzheimer-s-and-neurodegenerative-diseases 2026-07-14T20:13:21+00:00 hourly 0.9 https://trial.medpath.com/news/global-review-identifies-11-high-potential-preclinical-candidates-for-preeclampsia-exposing-gaps-in-evidence-quality-and-therapeutic-diversity 2026-07-14T20:13:20+00:00 hourly 0.9 https://trial.medpath.com/news/ftc-secures-landmark-settlement-with-cvs-caremark-to-reshape-pbm-business-practices-and-lower-drug-costs 2026-07-14T20:12:51+00:00 hourly 0.9 https://trial.medpath.com/news/personalized-vaccines-plus-checkpoint-inhibitors-proposed-as-a-new-therapeutic-frontier-for-endometriosis 2026-07-14T20:12:48+00:00 hourly 0.9 https://trial.medpath.com/news/milky-white-blood-in-infant-reveals-ultra-rare-familial-lipoprotein-lipase-deficiency 2026-07-14T20:12:18+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-replimune-s-twice-rejected-melanoma-viral-therapy-tudriqev-after-white-house-intervention 2026-07-14T20:11:43+00:00 hourly 0.9 https://trial.medpath.com/news/ark-invest-exits-biontech-position-amid-revenue-decline-and-leadership-transition 2026-07-14T20:10:58+00:00 hourly 0.9 https://trial.medpath.com/news/marchesini-group-to-showcase-pharma-and-aseptic-packaging-innovations-at-cphi-2026-in-milan 2026-07-14T20:10:47+00:00 hourly 0.9 https://trial.medpath.com/news/roswell-park-showcases-ai-powered-oral-cancer-detection-platform-and-precision-advances-at-ahns-2026 2026-07-14T20:10:46+00:00 hourly 0.9 https://trial.medpath.com/news/moderna-braces-for-uneventful-q2-as-investors-eye-pivotal-melanoma-vaccine-data-in-2026 2026-07-14T19:08:49+00:00 hourly 0.9 https://trial.medpath.com/news/south-african-researcher-awarded-r3m-grant-to-advance-trop2-targeted-theranostics-for-breast-cancer 2026-07-14T19:08:47+00:00 hourly 0.9 https://trial.medpath.com/news/avere-therapeutics-to-go-public-via-nextcure-merger-secures-320-million-to-advance-once-weekly-oral-il-23-antagonist-for-psoriasis 2026-07-14T18:07:40+00:00 hourly 0.9 https://trial.medpath.com/news/geneseeq-canada-named-first-genomic-testing-partner-in-uhn-s-sherlock-study-a-7000-patient-prospective-cancer-genomics-platform 2026-07-14T18:07:30+00:00 hourly 0.9 https://trial.medpath.com/news/nucleome-therapeutics-secures-us-patent-for-micro-capture-c-3d-genomics-platform-advancing-first-in-class-inflammatory-disease-pipeline 2026-07-14T18:07:23+00:00 hourly 0.9 https://trial.medpath.com/news/american-red-cross-declares-emergency-blood-shortage-as-supply-drops-to-crisis-levels 2026-07-14T17:39:00+00:00 hourly 0.9 https://trial.medpath.com/news/alport-syndrome-market-projected-to-surge-at-47-cagr-through-2036-fueled-by-emerging-disease-modifying-therapies 2026-07-14T17:10:16+00:00 hourly 0.9 https://trial.medpath.com/news/influenza-b-triggers-earlier-more-robust-immune-response-than-influenza-a-study-finds 2026-07-14T17:08:22+00:00 hourly 0.9 https://trial.medpath.com/news/exosomes-as-early-biomarkers-for-diabetes-tiny-vesicles-may-reveal-disease-before-symptoms-emerge 2026-07-14T17:08:17+00:00 hourly 0.9 https://trial.medpath.com/news/acrobiosystems-secures-pmda-material-suitability-confirmation-for-gmp-grade-il-15-streamlining-cell-therapy-approvals-in-japan 2026-07-14T17:07:07+00:00 hourly 0.9 https://trial.medpath.com/news/u-s-desiccants-market-projected-to-reach-565-78-million-by-2035-driven-by-pharmaceutical-and-biologics-packaging-demand 2026-07-14T17:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/lyora-therapeutics-launches-with-2-5m-seed-funding-to-advance-genetic-medicines-for-inherited-retinal-diseases 2026-07-14T17:06:59+00:00 hourly 0.9 https://trial.medpath.com/news/the-technology-is-ready-are-apac-s-regulators-continuous-manufacturing-faces-a-standoff-in-asia-pacific 2026-07-14T16:10:18+00:00 hourly 0.9 https://trial.medpath.com/news/innopharm-2026-to-convene-global-pharmaceutical-r-d-leaders-in-boston 2026-07-14T16:09:07+00:00 hourly 0.9 https://trial.medpath.com/news/global-vaccine-sales-market-to-reach-us-141-40-billion-by-2036-as-next-generation-platforms-accelerate-growth 2026-07-14T16:09:07+00:00 hourly 0.9 https://trial.medpath.com/news/immunobrain-s-anti-pd-l1-antibody-ibc-ab002-shows-early-biomarker-signal-in-phase-1b-alzheimer-s-trial-published-in-nature-medicine 2026-07-14T16:08:30+00:00 hourly 0.9 https://trial.medpath.com/news/masked-t-cell-engagers-and-pasritamig-raise-new-hope-for-advanced-prostate-cancer-immunotherapy 2026-07-14T16:07:12+00:00 hourly 0.9 https://trial.medpath.com/news/medunik-canada-secures-exclusive-distribution-rights-for-increlex-r-mecasermin-in-canada-bolstering-access-for-children-with-severe-primary-igf-1-deficiency 2026-07-14T16:07:10+00:00 hourly 0.9 https://trial.medpath.com/news/applied-biologics-manufactures-first-research-construct-for-disease-modifying-osteoarthritis-gene-therapy 2026-07-14T16:06:48+00:00 hourly 0.9 https://trial.medpath.com/news/umass-amherst-secures-2-1-million-for-advanced-optical-tweezers-and-micro-patterning-systems-to-accelerate-drug-discovery 2026-07-14T16:06:47+00:00 hourly 0.9 https://trial.medpath.com/news/biotech-visionary-john-f-crowley-to-keynote-emily-whitehead-foundation-s-2026-believe-ball-in-philadelphia 2026-07-14T15:06:56+00:00 hourly 0.9 https://trial.medpath.com/news/trump-administration-s-voluntary-mfn-drug-pricing-agreements-reshape-strategy-at-pfizer-abbvie-and-bristol-myers-squibb 2026-07-14T15:06:35+00:00 hourly 0.9 https://trial.medpath.com/news/lexitas-and-ocusun-launch-pilot-study-of-lanosterol-derived-eye-drop-for-age-related-cataract 2026-07-14T15:06:32+00:00 hourly 0.9 https://trial.medpath.com/news/sleep-habits-may-modify-how-aqp4-gene-variants-shape-early-alzheimer-s-brain-changes 2026-07-14T14:39:00+00:00 hourly 0.9 https://trial.medpath.com/news/mytomorrows-survey-reveals-52-of-clinical-trial-sites-say-1-in-5-referrals-are-ineligible-before-screening-even-begins 2026-07-14T14:08:14+00:00 hourly 0.9 https://trial.medpath.com/news/supernus-marks-five-years-of-qelbree-the-first-novel-non-stimulant-adhd-treatment-in-over-a-decade 2026-07-14T14:07:54+00:00 hourly 0.9 https://trial.medpath.com/news/inductive-bio-wins-third-consecutive-ai-drug-discovery-benchmark-topping-350-competitors-in-pxr-blind-challenge 2026-07-14T14:07:31+00:00 hourly 0.9 https://trial.medpath.com/news/new-drug-rso-021-shows-promise-in-mesothelioma-trial-by-targeting-cancer-s-energy-system 2026-07-14T14:07:29+00:00 hourly 0.9 https://trial.medpath.com/news/huyabio-s-hbi-8000-plus-nivolumab-delivers-58-improvement-in-progression-free-survival-in-phase-3-advanced-melanoma-trial 2026-07-14T14:07:12+00:00 hourly 0.9 https://trial.medpath.com/news/laboratory-operations-innovator-chris-clendening-joins-precision-for-medicine-to-lead-global-specialty-labs 2026-07-14T14:07:11+00:00 hourly 0.9 https://trial.medpath.com/news/epilepsygtx-partners-with-clearpoint-neuro-for-precision-delivery-of-gene-therapy-epy201-in-focal-refractory-epilepsy-trial 2026-07-14T14:06:38+00:00 hourly 0.9 https://trial.medpath.com/news/skinmedica-deepens-regenerative-science-commitment-with-advisory-board-launch-r-d-expansion-and-flagship-retail-debut 2026-07-14T13:08:14+00:00 hourly 0.9 https://trial.medpath.com/news/atrium-therapeutics-secures-fda-clearance-of-ind-for-atr-1072-first-disease-modifying-therapy-for-prkag2-syndrome 2026-07-14T13:06:47+00:00 hourly 0.9 https://trial.medpath.com/news/summit-therapeutics-sells-phase-iii-antibiotic-ridinilazole-to-ai-native-biossil-in-deal-worth-up-to-104-5-million 2026-07-14T13:06:41+00:00 hourly 0.9 https://trial.medpath.com/news/evonik-invests-100-million-to-modernize-indiana-api-manufacturing-facility-expanding-u-s-cdmo-capabilities 2026-07-14T12:10:48+00:00 hourly 0.9 https://trial.medpath.com/news/spero-therapeutics-secures-105-million-non-dilutive-royalty-financing-to-advance-anti-cd40l-antibody-sp001 2026-07-14T12:09:33+00:00 hourly 0.9 https://trial.medpath.com/news/innovent-and-spero-strike-1-1-billion-deal-for-third-generation-anti-cd40l-antibody-targeting-igg4-rd-and-sjogren-s-disease 2026-07-14T12:09:08+00:00 hourly 0.9 https://trial.medpath.com/news/late-stage-ckd-therapeutics-market-projected-to-reach-25-2-billion-by-2032-driven-by-integrated-cardio-renal-strategies-and-emerging-biologics 2026-07-14T11:09:05+00:00 hourly 0.9 https://trial.medpath.com/news/annexon-perfect-complement-to-a-speculative-biotech-portfolio 2026-07-14T11:09:02+00:00 hourly 0.9 https://trial.medpath.com/news/draig-therapeutics-secures-65m-series-b-to-advance-dt-101-phase-2-trials-in-major-depressive-disorder 2026-07-14T11:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/physiomics-director-ian-bagnall-increases-stake-with-ps5000-share-purchase 2026-07-14T09:07:25+00:00 hourly 0.9 https://trial.medpath.com/news/pervasive-gene-environment-interactions-reshape-polygenic-risk-score-utility-across-exposures 2026-07-14T09:07:10+00:00 hourly 0.9 https://trial.medpath.com/news/iluvien-meets-both-co-primary-endpoints-in-phase-4-synchronicity-trial-for-chronic-non-infectious-uveitis 2026-07-14T09:07:06+00:00 hourly 0.9 https://trial.medpath.com/news/myotonia-may-amplify-muscle-damage-in-myotonic-dystrophy-type-1-new-study-reveals 2026-07-14T08:09:33+00:00 hourly 0.9 https://trial.medpath.com/news/roche-launches-first-fully-automated-hepatitis-d-virus-diagnostic-test-addressing-critical-unmet-need 2026-07-14T07:09:14+00:00 hourly 0.9 https://trial.medpath.com/news/delhi-high-court-grants-quia-timet-injunction-barring-intas-from-launching-novartis-patented-dabrafenib 2026-07-14T07:09:06+00:00 hourly 0.9 https://trial.medpath.com/news/foundation-for-sarcoidosis-research-launches-groundbreaking-clinical-data-registry-across-13-leading-us-institutions 2026-07-14T06:48:00+00:00 hourly 0.9 https://trial.medpath.com/news/ai-eye-imaging-models-accelerate-ophthalmic-clinical-trial-recruitment-and-drug-development 2026-07-14T06:10:39+00:00 hourly 0.9 https://trial.medpath.com/news/crispr-therapeutics-and-vertex-s-casgevy-first-regulatory-approved-cell-based-gene-therapy-for-sickle-cell-disease-and-beta-thalassemia 2026-07-14T04:53:00+00:00 hourly 0.9 https://trial.medpath.com/news/brazil-weighs-patent-term-adjustment-legislation-as-pharmaceutical-innovation-faces-uncertainty 2026-07-14T02:09:36+00:00 hourly 0.9 https://trial.medpath.com/news/ireland-s-orphan-drug-access-crisis-reimbursement-delays-leave-rare-disease-patients-waiting-years 2026-07-14T02:09:35+00:00 hourly 0.9 https://trial.medpath.com/news/nearly-6-in-10-young-women-get-health-information-from-influencers-pew-survey-finds 2026-07-14T01:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/phase-iii-jcog1403-trial-single-dose-intravesical-pirarubicin-cuts-bladder-recurrence-after-nephroureterectomy 2026-07-14T00:10:05+00:00 hourly 0.9 https://trial.medpath.com/news/fda-finalizes-guidance-on-formal-meetings-with-drug-and-biologics-sponsors 2026-07-13T22:12:04+00:00 hourly 0.9 https://trial.medpath.com/news/blood-based-biomarker-tests-poised-to-transform-alzheimer-s-diagnosis-in-primary-care 2026-07-13T22:11:52+00:00 hourly 0.9 https://trial.medpath.com/news/protect-our-care-launches-national-sick-of-it-fix-health-care-now-campaign-across-nine-states 2026-07-13T22:10:54+00:00 hourly 0.9 https://trial.medpath.com/news/targeted-therapies-transform-stage-4-lung-cancer-from-death-sentence-to-chronic-condition 2026-07-13T22:10:32+00:00 hourly 0.9 https://trial.medpath.com/news/cu-anschutz-school-of-medicine-welcomes-class-of-2030-at-annual-matriculation-ceremony 2026-07-13T21:09:40+00:00 hourly 0.9 https://trial.medpath.com/news/electronic-symptom-monitoring-reduces-disparities-in-advanced-cancer-care-pro-tect-trial-shows 2026-07-13T19:14:22+00:00 hourly 0.9 https://trial.medpath.com/news/prolonged-spaceflight-linked-to-female-reproductive-dysfunction-and-transgenerational-effects-in-landmark-mouse-study 2026-07-13T19:14:14+00:00 hourly 0.9 https://trial.medpath.com/news/wvu-medicine-wetzel-county-hospital-expands-outpatient-infusion-center-to-seven-day-service 2026-07-13T19:14:11+00:00 hourly 0.9 https://trial.medpath.com/news/epigenetic-therapy-ntx-301-activates-hippo-pathway-to-overcome-treatment-resistant-aml 2026-07-13T19:12:02+00:00 hourly 0.9 https://trial.medpath.com/news/single-molecule-imaging-reveals-how-copper-imbalance-may-drive-alzheimer-s-parkinson-s-and-als 2026-07-13T19:11:29+00:00 hourly 0.9 https://trial.medpath.com/news/genome-scale-crispri-atlas-maps-gene-function-across-2-5-million-human-ipscs 2026-07-13T17:13:22+00:00 hourly 0.9 https://trial.medpath.com/news/beyond-the-pill-rna-interference-aldosterone-synthase-inhibition-and-incretins-reshape-hypertension-drug-development 2026-07-13T17:13:06+00:00 hourly 0.9 https://trial.medpath.com/news/federated-learning-gains-momentum-in-drug-discovery-as-pharma-giants-and-biotechs-build-collaborative-ai-networks 2026-07-13T17:13:01+00:00 hourly 0.9 https://trial.medpath.com/news/periscope-ii-gastrectomy-cytoreductive-surgery-and-hipec-do-not-improve-survival-in-gastric-cancer-with-limited-peritoneal-metastases 2026-07-13T17:11:00+00:00 hourly 0.9 https://trial.medpath.com/news/enovis-launches-next-generation-ct-revitl-veterinary-laser-therapy-system-in-the-u-s 2026-07-13T17:10:58+00:00 hourly 0.9 https://trial.medpath.com/news/uk-locks-pharma-patent-protections-into-swiss-trade-deal-sparking-nhs-cost-concerns 2026-07-13T17:09:55+00:00 hourly 0.9 https://trial.medpath.com/news/oliceridine-demonstrates-non-inferior-analgesia-and-superior-safety-vs-sufentanil-in-post-cesarean-pcia 2026-07-13T17:09:25+00:00 hourly 0.9 https://trial.medpath.com/news/alzheimer-s-survivor-82-embarks-on-650-mile-walk-across-england-to-demonstrate-potential-of-precision-medicine-protocol 2026-07-13T16:08:44+00:00 hourly 0.9 https://trial.medpath.com/news/first-patient-treated-in-phase-2-a-tango-trial-evaluating-yaqrit-s-tlr4-antagonist-yaq005-for-acute-on-chronic-liver-failure 2026-07-13T15:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/alzheimer-s-research-leaders-highlight-fda-approved-therapies-blood-biomarkers-and-prevention-strategies-at-date-with-a-cure-2026 2026-07-13T15:08:23+00:00 hourly 0.9 https://trial.medpath.com/news/military-handheld-blood-test-device-i-stat-alinity-deployed-to-middle-east-for-rapid-tbi-diagnosis-in-15-minutes 2026-07-13T15:08:19+00:00 hourly 0.9 https://trial.medpath.com/news/spine-surgery-s-new-bottleneck-data-infrastructure-not-the-operating-room 2026-07-13T14:48:00+00:00 hourly 0.9 https://trial.medpath.com/news/delonix-bioworks-doses-first-participant-in-china-phase-1-trial-of-next-generation-menb-omv-vaccine-dx-104 2026-07-13T14:11:38+00:00 hourly 0.9 https://trial.medpath.com/news/decentralized-clinical-trials-gain-momentum-in-nutraceutical-sector-as-regulatory-scrutiny-intensifies 2026-07-13T14:11:29+00:00 hourly 0.9 https://trial.medpath.com/news/bright-minds-biosciences-to-present-5-ht2-agonist-pipeline-at-upcoming-investor-conferences 2026-07-13T14:10:55+00:00 hourly 0.9 https://trial.medpath.com/news/survey-finds-strong-majority-support-for-vet-supervised-biomedical-animal-research-in-the-u-s 2026-07-13T14:10:51+00:00 hourly 0.9 https://trial.medpath.com/news/xtalks-webinar-to-explore-how-patient-perceptions-of-normalcy-and-identity-drive-clinical-trial-recruitment-decisions 2026-07-13T14:10:34+00:00 hourly 0.9 https://trial.medpath.com/news/tumor-microenvironment-responsive-prodrugs-emerge-as-a-strategy-to-overcome-hcc-treatment-barriers 2026-07-13T14:10:00+00:00 hourly 0.9 https://trial.medpath.com/news/kim-v-narry-becomes-first-korean-and-asian-recipient-of-hfsp-nakasone-award-for-pioneering-mrna-tail-research 2026-07-13T13:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/drug-farm-secures-55-million-series-d-to-advance-ai-discovered-first-in-class-candidates-df-003-and-df-006 2026-07-13T12:12:40+00:00 hourly 0.9 https://trial.medpath.com/news/daily-cannabis-use-may-shift-the-brain-into-an-adapted-operating-state-new-research-suggests 2026-07-13T12:12:20+00:00 hourly 0.9 https://trial.medpath.com/news/global-consortium-c-brain-launches-open-source-ai-toolbox-to-tackle-alzheimer-s-99-drug-failure-rate 2026-07-13T12:11:07+00:00 hourly 0.9 https://trial.medpath.com/news/thiogenesis-receives-fda-rare-pediatric-disease-designation-for-tti-0102-in-leigh-syndrome 2026-07-13T11:09:24+00:00 hourly 0.9 https://trial.medpath.com/news/agenus-secures-up-to-340-million-to-advance-neoadjuvant-bot-bal-in-mss-colon-cancer-pivoting-away-from-metastatic-setting 2026-07-13T11:09:23+00:00 hourly 0.9 https://trial.medpath.com/news/sen-mitch-mcconnell-reveals-fall-led-to-hospitalization-cites-post-polio-condition-and-mild-pneumonia 2026-07-13T11:09:10+00:00 hourly 0.9 https://trial.medpath.com/news/global-study-of-214000-older-adults-reveals-striking-country-specific-patterns-in-dementia-risk-factors 2026-07-13T11:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/china-expands-personalized-cosmetic-service-pilot-to-23-provincial-level-regions 2026-07-13T11:08:52+00:00 hourly 0.9 https://trial.medpath.com/news/dynamic-single-cell-transcriptomic-analysis-reveals-immune-dysregulation-in-anti-nmdar-encephalitis 2026-07-13T10:12:15+00:00 hourly 0.9 https://trial.medpath.com/news/eu-veterinary-vaccine-and-pharmacovigilance-training-courses-target-regulatory-gaps-under-regulation-2019-6 2026-07-13T10:12:12+00:00 hourly 0.9 https://trial.medpath.com/news/uk-markey-cancer-center-and-lexington-clinic-renew-cancer-care-collaboration-through-2028 2026-07-13T10:11:42+00:00 hourly 0.9 https://trial.medpath.com/news/global-biotech-achieves-1-2-million-in-cloud-savings-through-sap-bw-optimization-with-capgemini 2026-07-13T10:11:01+00:00 hourly 0.9 https://trial.medpath.com/news/institute-of-cancer-research-staff-extend-historic-strike-over-pay-warn-of-existential-crisis 2026-07-13T10:10:54+00:00 hourly 0.9 https://trial.medpath.com/news/charting-intratumor-heterogeneity-from-bench-to-bedside-a-comprehensive-review 2026-07-13T10:10:47+00:00 hourly 0.9 https://trial.medpath.com/news/genedrive-completes-paloh-uk-recruitment-nearly-6000-babies-tested-for-antibiotic-induced-hearing-loss-risk 2026-07-13T10:09:48+00:00 hourly 0.9 https://trial.medpath.com/news/covid-19-vaccines-remain-effective-despite-helminth-induced-immune-modulation-preclinical-study-shows 2026-07-13T08:10:35+00:00 hourly 0.9 https://trial.medpath.com/news/faron-updates-bexmarilimab-iit-portfolio-blaze-switches-to-nivolumab-bexar-cleared-in-sarcoma-finprove-cohort-discontinued 2026-07-13T08:08:54+00:00 hourly 0.9 https://trial.medpath.com/news/eu-pharmaceutical-reforms-reshape-rare-disease-and-pediatric-drug-development-strategies 2026-07-13T08:08:45+00:00 hourly 0.9 https://trial.medpath.com/news/qatar-s-hmc-launches-in-house-whole-exome-sequencing-expands-precision-medicine-with-20-million-annual-diagnostic-tests 2026-07-13T08:08:42+00:00 hourly 0.9 https://trial.medpath.com/news/ondine-biomedical-s-lantern-phase-3-trial-meets-primary-endpoint-showing-40-reduction-in-surgical-site-infections 2026-07-13T07:07:58+00:00 hourly 0.9 https://trial.medpath.com/news/scenesse-r-afamelanotide-approved-by-health-canada-for-erythropoietic-protoporphyria 2026-07-13T06:10:00+00:00 hourly 0.9 https://trial.medpath.com/news/routine-eye-tests-lead-to-rare-uveal-melanoma-diagnoses-highlighting-access-gap-for-life-extending-chemosaturation-therapy-in-the-uk 2026-07-13T06:09:57+00:00 hourly 0.9 https://trial.medpath.com/news/new-global-catalogue-of-239-human-infective-rna-viruses-identifies-pathogens-with-greatest-pandemic-potential 2026-07-13T06:09:56+00:00 hourly 0.9 https://trial.medpath.com/news/ihh-healthcare-and-fortis-announce-winners-of-inaugural-india-focused-healthcare-startup-accelerator 2026-07-13T05:09:38+00:00 hourly 0.9 https://trial.medpath.com/news/over-half-of-gps-in-wales-say-they-routinely-cannot-meet-patient-demand-amid-severe-underinvestment 2026-07-13T05:09:35+00:00 hourly 0.9 https://trial.medpath.com/news/fda-advisory-panel-begins-review-to-loosen-restrictions-on-unapproved-peptides-amid-safety-concerns 2026-07-13T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/fda-to-convene-advisory-committee-to-review-sydnexis-s-syd-101-for-pediatric-progressive-myopia 2026-07-13T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/low-uptake-of-cascade-germline-testing-in-cancer-represents-a-public-health-emergency-experts-warn 2026-07-13T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/addressing-social-inequalities-in-cancer-screening-uptake-among-underserved-populations 2026-07-12T21:21:28+00:00 hourly 0.9 https://trial.medpath.com/news/cultural-safety-in-healthcare-evidence-shows-it-saves-lives-amid-new-zealand-regulatory-overhaul 2026-07-12T21:20:20+00:00 hourly 0.9 https://trial.medpath.com/news/sana-biotechnology-upgraded-to-hold-amid-mixed-analyst-sentiment-and-stock-volatility 2026-07-12T20:11:33+00:00 hourly 0.9 https://trial.medpath.com/news/apogee-ceo-sells-20000-shares-under-pre-existing-trading-plan-as-zumilokibart-phase-3-looms 2026-07-12T20:11:28+00:00 hourly 0.9 https://trial.medpath.com/news/ucsf-consolidates-pediatric-bone-marrow-transplants-in-san-francisco-sparking-access-concerns-for-east-bay-families 2026-07-12T20:10:22+00:00 hourly 0.9 https://trial.medpath.com/news/lifesci-capital-maintains-buy-rating-on-tenax-therapeutics-with-35-price-target 2026-07-12T19:07:58+00:00 hourly 0.9 https://trial.medpath.com/news/tilray-medical-launches-eu-gmp-cbd100-oral-solution-in-panama-expanding-medical-cannabis-access-across-latin-america 2026-07-12T19:07:37+00:00 hourly 0.9 https://trial.medpath.com/news/analysts-maintain-bullish-stance-on-insilico-medicine-with-price-targets-up-to-hk-77-50 2026-07-12T17:42:33+00:00 hourly 0.9 https://trial.medpath.com/news/thumbay-group-partners-with-geneva-college-of-longevity-science-to-launch-uae-s-first-academic-programs-in-longevity-medicine 2026-07-12T17:42:31+00:00 hourly 0.9 https://trial.medpath.com/news/hdt-bio-launches-canadian-phase-1-trial-of-hdt-401-a-locally-administered-rna-immune-activator-for-glioblastoma 2026-07-12T17:42:11+00:00 hourly 0.9 https://trial.medpath.com/news/prioritizing-women-s-brain-health-can-save-lives-and-global-economies-leading-alzheimer-s-organizations-warn 2026-07-12T17:41:41+00:00 hourly 0.9 https://trial.medpath.com/news/princess-of-wales-praises-wimbledon-finalist-continuing-to-compete-through-breast-cancer-treatment 2026-07-12T17:41:20+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-receptor-agonists-gain-traction-among-public-figures-for-weight-management-and-cardiometabolic-health 2026-07-12T17:39:56+00:00 hourly 0.9 https://trial.medpath.com/news/brexit-blocks-uk-children-from-accessing-life-extending-drug-trial-for-aggressive-brain-cancer 2026-07-12T15:08:08+00:00 hourly 0.9 https://trial.medpath.com/news/growing-concern-over-opioid-abuse-and-addiction-among-sickle-cell-disease-patients-in-nigeria 2026-07-12T15:08:06+00:00 hourly 0.9 https://trial.medpath.com/news/gum-disease-bacterium-p-gingivalis-linked-to-heart-valve-calcification-via-il-1b-pathway 2026-07-12T15:08:02+00:00 hourly 0.9 https://trial.medpath.com/news/hemab-therapeutics-unveils-hmb-002-proof-of-mechanism-data-in-vwd-and-announces-novel-antifibrinolytic-hmb-003-at-isth-2026 2026-07-12T15:08:00+00:00 hourly 0.9 https://trial.medpath.com/news/evaxion-unveils-preclinical-data-for-ai-designed-cmv-vaccine-candidate-evx-v1-featuring-novel-antigens 2026-07-12T15:07:47+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-crispr-therapeutics-casgevy-for-pediatric-use-expanding-gene-editing-market-potential 2026-07-12T11:06:32+00:00 hourly 0.9 https://trial.medpath.com/news/maharashtra-fda-bars-sale-of-two-cadila-drugs-over-brand-confusion-seizes-rs-2-45-crore-stock 2026-07-12T10:07:10+00:00 hourly 0.9 https://trial.medpath.com/news/fda-clearance-of-qiastat-dx-bloodstream-panel-marks-a-potential-turnaround-for-qiagen-s-syndromic-testing-franchise 2026-07-12T10:06:20+00:00 hourly 0.9 https://trial.medpath.com/news/feeder-free-til-expansion-platform-reduces-il-2-dependence-and-enhances-anti-tumor-efficacy-in-preclinical-study 2026-07-12T08:08:18+00:00 hourly 0.9 https://trial.medpath.com/news/beta-technologies-completes-first-evtol-flights-in-us-government-pilot-program-transporting-manufactured-organs-for-united-therapeutics 2026-07-12T07:07:59+00:00 hourly 0.9 https://trial.medpath.com/news/yale-scientists-identify-two-membrane-proteins-that-drive-parkinson-s-disease-spread-through-the-brain 2026-07-12T05:09:22+00:00 hourly 0.9 https://trial.medpath.com/news/insurance-supported-integrative-oncology-program-delivers-clinically-meaningful-symptom-relief-for-cancer-patients 2026-07-12T05:08:53+00:00 hourly 0.9 https://trial.medpath.com/news/fda-approves-sanofi-s-sarclisa-subcutaneous-formulation-offering-new-dosing-option-for-multiple-myeloma 2026-07-12T05:08:27+00:00 hourly 0.9 https://trial.medpath.com/news/psilocybin-therapy-shows-promise-for-anorexia-nervosa-in-early-stage-trial 2026-07-12T05:08:25+00:00 hourly 0.9 https://trial.medpath.com/news/cafc-affirms-107-5-million-patent-invalidation-enablement-gaps-in-wyeth-s-egfr-inhibitor-dosing-claims 2026-07-12T04:09:54+00:00 hourly 0.9 https://trial.medpath.com/news/the-iron-lung-is-gone-polio-isn-t-experts-warn-against-complacency-as-last-american-iron-lung-user-dies-at-78 2026-07-12T03:07:27+00:00 hourly 0.9 https://trial.medpath.com/news/reed-jobs-yosemite-targets-350m-second-fund-as-ai-collides-with-cancer-drug-discovery 2026-07-12T02:08:39+00:00 hourly 0.9 https://trial.medpath.com/news/bacteria-use-hydrogel-powered-escape-pods-to-survive-opening-new-avenues-against-antibiotic-resistant-biofilms 2026-07-12T02:08:21+00:00 hourly 0.9 https://trial.medpath.com/news/glucose-and-hba1c-mediate-obesity-pancreatic-cancer-link-uk-biobank-study-finds 2026-07-12T01:06:39+00:00 hourly 0.9 https://trial.medpath.com/news/non-invasive-brain-stimulation-significantly-improves-depression-in-just-10-days-placebo-controlled-trial-finds 2026-07-12T01:06:36+00:00 hourly 0.9 https://trial.medpath.com/news/former-mayo-clinic-director-alleges-ai-research-misconduct-data-manipulation-and-retaliation-in-federal-lawsuit 2026-07-12T01:06:30+00:00 hourly 0.9 https://trial.medpath.com/news/holy-see-calls-for-renewed-global-commitment-to-end-aids-warns-children-remain-disproportionately-vulnerable 2026-07-11T23:08:47+00:00 hourly 0.9 https://trial.medpath.com/news/financial-headwinds-mount-for-milestone-and-mirum-pharmaceuticals-as-both-burn-through-cash 2026-07-11T23:08:46+00:00 hourly 0.9 https://trial.medpath.com/news/cleveland-clinic-launches-first-long-term-prescription-drug-drone-delivery-program-by-a-u-s-health-system 2026-07-11T23:08:45+00:00 hourly 0.9 https://trial.medpath.com/news/cruise-ship-ultrafine-particles-promote-inflammation-and-viral-replication-study-finds 2026-07-11T23:08:37+00:00 hourly 0.9 https://trial.medpath.com/news/point-of-care-car-t-manufacturing-achieves-15-day-vein-to-vein-time-in-jordan-phase-ii-trial 2026-07-11T23:08:24+00:00 hourly 0.9 https://trial.medpath.com/news/study-links-oxalate-to-systemic-inflammation-and-heart-damage-via-il-17a-pathway-in-kidney-disease 2026-07-11T22:08:18+00:00 hourly 0.9 https://trial.medpath.com/news/medical-ai-ecosystem-innovation-forum-highlights-data-driven-transformation-in-healthcare-and-drug-discovery 2026-07-11T22:07:51+00:00 hourly 0.9 https://trial.medpath.com/news/gsk-s-efimosfermin-opens-two-phase-3-trials-targeting-mash-cirrhosis-signaling-a-shift-toward-disease-modifying-outcomes 2026-07-11T21:42:00+00:00 hourly 0.9 https://trial.medpath.com/news/kmt2-mutations-predict-immunotherapy-benefit-in-esophageal-adenocarcinoma-not-squamous-cell-carcinoma 2026-07-11T21:07:40+00:00 hourly 0.9 https://trial.medpath.com/news/bruce-power-wins-regulatory-approval-to-process-cancer-fighting-lutetium-177-on-site 2026-07-11T21:07:39+00:00 hourly 0.9 https://trial.medpath.com/news/tp53-mutation-drives-cd8-t-cell-exhaustion-and-therapy-resistance-in-urothelial-carcinoma 2026-07-11T21:07:37+00:00 hourly 0.9 https://trial.medpath.com/news/focused-ultrasound-foundation-launches-five-preclinical-projects-targeting-glioblastoma-liver-cancer-and-breast-cancer 2026-07-11T20:10:44+00:00 hourly 0.9 https://trial.medpath.com/news/dietary-intervention-reduces-bmi-regardless-of-genetic-obesity-risk-clinical-trial-finds 2026-07-11T20:10:20+00:00 hourly 0.9 https://trial.medpath.com/news/san-francisco-mayor-signs-legislation-expanding-drug-free-supportive-housing-to-combat-overdose-crisis 2026-07-11T20:10:12+00:00 hourly 0.9 https://trial.medpath.com/news/insurance-denials-for-brand-name-drugs-surge-67-over-six-years-jama-study-finds 2026-07-11T19:07:35+00:00 hourly 0.9 https://trial.medpath.com/news/federal-grants-expand-street-medicine-training-to-bring-care-directly-to-people-experiencing-homelessness 2026-07-11T19:07:26+00:00 hourly 0.9 https://trial.medpath.com/news/mohs-surgery-demonstrates-97-99-cure-rates-in-select-early-stage-melanoma-with-real-time-margin-control 2026-07-11T18:07:24+00:00 hourly 0.9 https://trial.medpath.com/news/im-ms-irradiation-reduces-breast-cancer-mortality-but-fails-to-improve-overall-survival-in-node-negative-disease-20-year-eortc-analysis 2026-07-11T17:09:30+00:00 hourly 0.9 https://trial.medpath.com/news/emcure-subsidiary-gennova-divests-mrna-business-to-immunoscript-for-139-crore-to-refocus-on-biosimilars 2026-07-11T17:09:25+00:00 hourly 0.9 https://trial.medpath.com/news/immunotherapy-achieves-complete-remission-in-pregnant-patient-with-stage-iv-melanoma-brain-metastasis 2026-07-11T17:09:17+00:00 hourly 0.9 https://trial.medpath.com/news/cu-anschutz-launches-phase-2-trial-of-cbd-formulation-for-restless-legs-syndrome 2026-07-11T17:08:35+00:00 hourly 0.9 https://trial.medpath.com/news/ibri-to-host-inaugural-2026-global-forum-on-science-philanthropy-and-investment 2026-07-11T17:08:34+00:00 hourly 0.9 https://trial.medpath.com/news/california-awards-1-8-million-to-launch-next-generation-precision-medicine-research-program 2026-07-11T17:08:19+00:00 hourly 0.9 https://trial.medpath.com/news/ed-expands-kerala-organ-trafficking-probe-summons-senior-doctors-from-transplant-evaluation-committees 2026-07-11T17:08:03+00:00 hourly 0.9 https://trial.medpath.com/news/fermented-foods-gain-scientific-and-regulatory-traction-as-gut-health-takes-center-stage 2026-07-11T12:32:00+00:00 hourly 0.9 https://trial.medpath.com/news/single-nucleus-transcriptomics-based-drug-screening-platform-identifies-candidate-compounds-for-focal-cortical-dysplasia 2026-07-11T11:06:05+00:00 hourly 0.9 https://trial.medpath.com/news/tel-aviv-researchers-identify-hidden-regenerative-cell-population-in-the-inner-ear-opening-new-path-to-hearing-restoration 2026-07-11T10:08:12+00:00 hourly 0.9 https://trial.medpath.com/news/former-ny-nurse-practitioner-hit-with-record-544000-penalty-for-falsifying-162-children-s-vaccination-records 2026-07-11T07:07:14+00:00 hourly 0.9 https://trial.medpath.com/news/experimental-off-the-shelf-t-cell-therapy-achieves-56-8-response-rate-in-rare-often-fatal-brain-infection 2026-07-11T06:09:48+00:00 hourly 0.9 https://trial.medpath.com/news/scale-up-not-lab-results-is-now-the-binding-constraint-on-synthetic-biology-s-commercial-future 2026-07-11T06:09:16+00:00 hourly 0.9 https://trial.medpath.com/news/fda-proposes-rule-to-streamline-distributed-manufacturing-registration-and-close-foreign-api-supply-chain-gaps 2026-07-11T06:08:51+00:00 hourly 0.9 https://trial.medpath.com/news/chryscapital-led-consortium-acquires-controlling-stake-in-novartis-india-via-off-market-transfer 2026-07-11T05:07:05+00:00 hourly 0.9 https://trial.medpath.com/news/dietary-supplement-regulation-what-the-2026-listing-bill-would-and-would-not-change 2026-07-11T04:08:20+00:00 hourly 0.9 https://trial.medpath.com/news/judicial-delay-in-landmark-ribociclib-access-case-petitioner-dies-as-kerala-high-court-lists-matter-57-times-without-final-hearing 2026-07-11T03:07:03+00:00 hourly 0.9 https://trial.medpath.com/news/hearing-loss-affects-1-in-4-adults-with-type-2-diabetes-systematic-review-reveals 2026-07-11T01:14:33+00:00 hourly 0.9 https://trial.medpath.com/news/pygo2-identified-as-key-driver-of-1q21-multiple-myeloma-progression-and-potential-therapeutic-target 2026-07-11T01:14:10+00:00 hourly 0.9 https://trial.medpath.com/news/countable-labs-and-promega-forge-co-marketing-agreement-to-streamline-rare-variant-detection-with-single-molecule-pcr 2026-07-11T01:14:04+00:00 hourly 0.9 https://trial.medpath.com/news/children-s-wisconsin-becomes-first-u-s-hospital-to-administer-avlayah-a-blood-brain-barrier-crossing-enzyme-replacement-therapy-for-hunter-syndrome 2026-07-11T00:07:49+00:00 hourly 0.9 https://trial.medpath.com/news/vanda-pharmaceuticals-to-participate-in-b-riley-securities-2026-mind-muscle-vision-summit 2026-07-10T22:09:19+00:00 hourly 0.9 https://trial.medpath.com/news/uva-health-becomes-first-in-virginia-to-offer-hepzato-for-uveal-melanoma-with-liver-metastases 2026-07-10T21:17:00+00:00 hourly 0.9 https://trial.medpath.com/news/federal-340b-drug-discount-program-saves-uc-davis-health-289-million-expands-patient-access-to-vital-medications 2026-07-10T21:11:20+00:00 hourly 0.9 https://trial.medpath.com/news/targeting-neuroinflammation-in-spinal-cord-injury-from-inflammatory-mechanisms-to-pharmacological-interventions 2026-07-10T21:10:42+00:00 hourly 0.9 https://trial.medpath.com/news/state-medical-boards-say-ai-is-not-ready-for-independent-licensure-urge-physician-accountability 2026-07-10T21:10:37+00:00 hourly 0.9 https://trial.medpath.com/news/biotech-rally-poised-to-continue-as-innovation-obesity-market-and-m-a-drive-sector-momentum 2026-07-10T21:10:34+00:00 hourly 0.9 https://trial.medpath.com/news/trump-nominee-for-hhs-preparedness-role-questioned-vaccine-safety-raising-confirmation-clash 2026-07-10T21:10:12+00:00 hourly 0.9 https://trial.medpath.com/news/google-s-sensorfm-a-trillion-minute-foundation-model-that-rivals-clinical-lab-tests-for-wearable-health-ai 2026-07-10T21:10:11+00:00 hourly 0.9 https://trial.medpath.com/news/the-primary-care-crisis-paradox-medpac-data-challenges-prevailing-narrative-on-u-s-healthcare-reform 2026-07-10T20:09:33+00:00 hourly 0.9 https://trial.medpath.com/news/rural-radiation-oncology-clinic-closures-threaten-cancer-patient-care-across-the-u-s 2026-07-10T19:15:42+00:00 hourly 0.9 https://trial.medpath.com/news/maia-biotechnology-advances-site-specific-radioimmunoconjugate-platform-as-insiders-and-analysts-signal-confidence 2026-07-10T19:15:33+00:00 hourly 0.9 https://trial.medpath.com/news/eosinophil-diversity-unveiled-single-cell-atlas-reveals-distinct-subtypes-and-novel-therapeutic-targets 2026-07-10T19:15:25+00:00 hourly 0.9 https://trial.medpath.com/news/novartis-to-cut-up-to-130-jobs-in-basel-as-it-discontinues-small-scale-biologics-production 2026-07-10T19:15:24+00:00 hourly 0.9 https://trial.medpath.com/news/warburg-pincus-nears-7-billion-acquisition-of-rare-disease-specialty-pharmacy-pantherx-rare 2026-07-10T19:15:22+00:00 hourly 0.9 https://trial.medpath.com/news/precise-consortium-launches-to-build-predictive-cancer-vulnerability-maps-across-europe 2026-07-10T18:12:15+00:00 hourly 0.9 https://trial.medpath.com/news/blue-led-light-and-textbook-chemistry-enable-two-for-one-carbon-modification-accelerating-complex-drug-synthesis 2026-07-10T18:12:12+00:00 hourly 0.9 https://trial.medpath.com/news/wvu-and-johns-hopkins-launch-rural-health-research-series-with-focus-on-social-prescribing-and-cardiovascular-health-in-pregnancy 2026-07-10T18:12:11+00:00 hourly 0.9 https://trial.medpath.com/news/trimaster-crossover-trial-shows-routine-clinical-data-may-outperform-diabetes-subtypes-for-precision-prescribing 2026-07-10T18:10:57+00:00 hourly 0.9 https://trial.medpath.com/news/fda-issues-complete-response-letter-for-elevar-s-rivoceranib-camrelizumab-combination-in-first-line-hcc 2026-07-10T18:10:48+00:00 hourly 0.9 https://trial.medpath.com/news/niche-targeted-yap-taz-activation-offers-new-paradigm-for-bone-marrow-regeneration-after-myeloablative-therapy 2026-07-10T18:10:46+00:00 hourly 0.9 https://trial.medpath.com/news/glp-1-medications-in-adolescents-balancing-early-obesity-treatment-against-unanswered-long-term-questions 2026-07-10T18:10:39+00:00 hourly 0.9 https://trial.medpath.com/news/winn-clinical-investigator-pathway-program-launches-fifth-cohort-to-diversify-the-clinical-trial-workforce 2026-07-10T18:10:37+00:00 hourly 0.9 https://trial.medpath.com/news/asco-publishes-first-ever-guideline-on-ctdna-testing-in-solid-tumors-and-lymphoma 2026-07-10T18:09:43+00:00 hourly 0.9 https://trial.medpath.com/news/scientists-identify-microrna-signatures-that-predict-stem-cell-therapy-response-in-knee-osteoarthritis 2026-07-10T16:47:00+00:00 hourly 0.9 https://trial.medpath.com/news/fda-staffing-crisis-and-policy-chaos-threaten-u-s-biomedical-innovation-leadership-congressional-hearing-reveals 2026-07-10T16:13:33+00:00 hourly 0.9 https://trial.medpath.com/news/longevity-industry-moves-to-establish-its-own-regulatory-framework 2026-07-10T16:13:24+00:00 hourly 0.9 https://trial.medpath.com/news/senate-review-scrutinizes-federal-handling-of-covid-19-vaccine-safety-signals-through-vaers 2026-07-10T16:12:21+00:00 hourly 0.9 https://trial.medpath.com/news/ai-powered-histology-biomarker-predicts-aggressiveness-in-muscle-invasive-bladder-cancer 2026-07-10T16:11:59+00:00 hourly 0.9 https://trial.medpath.com/news/one-in-five-u-s-workers-tested-positive-on-hair-drug-tests-in-2025-while-fentanyl-positivity-fell-by-nearly-half 2026-07-10T16:11:27+00:00 hourly 0.9 https://trial.medpath.com/news/greenland-mines-secures-australian-patent-for-klotho-based-gene-therapy-targeting-als-and-neuromuscular-diseases 2026-07-10T16:11:10+00:00 hourly 0.9 https://trial.medpath.com/news/vmd-launches-digital-pharmacovigilance-reporting-platform-for-animal-medicines-industry 2026-07-10T16:10:50+00:00 hourly 0.9 https://trial.medpath.com/news/probiotic-micro-pellets-market-poised-to-reach-1-1-billion-by-2036-on-11-3-cagr 2026-07-10T16:10:33+00:00 hourly 0.9 https://trial.medpath.com/news/un-women-reports-1-million-women-and-girls-cut-off-from-life-saving-aid-amid-global-funding-crisis 2026-07-10T16:10:27+00:00 hourly 0.9 https://trial.medpath.com/news/phelan-mcdermid-syndrome-prevalence-estimated-at-1-in-7300-far-higher-than-previously-thought 2026-07-10T14:17:52+00:00 hourly 0.9 https://trial.medpath.com/news/ifebemtinib-plus-garsorasib-shows-82-orr-and-22-month-pfs-in-first-line-kras-g12c-mutant-nsclc 2026-07-10T12:10:07+00:00 hourly 0.9 https://trial.medpath.com/news/automated-liquid-handling-technologies-market-to-reach-us-7-4-billion-by-2034-driven-by-ai-integration-and-drug-discovery-demand 2026-07-10T12:09:41+00:00 hourly 0.9 https://trial.medpath.com/news/bausch-lomb-halts-glaucoma-program-for-bl1107-eye-drops-after-phase-2-miss-shifts-focus-to-geographic-atrophy-implant 2026-07-10T11:09:26+00:00 hourly 0.9 https://trial.medpath.com/news/united-therapeutics-builds-momentum-with-positive-teton-1-data-in-ipf-and-pipeline-expansion 2026-07-10T08:09:18+00:00 hourly 0.9 https://trial.medpath.com/news/jiva-pharma-ceo-om-prakash-goel-honored-by-marquis-who-s-who-for-six-decades-of-drug-discovery-innovation 2026-07-10T08:09:14+00:00 hourly 0.9 https://trial.medpath.com/news/fda-and-medtech-industry-agree-on-mdufa-vi-draft-commitment-letter-with-faster-pre-submission-pathway-and-enhanced-performance-goals 2026-07-10T08:08:05+00:00 hourly 0.9 https://trial.medpath.com/news/world-first-study-shows-hifu-is-safe-and-promising-for-treating-twin-to-twin-transfusion-syndrome 2026-07-10T08:08:01+00:00 hourly 0.9 https://trial.medpath.com/news/ovid-therapeutics-reshapes-executive-leadership-to-drive-next-phase-of-cns-pipeline-development 2026-07-10T07:07:30+00:00 hourly 0.9 https://trial.medpath.com/news/frog-gut-bacterium-ewingella-americana-achieves-100-tumor-elimination-in-mice-with-a-single-dose 2026-07-10T06:08:23+00:00 hourly 0.9 https://trial.medpath.com/news/fasting-activates-gut-microbe-akk-to-prime-intestinal-repair-after-radiation-injury 2026-07-10T06:07:53+00:00 hourly 0.9 https://trial.medpath.com/news/hlb-s-liver-cancer-drug-rivoceranib-hits-third-fda-setback-over-manufacturing-compliance-issues 2026-07-10T06:07:50+00:00 hourly 0.9 https://trial.medpath.com/news/rural-healthcare-must-move-beyond-hospitals-ai-first-care-models-and-structural-transformation-needed 2026-07-10T04:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/antitrust-battle-over-enbrel-monopoly-escalates-as-amici-clash-in-fourth-circuit-appeals 2026-07-10T03:08:03+00:00 hourly 0.9 https://trial.medpath.com/news/hillsboro-medical-center-to-close-one-of-oregon-s-three-geriatric-psychiatry-units-amid-staffing-crisis 2026-07-10T03:07:55+00:00 hourly 0.9 https://trial.medpath.com/news/katalin-kariko-traces-mrna-journey-from-discovery-to-therapeutic-revolution-at-75th-lindau-nobel-laureate-meeting 2026-07-10T03:07:48+00:00 hourly 0.9 https://trial.medpath.com/news/first-line-ici-combinations-show-encouraging-response-but-no-definitive-survival-benefit-in-advanced-pancreatic-cancer 2026-07-10T00:00:00+00:00 hourly 0.9 https://trial.medpath.com/news/dengue-cases-surge-to-record-14-6-million-in-2024-as-climate-change-drives-mosquito-borne-diseases-into-new-regions 2026-07-09T23:09:52+00:00 hourly 0.9 https://trial.medpath.com/news/spatial-proteomics-market-poised-to-reach-usd-29-97-billion-by-2034-driven-by-precision-oncology-and-high-plex-imaging 2026-07-09T23:09:20+00:00 hourly 0.9 https://trial.medpath.com/news/biohaven-reshapes-scientific-leadership-pirman-promoted-to-head-of-discovery-car-transitions-to-chief-innovation-officer 2026-07-09T23:08:36+00:00 hourly 0.9 https://trial.medpath.com/news/microneedle-technology-poised-to-transform-transdermal-drug-delivery-as-clinical-evidence-mounts 2026-07-09T23:07:37+00:00 hourly 0.9 https://trial.medpath.com/news/six-gene-signature-in-hidden-liver-micrometastases-may-predict-colorectal-cancer-recurrence-risk 2026-07-09T22:10:10+00:00 hourly 0.9 https://trial.medpath.com/news/space-station-bioprinting-breakthrough-human-liver-and-kidney-tissues-manufactured-in-orbit-for-the-first-time 2026-07-09T22:09:39+00:00 hourly 0.9 https://trial.medpath.com/news/nanoparticles-navigating-the-blood-brain-barrier-a-new-frontier-in-neurodegenerative-disease-therapy 2026-07-09T22:09:38+00:00 hourly 0.9 https://trial.medpath.com/news/20-20-biolabs-charts-path-toward-medicare-reimbursement-for-onetesttm-mced-blood-test-reports-strong-q2-revenue-growth 2026-07-09T22:08:32+00:00 hourly 0.9 https://trial.medpath.com/news/postoperative-pain-pipeline-2026-over-40-companies-advance-novel-therapies-with-extended-release-and-non-opioid-candidates 2026-07-09T21:08:23+00:00 hourly 0.9 https://trial.medpath.com/news/delcath-systems-doses-first-patient-in-phase-2-deluma-trial-of-hepzato-for-liver-dominant-metastatic-breast-cancer 2026-07-09T20:13:05+00:00 hourly 0.9